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Background: Dementia and diabetes mellitus are common long-term conditions that coexist in a large
number of older people. People living with dementia and diabetes may be at increased risk of
complications such as hypoglycaemic episodes because they are less able to manage their diabetes.
Objectives: To identify the key features or mechanisms of programmes that aim to improve the
management of diabetes in people with dementia and to identify areas needing further research.
Design: Realist review, using an iterative, stakeholder-driven, four-stage approach. This involved scoping
the literature and conducting stakeholder interviews to develop initial programme theories, systematic
searches of the evidence to test and develop the theories, and the validation of programme theories with
a purposive sample of stakeholders.
Participants: Twenty-six stakeholders (user/patient representatives, dementia care providers, clinicians
specialising in dementia or diabetes and researchers) took part in interviews and 24 participated in a
consensus conference.
Data sources: The following databases were searched from 1990 to March 2016: MEDLINE (PubMed),
Cumulative Index to Nursing and Allied Health Literature, Scopus, The Cochrane Library (including the
Cochrane Database of Systematic Reviews), Database of Abstracts of Reviews of Effects, the Health Technology
Assessment (HTA) database, NHS Economic Evaluation Database, AgeInfo (Centre for Policy on Ageing – UK),
Social Care Online, the National Institute for Health Research (NIHR) portfolio database, NHS Evidence, Google
(Google Inc., Mountain View, CA, USA) and Google Scholar (Google Inc., Mountain View, CA, USA).
Results: We included 89 papers. Ten papers focused directly on people living with dementia and diabetes,
and the rest related to people with dementia or diabetes or other long-term conditions. We identified six
context–mechanism–outcome (CMO) configurations that provide an explanatory account of how interventions
might work to improve the management of diabetes in people living with dementia. This includes embedding
positive attitudes towards people living with dementia, person-centred approaches to care planning, developing
skills to provide tailored and flexible care, regular contact, family engagement and usability of assistive devices.
A general metamechanism that emerges concerns the synergy between an intervention strategy, the dementia
trajectory and social and environmental factors, especially family involvement. A flexible service model for people
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with dementia and diabetes would enable this synergy in a way that would lead to the improved management
of diabetes in people living with dementia.
Limitations: There is little evidence relating to the management of diabetes in people living with dementia,
although including a wider literature provided opportunities for transferable learning. The outcomes in our
CMOs are largely experiential rather than clinical. This reflects the evidence available. Outcomes such as
increased engagement in self-management are potential surrogates for better clinical management of
diabetes, but this is not proven.
Conclusions: This review suggests that there is a need to prioritise quality of life, independence and patient
and carer priorities over a more biomedical, target-driven approach. Much current research, particularly that
specific to people living with dementia and diabetes, identifies deficiencies in, and problems with, current
systems. Although we have highlighted the need for personalised care, continuity and family-centred
approaches, there is much evidence to suggest that this is not currently happening. Future research on the
management of diabetes in older people with complex health needs, including those with dementia, needs
to look at how organisational structures and workforce development can be better aligned to the needs of
people living with dementia and diabetes.
Study registration: This study is registered as PROSPERO CRD42015020625.
Funding: The NIHR HTA programme.
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Glossary
Context The condition that influences the success or failure of an intervention or programme.
Mechanism The generative force that leads to outcomes; that which influences the reasoning and
behaviours of people.
Mid-range theory Delimited in its area of application, the intermediate between a working hypothesis
for testing and an all-inclusive grand theory.
Outcome A pattern resulting from the interplay between context and mechanism.
Programme theory Practical and specific to each programme or intervention, it specifies the components
of a programme (or intervention) intended to mitigate or resolve the problem and the expected outcomes.
Realist synthesis The process of evidence review that follows the realist approach (also known as
realist review).
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Research
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Plain English summary
Both dementia and diabetes mellitus are common in older people and many people may be living withboth conditions. People living with dementia can find it more difficult to manage their diabetes. They
are at increased risk of diabetes-related problems such as low blood sugar. Family members often help
them to manage their diabetes.
In this study, evidence about the management of diabetes in people living with dementia was reviewed to
find out what might work, how, why and in what contexts. Engaging with stakeholders throughout, we
developed an initial ‘theory’ or idea about how interventions for people living with both dementia and
diabetes should work. This idea was then tested and refined through a structured search for evidence.
We then went back to the stakeholders to test out the findings of the review and refine them further.
The findings from this study indicate that services for people living with dementia and diabetes need to
consider the following points.
l Self-management support for people with dementia and diabetes should focus on abilities and building
confidence; the involvement of family carers is key.
l Health-care professionals need to have the skills to provide care that is tailored to the needs and
priorities of the people with dementia and diabetes.
l Regular contact with a supportive health-care professional is likely to improve management of diabetes
in people with dementia and can help to identify if they are having problems managing their diabetes.
l Family carers are likely to be involved in care and may need support and diabetes-related education.
Further research in this area needs to look at how services can better fit with the needs of people with
dementia and diabetes and their family carers.
l Technology needs to be tailored to the needs of people with dementia and their family carers,
for example by promoting independence.
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Scientific summary
Background
Dementia and diabetes mellitus are common long-term conditions that may coexist in a large number of older
people. People with dementia may be less able to understand and manage their diabetes and may be at risk of
complications such as hypoglycaemic episodes, cardiovascular conditions and amputations, which place a huge
burden on health and social care economies. Moreover, the impact of dementia and diabetes on patients and
their families is considerable. There is a need to consider what kind of programmes or interventions are needed
for the effective management of diabetes in people with dementia, including how interventions work, for
whom and in what contexts, and how interventions might be tailored to this patient group.
Objectives
The overall objectives were to identify key features or mechanisms of programmes and approaches that
aim to improve the management of diabetes in people with dementia, to understand how those
mechanisms operate in different contexts to achieve particular outcomes for this population, to make
explicit the barriers to, and facilitators of, implementation and to identify areas needing further research.
Methods
The review followed recognised realist principles and published guidance. We used an iterative four-stage
approach that optimised the knowledge and networks of the research team. Stakeholders were involved in
developing the scope of the review, refining the review questions, developing the programme theory and
interpreting the evidence. The four phases were as follows:
1. Development of initial programme theories through a first scoping of the literature and consultation
with key stakeholder groups (user/patient representatives, dementia-care providers, clinicians, dementia
and diabetes researchers, and diabetes specialists).
2. Systematic searches of the evidence to test and develop the theories identified in phase 1. Data sources
(searched with a date range of 1990 to March 2016) included MEDLINE (PubMed), Cumulative Index to
Nursing and Allied Health Literature, Scopus, The Cochrane Library (including the Cochrane Database of
Systematic Reviews), DARE (Database of Abstracts of Reviews of Effects), the Health Technology
Assessment (HTA) database, NHS EED (NHS Economic Evaluation Database), AgeInfo (Centre for Policy
on Ageing – UK), Social Care Online, the National Institute for Health Research (NIHR) portfolio
database, NHS Evidence, Google (Google Inc., Mountain View, CA, USA) and Google Scholar (Google
Inc., Mountain View, CA, USA).
3. Validation of programme theories with a purposive sample of participants from phase 1. This involved
face-to-face interviews and a consensus conference.
4. Development of actionable recommendations for the management of diabetes in people living
with dementia.
Results
We included 89 papers, 10 of which focused directly on our target group of people living with dementia
and diabetes. The majority of the remaining evidence related to people with dementia or diabetes or other
long-term conditions and was included because of the opportunities it provided for transferable learning.
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Our review has resulted in six context–mechanism–outcome (CMO) configurations that provide an
explanatory account of how interventions might work to improve the management of diabetes in people
living with dementia. Although designed to be specific to people with dementia, the CMOs are also likely
to be transferable to other groups who experience problems with diabetes management, for example
older people with complex health and social care needs.
Context–mechanism–outcome 1: embedding positive attitudes towards people living
with dementia
Health and social care systems need to foster a belief in health-care professionals (HCPs), people living with
dementia and their family carers that people living with dementia have the potential to be involved in self-
management (SM). Components of SM interventions that are likely to be important for people with dementia
and diabetes include focusing on strengths and abilities, being emotion focused rather than problem focused,
respecting autonomy and working to build confidence and empowerment. The involvement of family carers in
programmes is key, but it is important to balance the needs of the person with dementia and the carer to
ensure that people living with dementia are not disempowered. More research is needed relating to SM in
people living with dementia and diabetes.
Context–mechanism–outcome 2: person-centred approaches to care planning
The SM of diabetes in people with dementia is likely to be contingent on the development of trusting
relationships between HCPs and the person with dementia and their family, involving understanding and
incorporating patient priorities and how this may change over time. This in turn facilitates a person-centred
approach to care planning and diabetes management. There is currently little research that looks at a
person-centred approach to diabetes management in people living with dementia. Further research is
needed to develop interventions that support partnership working and that incorporate the consideration
of the risk–benefit balance for different treatment options.
Context–mechanism–outcome 3: developing skills to provide tailored and flexible care
To be able to provide flexible and individualised care for people living with dementia and diabetes, HCPs
need to prioritise communication, negotiation and partnership working. They need to be provided with
appropriate training and support so that they have the confidence to focus more on quality of life and
patient abilities and less on biometrics and clinical targets. However, currently the evidence to link this with
glycaemic control or a reduction in adverse diabetes-related events is limited.
Context–mechanism–outcome 4: regular contact
Continuity of care and regular contact are important for people with dementia and those with diabetes,
but they are likely to be even more critical for those with both conditions. Continuity can help professionals
recognise times of transition (e.g. worsening symptoms of dementia impacting on diabetic control and
increased risk of hypoglycaemia) and provide patients and family caregivers with appropriate support.
Ensuring that all professionals have expertise in dementia and diabetes would be difficult; collaborative
practice is likely to be necessary for people with both conditions, particularly for more complex cases such
as people who are insulin dependent or those with advanced dementia.
Context–mechanism–outcome 5: family engagement
Self-management for people with dementia and diabetes needs to be conceptualised as an activity that
frequently involves not just the person with dementia but also their family members. Interventions need to
take into account the needs and capabilities of family carers and the anxieties associated with managing
medication and diet and preventing adverse events such as hypoglycaemic attacks. Including the family
carers of people with dementia and diabetes should be the default option, and they should be included
early, when the person living with dementia still has the capacity to decide and before SM breaks down.
Context–mechanism–outcome 6: usability of assistive technology
Evidence suggests that to make assistive technology usable to both people living with dementia and
diabetes and their families, it needs to be focused on the needs of the user (e.g. maintaining autonomy),
SCIENTIFIC SUMMARY
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involve people with dementia and their carers in its development, and include family carers in installation
and training. Telehealth and telecare should be designed to involve (as the default option) care partners
such as other members in the family network. Appropriate support in the form of face-to-face contact
appears to be an important contextual factor that may lead to improved motivation and adherence.
Summary of context–mechanism–outcome configurations
The CMOs require changes in individual or organisational behaviour or understanding, and in many cases
both. For example, CMO 3 – which focuses on skills development – requires the development of skills at an
individual level but also organisational changes that legitimise the importance of those skills and allow the time
for them to be acquired and practised. The outcomes we specified in the protocol for this synthesis included a
number of clinical outcomes, such as the prevention of hypoglycaemia, the management of cardiovascular risk
factors and the identification and management of long-term complications such as neuropathy. However, the
outcomes that emerged from the evidence available are primarily experiential rather than clinical, focusing on
the need to trigger mechanisms such as trust, confidence and empowerment.
Conclusions
This realist synthesis provides a theory-driven understanding of the factors influencing the management
of diabetes in people living with dementia and the conditions under which interventions are more likely to
be successful. A general metamechanism that emerges is that there is some form of synergy between
an intervention strategy, disease progression (in particular the progression of dementia) and social and
environmental factors, in particular the involvement of family members. We suggest that a flexible service
model for people with dementia and diabetes would enable this synergy in a way that would lead to
improved management of diabetes in people living with dementia.
This review suggests that there is a need to prioritise quality of life, independence and patient and carer
priorities over a more biomedical, target-driven approach. Much of the research included in this review,
particularly that specific to people living with dementia and diabetes, identifies deficiencies in, and
problems with, current systems. Although we have highlighted the need for personalised care, continuity
and family-centred approaches, there is much evidence to suggest that this is not currently happening.
Future research on the management of diabetes in older people with complex health needs, including
those with dementia, needs to look at how organisational structures and workforce development can be
better aligned to the needs of people with dementia and diabetes.
The priority for HCPs is how to accommodate the challenges of living with dementia as a long-term
condition with the minimum requirements of good diabetic control, recognising that perceptions of ‘good’
are situation specific, differ for people with dementia and for family carers, and will change over time. This
review suggests that there is a need for further work to establish a shared understanding of what needs to
be in place to engage effectively with people living with dementia, including those with diabetes, and their
supporters to establish how ‘good support’ is operationalised and measured.
Implications for practice
l Self-management for people with dementia and diabetes needs to be conceptualised as an activity that
frequently involves not just the person with dementia but also their family members. Therefore, SM
should include the identification of family carers, appropriate training in carer engagement for staff,
and protocols regarding confidentiality and information sharing.
l Self-management support needs to be seen as a legitimate activity by HCPs. Pathways should be
adapted to enable the regular assessment of SM capabilities and provide appropriate SM support for
people living with dementia and diabetes and for their family carers.
DOI: 10.3310/hta21750 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 75
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Bunn et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
xxiii
l Family carers are likely to require diabetes-specific education and advice, for example on the appropriate
timing of medication and access to food, how to recognise the common signs and symptoms of
hypoglycaemia and how to distinguish between symptoms of dementia and those of diabetes.
l Staff caring for people with diabetes need appropriate training on dementia and how this might have
an impact on the management of diabetes. This applies to staff at all levels, including more senior staff.
l Health-care professionals caring for people with dementia and diabetes need education in enablement
approaches to SM.
l Health-care professionals caring for people with dementia and diabetes need to regularly assess patients’
ability to self-manage and identify when they, or their family carer, may need additional support.
l Health-care professionals caring for people with dementia and diabetes may need training or
guidance on how to incorporate ideas about deprescribing and minimally disruptive medicine
(e.g. the management of uncertainty).
l There is a need for better integration of physical and mental health-care systems, that is, old-age
psychiatry teams and geriatric teams working together and community-based geriatric and frailty teams
having specialist mental health staff as an integral part of the team.
l People with dementia and diabetes who live alone, or who do not have family support, may be
particularly disadvantaged and may need additional help and monitoring from health and care staff.
l People with dementia and diabetes are likely to benefit from longer appointments, both in primary and
secondary care, and booking systems should allow for this.
l People living with dementia and diabetes, particularly those who live alone, are likely to need regular
(preferably face-to-face) contact with HCPs who are familiar with their needs and problems.
Suggestions for future research
A number of potential areas for future research were identified by the review. These are listed in order
of priority.
l What is the impact of SM interventions for people with dementia and diabetes that involve family carers?
l What interventions can be used to improve medication management in people with dementia and
diabetes and their family carers; for example, what is the impact of pharmacist-led interventions?
l What sort of care pathway is most appropriate and effective [e.g. a specific dementia and diabetes
pathway or a pathway for older adults with complex needs (vulnerability pathway)]?
l What sort of support do family caregivers of people with dementia and diabetes want, and how can
interventions be designed to reflect this?
l How can professionals caring for people with dementia and diabetes be helped to recognise when a
person is no longer able to self-manage, or when there is a need to ‘gear-up’ or ‘gear-down’ support?
l What are important outcomes and goals for people with dementia and diabetes and for their family carers?
l How can assistive technology support SM for people with dementia and diabetes and how do their
needs change as the dementia trajectory progresses?
l How does the stage/extent of cognitive and physical impairment have an impact on the uptake and
outcomes of interventions?
l Are interventions that take an assets-based approach to the care of people with dementia and diabetes
(e.g. promoting confidence, empowerment, independence) more effective?
Study registration
This study is registered as PROSPERO CRD42015020625.
Funding
Funding for this study was provided by the HTA programme of the NIHR.
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Chapter 1 Background
This chapter includes text from the protocol, which was published by Bunn et al.1 This article is distributedunder the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.
org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons
license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless
otherwise stated.
Introduction
Dementia and diabetes mellitus are common long-term conditions that may coexist in a large number of
older people.2,3 People with dementia may be less able to understand and manage their diabetes and may be
at risk of complications such as hypoglycaemic episodes, cardiovascular conditions and amputations,4–6 which
place a huge burden on health and social care economies.7 Moreover, the impact of dementia and diabetes
on patients and their families is considerable. There is a need to consider what kind of programmes or
interventions are needed for the effective management of diabetes in people with dementia, including how
interventions work, for whom and in what contexts; the barriers to, and facilitators of, the effective
management of diabetes in people living with dementia; and how interventions might be tailored to this
patient group.
Dementia and diabetes in older people
In the UK, there are an estimated 850,000 people living with dementia,8 the most common form being
Alzheimer’s disease.9 The number is forecast to exceed 2 million by 2050.10 The prevalence of diabetes
mellitus in the UK is also rising rapidly: since 1996, the number of people diagnosed with diabetes has
more than doubled, from 1.4 million to almost 3.5 million.11,12 The risk of both conditions increases with
age. Dementia affects 1 in 20 people aged > 65 years and 1 in 5 people aged > 80 years.13 In 2010, the
prevalence of all types of diabetes was 0.4% in people aged 16–24 years, rising to 15% of people aged
70–84 years.14 Owing to the high prevalence rates of both conditions in older people, they may inevitably
coexist. A scoping review found data to suggest that rates of diabetes in people with dementia are
between 13% and 20%.2
There is increasing evidence that diabetes – in particular type 2 diabetes – is associated with an increased
risk of cognitive impairment and dementia. Observational studies report that type 2 diabetes is associated
with both of the major subtypes of dementia, with an approximate 2.5-fold increased risk of incident
vascular dementia and a 1.5-fold increased risk of Alzheimer’s disease.15,16 The association between vascular
dementia and diabetes is not entirely surprising because diabetes is a risk factor for lacunar infarction and
major stroke, and vascular disease is an essential aetiological factor of vascular dementia.15 Although the
underlying pathological pathways between type 2 diabetes and Alzheimer’s disease are not entirely clear,
it is thought that metabolic factors may play a role,15 leading to Alzheimer’s disease being labelled by some
as ‘type 3 diabetes’.17
Dementia has been consistently and independently associated with an increased risk of hypoglycaemia,18,19
possibly because of an increased likelihood of errors in self-medication (e.g. with insulin or sulphonylurea
treatments), irregular eating habits and an inability to recognise and treat hypoglyceamia.20 Furthermore,
there are a number of age-related changes that may affect diabetes treatment and management. Deficits in
renal and liver functioning associated with increasing age can have an impact on medication effectiveness,
making the older person either more or less sensitive to a drug’s potency.21 In addition, older people may be
DOI: 10.3310/hta21750 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 75
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Bunn et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
1
more likely to demonstrate ‘hypoglycaemic unawareness’, whereby the central nervous system shows
greater insensitivity to hypoglycaemic symptoms.22 Hypoglycaemia is a serious cause of morbidity and
mortality in frail older people23 and may increase the risk of robust individuals with diabetes becoming
frail.24 The relationship between dementia, frailty and hypoglycaemia is complex, and it has recently
been reviewed.25
Current guidance on the management of diabetes in people
with dementia
Clinical guidance on the management of diabetes in older adults26–30 suggests that glycaemic targets should
be individualised for older people and that care should be personalised to take into account factors such as
age, dementia, frailty, comorbidities and polypharmacy.31 However, despite this guidance, and although the
harms of intensive treatment are likely to exceed the benefits for older people with complex or poor health
status, a substantial proportion of older adults is potentially overtreated.32 This may be because clinicians are
not aware of existing guidelines, because they are uncertain about when and how to de-intensify diabetes
medications and/or because they apply performance targets [such as the Quality and Outcomes Framework
(QOF)] to the management of older people with diabetes rather than individualising care.33
Self-management
The main approach to the management of long-term conditions such as diabetes revolves around
self-management (SM) strategies that focus on the attitudes and self-efficacy of the patient. The successful
SM of chronic conditions is based on the idea that the patient collaborates with health-care professionals
(HCPs) in the management of the condition, allowing the patient to become knowledgeable about their
condition, share in decision-making and receive educational support.34 In relation to diabetes, self-care
has been defined as ‘an evolutionary process of development of knowledge or awareness by learning to
survive with the complex nature of the diabetes in a social context’,35 and consists of seven key behaviours:
healthy eating, being physically active, monitoring blood sugar, complying with medications, good
problem-solving skills, healthy coping skills and risk-reduction behaviours.36
Although SM is well established as fundamental to the management of long-term conditions, there has
been a paucity of literature about SM for people living with dementia. This may be due to the general
belief of the ‘hopelessness’ of dementia promulgated by both professionals and lay people, coupled with
limited research focusing on the daily needs and lives of those living with dementia.37 Recently, these
negative perceptions of people living with dementia have been challenged, and a more strength-based
approach drawing on personhood has emerged.38 There are, however, clearly differences between the
skills needed to self-manage dementia and those required for diabetes, and people living with dementia
are often reliant on others, usually family carers, to facilitate their access to services and support and to
help them manage the condition.39
Although there are differences in the physical and cognitive effects of the different types of dementias, all are
usually progressive, involve increasing physical and mental deterioration, and lead to a person with dementia
becoming increasingly dependent, all of which has an impact on their ability to understand and manage their
diabetes.2,4,6 Dementia has an impact on a person’s ability to undertake self-care management tasks such as
managing medication, monitoring blood glucose and maintaining a healthy-eating regimen.39–41 There are
additional difficulties related to insulin management. Interviews conducted as part of a recent National Institute
for Health Research (NIHR) study suggest that, as people living with dementia become unable to manage their
own medication, they find injections distressing and painful.39 The situation can be further complicated by
the presence of behavioural and psychological symptoms which may have an impact on diabetes self-care
regimens42 and lead to dementia becoming the focus of attention to the detriment of diabetes management.43
Physical frailty or end-stage dementia compounds the complexity of diabetes management, with decisions
BACKGROUND
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needing to be made about whether to maintain strict treatment or consider admission into nursing home
care.44 Therefore, for people with dementia, SM needs to be conceptualised as a multidimensional, complex
phenomenon affecting individuals, dyads and families, and interventions may need to target family carers.41,45
Rationale for the research
As the population ages and the proportion of people with dementia and diabetes increases, the delivery of
health and social care for this group becomes increasingly complex and challenging.39 There is, however,
currently no systematic approach to the management of dementia and diabetes,28 and many care pathways
for diabetes do not take into account the needs of people with dementia.46 Moreover, there is a gap in
provision of services in mental health trusts for diabetes care and, similarly, a gap in acute hospital trusts for
dementia care.28 Recent guidance on the management of diabetes in people with dementia outlines a
number of recommendations, including better case-finding of both conditions, better training for staff,
adequate carer support, and care that is tailored to the needs of the individual.28,31 However, currently there
is little research evaluating interventions to improve the management of diabetes in people living with
dementia; indeed, many diabetes-related studies exclude people with dementia or cognitive impairment.
Interventions designed to improve the management of diabetes in people with dementia are likely to be
multicomponent, specific to different stages of the dementia trajectory, and dependent on the behaviours
and choices of those delivering and receiving the care. They are also likely to be contingent on contextually
situated decision-making. There is a need, therefore, to synthesise the different strands of research
evidence in order to develop a theoretical understanding of the realities of working in and across complex,
overlapping systems of care, and why and how different interventions may work. Realist synthesis is a
systematic, theory-driven approach that aims to make explicit the mechanism(s) of how and why complex
interventions work (or not) in particular settings or contexts.47–49 Realist synthesis takes account of a broad
and eclectic evidence base including the experiential and clinical knowledge that relates to the physiology
and management of diabetes in older people, and specifically older people with dementia.
Aims and objectives
The overall aim was to identify the key features or mechanisms of programmes and approaches that aim
to improve the management of diabetes in people with dementia, to understand how those mechanisms
operate in different contexts to achieve particular outcomes for this population, to make explicit the
barriers to and facilitators of implementation, and to identify areas needing further research.
We used an iterative four-stage approach that optimised the knowledge and networks of the research team.
The synthesis was based on the stages set out by Pawson et al.48,50 and follows the Realist and Meta-narrative
Evidence Syntheses: Evolving Standards (RAMESES) publication standards.47 The objectives were to:
1. identify how interventions, or elements of interventions, to manage diabetes in people with dementia
are thought to work, on what range of outcomes (i.e. organisational, resource use, and patient care
and safety) and for whom they work (or why they do not work) and in what contexts
2. identify the barriers to and facilitators of the acceptability, uptake and implementation of interventions
designed to manage diabetes in people with dementia
3. establish what evidence there is on the feasibility and potential value of interventions to manage
diabetes in people with dementia
4. establish what is known about the design of diabetes management technologies and identify the
potential benefits of involving end-users (people with dementia and their carers) in their development.
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Chapter 2 Methods
This chapter includes text from the protocol, which was published by Bunn et al.1 This article is distributedunder the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.
org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons
license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless
otherwise stated.
We used an iterative four-stage approach that optimised the knowledge and networks of the research
team. The review was based on the stages for realist review set out by Pawson et al.50 and follows the
RAMESES publication standards for realist syntheses.47 Figure 1 provides an overview of the study design.
Rationale for using realist approach
The rationale for using a realist synthesis approach is that interventions for the management of diabetes
in people living with dementia are likely to be multicomponent and will be dependent on the behaviours and
choices of those delivering and receiving the care. Realist review is a theory-driven interpretive approach to
evidence synthesis47,48,51 that assumes that there is more to reality than how we see it. There is an external
reality or world that can be observed and measured, but how this reality is articulated and responded to is
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FIGURE 1 Summary of study design.
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constantly being shaped by individuals’ perceptions and reasoning and/or dominant social and cultural
mores. It is this constant interaction that creates particular responses that lead to observed outcomes.52
Realist synthesis, therefore, endeavours to go beyond lists of barriers to and enablers of care, to unpack
the ‘black box’ of how interventions might help people living with dementia manage their diabetes. The
much-repeated statement used to explain the focus and purpose of realist synthesis is that it makes explicit
‘what works, for whom, why and in what circumstances’. It uses a theory-driven approach to articulate how
particular contexts (C), including resources, have prompted certain mechanisms (M) or responses to lead to
the observed outcomes (O). The iterative process of the review tests those theories that are thought to work
(initial programme theory) against the observations reported in the evidence included in the syntheses.53 The
definitions of key realist terminology used in the review are provided in Box 1. The review process results in
the emergence of ‘demi-regularities’ or patterns, which provide insight into how interventions work or not,
and in what contexts. A realist synthesis enables us to take account of a broad evidence base, including
experiential and clinical knowledge that relates to the physiology and management of diabetes in older
people, and specifically older people living with dementia.
Changes in the review process
As recommended in the RAMESES publication standards,47 changes in the review process are documented
in Table 1.
Phase 1: defining the scope of the realist review – concept mining and
theory development
In phase 1, we were concerned with developing an initial programme theory/theories or hypotheses
about why diabetes management programmes for people living with dementia work or do not work.
This scoping or concept mining involved a variety of evidence sources, including the commissioning brief,
policy/guidance and grey and published literature. In addition, we consulted with a range of content
experts via interviews with stakeholders and discussions with the Research Management Team (RMT) and
Project Advisory Group (PAG). The PAG included experts in the fields of diabetes, dementia, older people’s
BOX 1 Definitions of realist terms and how they have been applied in the review
l Context (C): the ‘backdrop’ conditions (which may change over time), for example provision of training in
diabetes and/or dementia care delivery systems. Context can be broadly understood as any condition that
triggers and/or modifies the behaviour of a mechanism.
l Mechanism (M): a mechanism is the generative force triggered in particular contexts that leads to outcomes.
Often denotes the reasoning (cognitive or emotional) of the various ‘actors’ (i.e. people living with dementia
and diabetes, relatives and HCPs). Mechanisms are linked to, but are not the same as, a service’s strategies or
interventions. Identifying the mechanisms goes beyond describing ‘what happened’ to theorising ‘why it
happened, for whom and under what circumstances’.
l Outcomes (O): the outcome is a result of the interaction between a mechanism and its triggering context.
This may include greater engagement in SM behaviours or a reduction in adverse events.
l Programme theory: those ideas about what needs to be changed or improved in how diabetes is managed
for people living with dementia, what needs to be in place to achieve an improvement(s) and how
programmes are believed to work. It specifies what is being investigated and the elements and scope of
the review.
METHODS
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health and realist methods (see Appendix 1). The first RMT meeting included an open discussion in which
the team were asked to draw on their expertise to articulate:
1. the dominant approaches and assumptions that informed current thinking about what supported the
management of diabetes in people living with dementia
2. important outcomes.
Scoping interviews
To complement the expertise provided by the team, we interviewed 19 stakeholders (Table 2).
In the first instance, stakeholders were identified through the clinical and research networks of the RMT
and PAG. A process of snowballing was used to identify additional participants.
Interview procedures
Interviews were conducted either face to face or via telephone by one of three researchers (FB, PRJ and
BR). Participants were given a copy of the study information sheet, which provided contact details of the
TABLE 1 Revisions to the protocol
Protocol Revisions/changes Agreed
The inclusion criteria stated that
we would include people ‘resident
in the community or a care home
or other long-term setting’
At the second project workshop (involving eight
members of the RMT) it was decided that further
refinement was needed of the inclusion and
exclusion criteria. The RMT felt that the issues
of managing diabetes for people living with
dementia in care homes are different from those
for people living in their own homes and that
literature relating to care homes should
be excluded
Research management team
(April 2016) and supported by
the PAG. The PAG agreed that
the decision was appropriate
because there were significant
differences between the
two environments
The protocol stated that in phase 3
we would review the hypotheses
and supporting evidence through
telephone interviews with up to
15 stakeholders
We conducted only seven individual interviews
in phase 3. However, in addition, hypotheses
(CMOs) and supporting evidence were presented
and discussed at a consensus meeting involving
24 participants
CMO, context–mechanism–outcome; PAG, Project Advisory Group; RMT, Research Management Team.
TABLE 2 Rationale for selection of stakeholder groups
Group Rationale
1. Clinicians with a special interest in the management of
diabetes in older people
To understand organisational process and protocols and
current ‘best practice’ for older people with diabetes.
To be aware of factors which facilitate the implementation
of guidelines
2. Providers of care in primary and secondary care
(e.g. diabetes specialist nurses, GPs and other clinicians)
To gain the perspectives of clinicians who are likely to be
providing diabetes care for people living with dementia
3. User representatives, including recipients of care and their
family carers, and relevant diabetes or dementia charities
To give the closest possible approximation of the views of
people living with dementia and diabetes
4. Dementia specialists from primary, secondary and tertiary
care and the voluntary sector (e.g. old-age psychiatrists,
dementia specialist nurses and GPs with an interest in
dementia)
To understand organisational process and protocols and
current ‘best practice’ for caring for people living with
dementia. To be aware of factors which facilitate the
implementation of guidelines
5. Academics and those involved in developing education
and guidance for older people with diabetes
To ensure that we are up to date with the most relevant
current research
GP, general practitioner.
DOI: 10.3310/hta21750 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 75
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Bunn et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
7
research team, and a consent form, which they were asked to read and sign. Interviews were conducted
using an interview schedule and were audio-recorded and transcribed. Ethics approval was obtained from
the University of Hertfordshire Health and Human Sciences Ethics Committee with delegated authority
(CSK/SF/UH/00106). The interview schedules were designed to explore:
l participants’ experiences of (a) working with people living with dementia and diabetes, (b) living with
dementia and diabetes or (c) acting as an informal carer to someone with dementia and diabetes
l current problems and challenges facing people and families who have to manage dementia and
diabetes, and what needs to be in place to address the effects of dementia
l what good diabetes care looks like for people living with dementia and what is needed to achieve it
l changes required to improve the management of diabetes in people living with dementia.
First search and mapping of the literature
Literature for the scoping was initially drawn from a number of sources. This included searches recently
undertaken for a scoping review for a NIHR study about dementia and comorbidity2 and for the development
of clinical guidance on dementia and diabetes.28 These were supplemented by a search of ProQuest Pro
(2010–December 2015): this contains 13 databases, including British Nursing Index, PsycINFO and SocialSciences
collection; Cumulative Index to Nursing and Allied Health Literature (CINAHL), MEDLINE, EBSCOhost, Web of
Science, The Cochrane Library, Health Technology Assessment (HTA) database, National Institute for Health and
Care Excellence guidelines and Google Scholar (Google Inc., Mountain View, CA, USA). Key words used in
the searches included dementia OR Alzheimer’s disease OR vascular dementia OR mild cognitive impairment
OR MCI OR frail elderly OR severe mental illness AND diabetes, T1DM OR T2DM AND self-management OR
self-care OR chronic illness OR case-management OR assistive technology OR telemedicine/care OR family carer
OR social support OR eating/meal times OR medicine management OR adherence OR exercise/leisure, OR health
and social care professionals.
Records were originally categorised as diabetes biology/pathophysiology, candidate theories, case management,
SM and technology. Portable Document Format (PDF) files of potentially relevant papers were stored in a private
group on Mendeley (Elsevier, Amsterdam, the Netherlands) to which all members of the research team had
access. Records were screened by two reviewers independently (from FB, PRJ, BR and DT) and decisions were
recorded on a Microsoft Excel® (Microsoft Corporation, Redmond, WA, USA) spreadsheet. Disagreements were
resolved by discussion.
The initial scoping of the literature produced minimal research that investigated how diabetes is managed
in people living with dementia, apart from the recognition that cognitive decline may be accelerated in
people with diabetes. As an initial step to literature scoping, a framework was required that could link the
management of diabetes (in older people) to the management of dementia (mild cognitive impairment to the
end of life). Following the first project management meeting, a potential conceptual framework was identified
based on the work of Glass and McAtee54 and extended by Greenhalgh et al.55 This framework was used
as a way of identifying key theories that could influence the management of dementia and diabetes care and
linking the management of diabetes (in older people) and the management of dementia (mild cognitive
impairment to the end of life). The framework highlights the complex influences that affect the management
of diabetes in people living with dementia (Figure 2) and was used as a guide to ‘sketch the terrain’47 to be
investigated and, through this process, to assist in refining the elements and scope for the review.
From the literature and from listening to stakeholder transcripts, a series of explanatory accounts were built
up that contained ‘if–then’ statements that helped to specify context and mechanism. ‘If–then’ statements
are the identification of an intervention/activity linked to outcome(s), and they contain references to contexts
and mechanisms (although these may not be very explicit at this stage) and/or barriers and enablers (which
can be both mechanism and context).56 The ‘if–then’ statements provided a helpful way of structuring our
thinking. They also helped to focus the process of taking ideas and assumptions about how interventions
work and testing them against the evidence we found. Initially, we generated 20 ‘if–then’ statements,
which, after further discussion, were reduced to three (Box 2).
METHODS
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The ‘if–then’ statements were discussed with the PAG members, who made several suggestions that
influenced our thinking and the development of our theory areas. For example, they suggested that we
map what constitutes good diabetes care (e.g. that specified in current guidelines) against the barriers
created by dementia. Members also felt that the review should not be too biomedically focused.
Structural influences
Physical, biological and psychological
Patient/family action
Macro
Micro
Diagnosis of
dementia and
diabetes
Technological
support
Access to
services:
integration and
flexibility
Assessment
strategy
Medication
regime
Availability of family support
Cultural/social norms
Professional expectations
Medical vs. social care models
Carer burden
Self-
management
abilities
Stigma
Self-efficacy Adherence
Patient workload vs. patient capacity
Burden of illness and treatment
Diabetes
presentation
and prior
experience
Cognitive
abilities
Type of
dementia
Physiological
status
Patient and family perceptions of dementia and 
diabetes illness representation
Physical
status (e.g.
frailty, other
comorbidities)
MCI, 
early-stage
dementia
End of life
Empowerment
FIGURE 2 Nested hierarchy of influences around diabetes management in people living with dementia. MCI, mild
cognitive impairment.
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9
In response, we mapped ideas about ‘good’ diabetes care against the barriers for people living with dementia
identified by the literature and the stakeholder interviews. We also identified potential interventions and
emerging theory (Figure 3). This became theory area 1: clinically based approach. Theory area 1 was,
however, felt to be rather biomedically focused, and additional theory areas around supportive partnerships
(theory area 2) and coproduction (theory area 3) were developed to reflect other areas identified in the
scoping. Figure 4 provides an overview of all of the initial theory areas.
Phase 2: retrieval, review and synthesis
Searching processes
In phase 2 we undertook systematic searches of the evidence to test and develop the theories identified in
phase 1. The main inclusion criteria were:
l people with mild, moderate or advanced dementia [of any type, e.g. Alzheimer’s disease, vascular
dementia, Lewy body dementia, Parkinson’s disease dementia, frontotemporal dementia (Pick’s disease)
and alcohol-related dementia] and type 1 or type 2 diabetes, resident in the community
l studies of any intervention designed to promote the management of diabetes in people living with
dementia and the prevention of potential adverse effects associated with poorly managed diabetes,
such as falls, blindness, vascular complications and renal failure
BOX 2 If–then statements
1. If interventions designed to promote SM use a comprehensive toolbox approach tailored to individual needs
(including, for example, skill building, education, how to manage emotions, and coping mechanisms), then
the person living with dementia and diabetes (and their family/carers) is (are) more likely to engage positively
with managing their diabetes because they feel more in control (are more autonomous, confident,
motivated, empowered), which results in (for the individual):
l greater self-esteem
l being better equipped/adaptive to change
l better quality of life
l less dependency on (health and social care) services.6,28,57–64
2. If models of care reflect a person-centred partnership approach (incorporating holism, and that are
participatory, relational), and are balanced (with focus on diabetes management, therapeutic alliance), then
relationships between the person living with dementia and diabetes (and family/carers) and HCPs are more
likely to be effective because there is mutual trust and understanding and better communication between
them, which results in:
l increased self-efficacy for the individual
l improvement in well-being and feeling of place in society for the individual
l better management of care for the HCPs.64–69
3. If local specialist and primary services reflect a seamless approach that is responsive and accessible for people
living with dementia and diabetes (including having the right systems, processes and people in place), then
the person (and their family/carers) and the HCP will feel better supported and informed, which results in:
l better engagement with services for the individual
l increased confidence for the HCPs in care management.59,70–73
METHODS
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Individualised
care plan
Education and
information
Dietary management
Blood glucose
measurement and
targets
Exercise
Being invested in
Programme
theory
Potential
interventions
Barriers for
PLWD
Components
of good care
Tailor the knowledge
Give me a choice and
help me remember
Key themes
Keep it simple and safe
Pushing the limits,
positive encounters
•  Current pathways do
    not take into account
    needs of PLWD
•  Do not routinely
    involve family
    members
•  Needs may change as
    dementia worsens
•  People living with
    dementia may have
    poorer access to care
•  Loss of previous SM skills
    or unable to develop
    new skills
•  Current education not
    appropriate (e.g.
    group based, does
    not include the
    family carer)
•  Dementia has an 
    impact on awareness 
    of importance of diet
•  Forget to eat or eat
    more than once
•  Unable to co-ordinate
    diet and medication
•  Loss of appetite or
    change in preferences
•  High risk of
    hypoglycaemia
•  Hypoglycaemia can
    exacerbate confusion
•  Lack of hypo
    awareness
•  Frailty/physiological
    changes
•  Loss of ability to test 
    blood sugar
•  May refuse testing
•  Lose awareness of
    importance of
    exercise
•  Safety concerns 
    (e.g. wandering)
•  Needs prompting/
    reminding
•  Not clear what best
    type/intensity/
    frequency of 
    programme
•  Assessment and
    review
•  Involve family
•  Include the needs of
    people living with
    dementia in guidance
•  Person-centred care
•  Regular monitoring
•  Person-centred, personalised care tailored to needs of person living with dementia and family carer
•  Supportive relationships with HCPs – continuity important
•  Shared decision-making involving person living with dementia and family carer (e.g. around setting goals, medication), therapeutic alliance, 
    focus on quality of life and safety
•  Regular assessment and review
•  Supportive strategies/technology
•  Multidisciplinary working/integrated working/teamworking
•  Involve family in
    education
•  Tailor education to
    people living with
    dementia
•  Focus on promoting
    independence, choice
•  Routine/reminders
•  Take preferences into
    account
•  Continuity of support
    from social care
•  Monitoring and
    assessment
•  Focus on safety/quality
    of life
•  Simplify routines
•  Technology
•  Reminders/routine
•  Involve family carer
•  Strategies to
    maintain/promote
    self-efficacy
•  Tailored
•  Promote social
    inclusion
FIGURE 3 Good diabetes care mapped against potential barriers, interventions and emerging programme theory areas. PLWD, people living with dementia.
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l studies that provide evidence on barriers to, and facilitators of, the implementation and uptake of
interventions designed to improve the physical health of people living with dementia (e.g. dementia-friendly
initiatives, the impact of the cognitive vs. behavioural and psychological symptoms of dementia and the
impact of the progression of dementia on family carers and service providers)
l studies that offer opportunities for transferable learning, such as those that evaluate interventions for
people living with dementia and other clinical conditions, or those that look at the way in which
services are delivered and implemented for people living with dementia (e.g. interventions to improve
access or continuity, tailor care to the needs of individuals with dementia or support family carers).
The purpose of the searches was not to identify an exhaustive set of studies but rather to be able to reach
conceptual saturation in which sufficient evidence was identified to meet the aims of the review.74 A
diversity of evidence provides an opportunity for richer data mining and theory development. Therefore,
we included studies of any design, including randomised controlled trials (RCTs), controlled studies,
uncontrolled studies, interrupted time series studies, cost-effectiveness studies, process evaluations,
surveys, and qualitative studies of participants’ views and experiences of interventions. We also included
grey literature, policy documents and information about locally implemented programmes in the UK. As is
usual with a realist review, the process of identifying relevant information and deciding what to include
was iterative, involving tracking backwards and forwards between the literature and our review
questions.50 As such, the identification of relevant literature carried on during the course of the review, and
some studies initially thought to be relevant were later excluded.
The search terms were devised in conjunction with an information scientist and chosen to reflect the
theory areas identified in phase 1. The searches were split into three main categories:
l A – theory areas + dementia AND diabetes
l B – theory areas + dementia
l C – theory areas + diabetes.
TA3: coproduction
TA2: supportive partnership
Shared
decision-
making
Best
interests
SM
Risk based
Service as
it is now
Transitions in
cognitive
functioning
Levering
services to fit
with the
preferences
and
experiences of
people living
with dementia 
and diabetes and
their families
TA1: clinically based approach
FIGURE 4 Initial programme areas that emerged from phase 1. TA, theory area.
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The main searches were category A, which included terms for the theory areas combined with both
dementia and diabetes. However, because the scoping had identified little literature that covered both
dementia and diabetes, we also searched for literature that focused on the theory areas and either dementia
only (B searches) or diabetes only (C searches). As a result of discussions at the second project team
workshop, an additional search was conducted (search D). This focused on tailored and individualised care
for people with complex health needs (e.g. comorbidity and frailty). For full search terms, see Appendix 2.
For searches A, B and C, we searched the following electronic databases from 1990 to March 2016:
MEDLINE (PubMed), CINAHL, Scopus, The Cochrane Library (including the Cochrane Database of Systematic
Reviews), DARE (Database of Abstracts of Reviews of Effects), the HTA database, NHS EED (NHS Economic
Evaluation Database), AgeInfo (Centre for Policy on Ageing – UK), Social Care Online, the NIHR portfolio
database, NHS Evidence, Google (Google Inc., Mountain View, CA, USA) and Google Scholar. For search D,
we searched PubMed, CINAHL, Scopus, Google Scholar and The Cochrane Library (1990–April 2016).
An alert was set up in PubMed so that the team received weekly updates of new records identified by the
search terms (March 2016–December 2016).
Previous dementia reviews undertaken by members of the project team have highlighted the importance
of lateral searching for identifying studies for dementia-related reviews.75 Therefore, in addition to the
electronic database searches, we undertook lateral searches, which included checking reference lists, and
citation searches using the ‘cited by’ option on Google and the ‘related articles’ option on PubMed.
Selection and appraisal of documents
Search results were downloaded into bibliographic software and, when possible, duplicates were deleted.
Records from search A were split into two files and each file was screened independently by two reviewers
(file 1 by PRJ and DT and file 2 by FB and BR). After each pair of reviewers had discussed the results of their
screening, all four authors met to resolve any disagreements and amend the inclusion criteria as necessary.
Records from the other searches (B and C) were screened by one reviewer, with 10% checked by a second.
When studies appeared potentially relevant, PDF files were obtained, stored in Mendeley and screened by two
reviewers. To enable us to keep track of the large number of records screened, and the changes in inclusion
criteria, decisions made at different times were recorded in the Microsoft Excel spreadsheet created in phase 1.
Data extraction
A bespoke data extraction form was developed based on our three main theory areas. The form was piloted
on six records by team members (FB, PRJ, BR and DT) and further refined as necessary. Once the final
fields for data extraction were agreed, an electronic version was created in Microsoft Access® (Microsoft
Corporation, Redmond, WA, USA). The data extraction form included fields relating to study aims, design
and methods, the types of participants (e.g. dementia only, diabetes only, dementia and diabetes, other),
outcomes, information relevant to the theory areas, and emerging context–mechanism–outcomes (CMOs)
(see Appendix 3). Data were extracted by one reviewer, with 50% checked by a second. It should be noted
that ‘data’ in a realist sense are not just restricted to the study results or outcomes measured. Therefore,
author explanations and discussions can provide a rich source, or ‘nugget’, of ‘data’, and these were
included in the data extraction form.
A test of whether or not to include an item in a realist review is to use ‘good enough and relevant enough’.76
For a previous realist review,77 members of the research team created a set of constructs to ensure that the
test of ‘good enough and relevant enough’ was transparent and clear to all team members. ‘Good enough’
was deconstructed as the quality of evidence expressed through fidelity, trustworthiness and value. ‘Relevant
enough’ related to the contribution of the evidence to the theories and its potential contribution to the
review. This set of constructs was added to the data extraction form in the form of a flow chart.
Analysis and synthesis processes
Realist reviews identify the task of synthesis as one of refining theory. Programmes operate through highly
elaborate implementation processes. A realist review starts with a preliminary understanding of those
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processes, the initial programme theories (phase 1), and then seeks to refine them by extracting and
evaluating the identified literature (phase 2).
The analytical task involved synthesising across the extracted information the relationships between
mechanisms (e.g. underlying processes, structures and entities), contexts (e.g. conditions, types of setting,
organisational configurations) and outcomes (i.e. intended and unintended consequences and impact).
From the data fields in Microsoft Access, tables were constructed as the basis for further discussions about
the emerging contingencies seen within and across the extracted data. These data were discussed with the
wider RMT during a second half-day workshop. From these tables, we attempted to identify prominent
recurrent patterns of contexts and outcomes (demiregularities) in the data and then sought to explain
these through the means (mechanisms) by which they occurred.78 This deliberative and iterative process
enabled iteration from plausible hypotheses to the uncovering of potential CMO configurations.
The research team (FB, PRJ and BR) managed this extraction and synthesis process on a day-to-day basis,
with regular consultation [via e-mail and telephone/SkypeTM (Microsoft Corporation, Redmond, WA, USA)
conferencing]. Data synthesis involved individual reflection and team discussion that:
1. questioned the integrity of each theory
2. adjudicated between competing theories
3. considered the same theory in different settings
4. compared the stated theory with actual practice.
Phases 3 and 4: test and refine programme theories (validation) and
develop actionable recommendations
To enhance the trustworthiness of the resultant hypotheses, and to develop a final review narrative to
address what is necessary for the effective implementation of programmes to manage diabetes in people
living with dementia, we reviewed the hypotheses and supporting evidence through consultation with the
PAG and with stakeholders, some of whom had participated in the scoping. Stakeholder consultation was
carried out by telephone interviews (n = 7) and by group discussions at a consensus conference involving
24 participants. Participants at the conference were purposively sampled to ensure that all of the key
stakeholder groups in phase 1 were represented.
Consensus conference
The meeting began with a presentation from the research team in which the development of the hypotheses
was outlined. This was followed by small group discussions about the proposed CMO configurations.
Participants were split into three groups, with each including a mix of specialists in dementia and diabetes
and at least one service user representative. Each group included two members of the research team, one to
facilitate the group and one to take notes. At this stage there were six CMOs and each group was asked
to focus on two. To encourage a quick generation of ideas, participants had just 10 minutes to write their
recommendations on the ideas templates. The templates required participants to name what they thought
the CMO might look like in practice (what needs to be in place), and what were the priorities and mediating
factors. The facilitator for each group then asked participants to share their thoughts and these were
recorded by the note-taker. Finally, the conference facilitator consolidated the recommendations by asking
each of the groups to put forward their ideas to the larger group. Recommendations were discussed and
recorded on a flip chart at the front of the room.
Following the consensus conference, members of the core project team (FB, PRJ and BR) met to review and
discuss the outputs of the conference and amend the CMOs as appropriate. The revised CMOs were then
checked against data from the literature and against transcripts of all the stakeholder interviews. The final
CMOs and the supporting evidence are presented in Chapter 3.
METHODS
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Patient and public involvement
A well-established Public Involvement in Research Group at the University of Hertfordshire trains and
provides support to public members and has a broad membership of service users and carers. Two members
of this group (Dr Paul Millac and Mrs Diane Munday), both of whom have experience of caring for a family
member with dementia and/or diabetes, were involved throughout the project. They were involved in
defining the scope of the review (e.g. commenting on stakeholder interview transcripts), overseeing the
project as members of the PAG and verifying findings as participants at the consensus meeting. As part of
the realist review process, we also recruited additional patient and public involvement representatives for
stakeholder interviews and the consensus conference. They were involved in defining the scope of the
review and validation of the findings.
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Chapter 3 Results
Description of studies
We included 89 papers.25,28,30,37,39,42,43,45,57–73,79–142 These comprised 79 research papers and 10 guidelines or
discussion pieces. Other papers cited in this chapter are for background information and did not undergo
full data extraction. Twenty-two of the 79 research papers were reviews. Of those, 15 were systematic
reviews,79,80,82,84,89,90,93,101,125–127,131,132,137,143 one was a realist review134 and six were non-systematic
reviews.25,37,45,66,73,105 The rest of the research papers (n = 57) related to primary research. Several studies
were reported in more than one publication: the 57 primary research papers reported 51 studies. The main
types of primary research were qualitative studies, RCTs or controlled studies. The rest were a mix of
designs, including feasibility studies, surveys, before-and-after studies and observational studies. Ten
papers25,28,39,42,59,64,66,83,123,142 focused on people living with dementia and diabetes; the rest were concerned
with diabetes (n = 32), dementia (n = 31) or other groups, such as those with chronic illness or frailty.
An overview of the selection process can be seen in Figure 5.
Of the 57 papers reporting primary research, the majority were from the UK (n = 2928,39,60,67,85–87,91,92,97,103–105,
109–111,115,118–121,123,132,133,138–142), the USA (n = 1842,45,59,62–64,68,70,71,81,98–100,107,112,116,117,140) or Europe (n = 1058,61,72,95,
96,106,113,114,122,124). As there was limited literature directly relevant to our target group, which we had
anticipated, we included studies that offered opportunities for transferable learning, for example SM
strategies for people living with dementia or diabetes care for older people. This evidence offered the
opportunity to consider which challenges or issues were specific to people with dementia and diabetes and
which were more general to other populations with diabetes (e.g. related to visual or sensory loss or other
Reason for exclusion 
• Background not review, n = 27
• Diabetes as risk factor for dementia, n = 16
• Not relevant to theory areas/no added
   value, n = 80
• Not relevant to population/setting, n = 55
• Discussion piece, n = 19
• Protocol, n = 20
• Full paper not available, n = 2
• Not in English, n = 1
• Failed on rigour/relevance after full data
   extraction, n = 36
 
Potentially relevant
papers: hard
copies screened
(n = 345)
Focus of included item
• Diabetes, n = 32
• Dementia/CI, n = 31
• Dementia and diabetes, n = 10
• Chronic illness/frailty/older
   people, n = 16
Excluded at initial
screening of hard copies
(n = 220)
Excluded after data
extraction
(n = 36)
Final number included
(n = 89)
Number of electronic database records
screened
(n = 23,847)
• Search A (dementia and diabetes), n = 3637
• Search B (dementia only), n = 9152
• Search C (diabetes only), n = 8826
• Search D (tailored care), n = 2232
+ extensive lateral screening
FIGURE 5 Flow chart detailing study selection process. CI, cognitive impairment.
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age-related problems). The types of papers we included, together with a summary of areas on which they
focused and the sorts of outcomes they reported, can be seen in Table 3. Further details of individual
studies are provided in Appendix 4. It is worth noting that much of the evidence on which we drew,
particularly that relating to people with dementia and older people with diabetes, was detailing the
absence or lack of care for these groups. Therefore, although there is literature that makes
recommendations about what ought to be in place for these vulnerable groups, there is a lack of evidence
that tests out these ideas.
Context–mechanism–outcome configurations
The theory development, refinement and testing process (see Chapter 2) led to the development of six
CMO configurations (Table 4). Together, these explanations or hypotheses constitute a programme theory
about ‘what works’ (or ‘what might work’) in the management of diabetes in people living with dementia.
These CMO configurations were developed from evidence taken from interviews and the literature, and
then were further tested in the literature and verified with stakeholders. The CMOs are not mutually
exclusive and we would suggest that it is how the different elements of each interact that is important.
We now present each of the six CMOs in more detail. Further evidence supporting the CMOs can be
seen in Appendices 5 and 6; this includes evidence from the papers (see Appendix 5) and interviews
(see Appendix 6).
TABLE 3 Overview of included studies and papers by focus, methodological approach and types of outcomes
reported
Focus Included studies Methodological approach Types of outcomes
Dementia AND
diabetes (n= 10)
l Clinical guidance on
management of
diabetes in people
living with dementia
l Impact of dementia
on SM
l SM support for people
with CI
Abdelhafiz et al., 201625 l Three literature reviews
l One controlled
(not randomised) study
l One guideline
l Two qualitative
l One description of a service
l One cross-sectional survey
l One mixed methods
l HbA1c level
l Hypoglycaemia
l Impact of dementia on SM
Note that only one study
evaluated an intervention
(Camp et al.59)
Brown et al., 201583
Bunn et al., 201639
Bunn et al., 2017142
Camp et al., 201559
Feil et al., 200942
Feil et al., 201164
Hackel, 201366
Sachar, 2012123
Sinclair et al., 201428
Dementia NOT diabetes
(n = 31)
Includes:
l SM support for people
living with dementia
l Support for family carers
l Medication management
l Home-based support
for people living with
dementia (e.g. delivered
by an OT)
l Cognitive rehabilitation
Alsaeed et al., 201679 l Nine qualitative
l Nine SRs
l Seven RCTs (three papers
reported one study)
l Six other
Patient outcomes include:
l Cognitive function
l SM-related behaviours
such as knowledge and
self-efficacy (but not diabetes
focused)
l Quality of life
l Experiences and views
l Mood
Bahar-Fuchs et al., 201380
Boots et al., 201482
Boots et al., 201661
Clare et al., 201385
Clare et al., 201086
Dhedi et al., 201487
Dugmore et al., 201589
Fleming and Sum, 201490
Gibson et al., 201591
Giebel et al., 201592
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TABLE 3 Overview of included studies and papers by focus, methodological approach and types of outcomes
reported (continued )
Focus Included studies Methodological approach Types of outcomes
Gillespie et al., 201293
Goodwin et al., 2013138
Graff et al., 200665
Graff et al., 200896
Graff et al., 200795 Carer outcomes include:
l Carer stress, burden and
quality of life
l Experiences and views
Iliffe et al., 200667
Jekel et al., 2015101
Knapp et al., 2015105
Laakkonen et al., 2016106
Lingler et al., 2016107
Martin et al., 2013109
Martin et al., 2015110
Mountain, 200637
Mountain and Craig,
2012115
Quinn et al., 2015143
Quinn et al., 2016136
Schaller et al., 2016124
Span et al., 2013127
Suh et al., 2004128
Toms et al., 2015132
Diabetes NOT dementia
(n = 32)
Participants include older
adults, those with complex
health needs (comorbidity,
frailty, etc.), people with
mental illness and adults
with T2DM
Includes:
l Interventions related to
improving SM (e.g. use
of AT, SM support or
decision aids)
l Better understanding of
the needs of people
with diabetes
Aikens et al., 201563 l Five guidelines
l Nine other (variety of
study designs)
l Seven qualitative
l Five RCTs
l Five SRs
l Glycaemic control
l Patient knowledge,
self-efficacy
l Diabetes self-care practices
l Feasibility and acceptability
of interventions
l Quality of life
l Views and experiences
Bailey et al., 201681
Baxter, 201457
Beverly et al., 201470
Branda et al., 201371
Chrvala et al., 201684
Care Quality
Commission, 2016139
Donald et al., 201388
Goeman et al., 201694
Heisler et al., 200398
Hsu et al., 201699
Huang et al., 2005100
Jowsey et al., 201469
Jowsey et al., 2016102
Markle-Reid et al.,
2016108
Mathers et al., 2012111
continued
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TABLE 3 Overview of included studies and papers by focus, methodological approach and types of outcomes
reported (continued )
Focus Included studies Methodological approach Types of outcomes
Mayberry et al., 201168
Mayberry et al., 2016112
McBain et al., 2016137
McBain et al., 2016140
Munshi et al., 2011117
Munshi et al., 2013116
Newton et al., 2016118
Penn et al., 2015119
Piette and Kerr, 200643
Reinhardt Varming et al.,
2015122
Schulman-Green et al.,
2016125
Sherifali et al., 2015126
IDF, 201330
Sun et al., 2013129
Tan et al., 2015130
Taylor et al. 2016141
Other (e.g. people with
chronic illness, frail older
people, people with
multimorbidity or LTCs)
(n = 15)
Includes:
l SM support for
conditions other
than diabetes
l Service organisation
l Use of AT in
older people
Anderson et al., 201573 l Five qualitative
l Four RCTs
l One SR
l Four other
l Views and experiences
l Self-care related outcomes
(e.g. knowledge, self-efficacy)
l Use of AT
Bergdahl et al., 201372
Davis et al., 201262
De Vriendt et al., 201558
Greenhalgh et al.,
201397
Kennedy et al., 2013103
Kennedy et al., 2014104
Kennedy et al., 201460
Metzelthin et al., 2013;113
and Metzelthin et al.,
2013114
Procter et al., 2014120
Ryan and Sawin, 200945
Taylor et al., 2014131
Wherton et al., 2012133
Yardley et al., 2015134
AT, assistive technology; CI, cognitive impairment; HbA1c, glycated haemoglobin; IDF, International Diabetes Federation;
LTC, long-term condition; OT, occupational therapist; SR, systematic review; T2DM, type 2 diabetes mellitus.
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TABLE 4 The six CMO configurations
Title Context Mechanism and outcome Included evidence
1: embedding
positive attitudes
towards people
living with dementia
If health and social care
delivery systems propagate
and reinforce positive
attitudes towards people
living with dementia and
diabetes and their families
through tailored SM
support . . .
. . . then this fosters a belief
in staff that people living with
dementia and diabetes have
the potential to be involved
in SM and the right to access
diabetes-related services
(even when the trajectory
is one of deterioration),
(M) prompting treatment
confidence in people living
with dementia and diabetes
(M), which leads to
engagement in SM practices
by people living with
dementia and diabetes, their
family carers and HCPs (O)
28,37,39,59,60,62,65,67,80,85,86,95,96,104–106,109,110,115,
121,131,132,134,136,142
2: person-centred
approaches to
care planning
If delivery systems promote
a person-centred and
partnership approach to
care, allowing HCPs to
understand the individual
needs and abilities of
people living with dementia
and diabetes and their
families . . .
. . . then (1) HCPs feel
confident that they are acting
in the best interests of people
living with dementia and
diabetes and their families
(M), and (2) this generates
trust between HCPs and
people living with dementia
and diabetes and their families
(M), leading to a better fit
between care planning and
patient and carer needs, and
(potentially) a lessening of the
burden of medicalisation
experienced by people living
with dementia and diabetes
and their families (O)
45,58,59,65,67,69,71–73,79,87,94,95,98,100,102,108,111,114,
116,118,122,125–127,130,132,134,137,138
3: developing skills
to provide tailored
and flexible care
If HCPs are expected to
develop skills that enhance
the delivery of individualised
and tailored care to people
with dementia and diabetes
(e.g. enablement rather
than management,
listening/communication/
negotiation, shared
decision-making) . . .
. . . then this legitimises the
work creating the expectation
in patients and in HCPs that
diabetic care for people living
with dementia is important
(M), leading to the provision
of more tailored diabetes care
(O) and better engagement in
SM by people living with
dementia and diabetes and
their family carers (O)
25,60,67,69,71,79,88,89,98,103,104,111,113,114,116,117,119,
122,123,129,134
4: regular contact If HCPs maintain regular
contact over time (e.g. face
to face, by telephone or by
e-mail) with the person
living with dementia and
diabetes and their family
carer, monitoring and
anticipating needs
throughout the dementia
trajectory . . .
. . . then HCPs feel more
equipped to meet patients’
needs (M), and people living
with dementia and diabetes
and their families believe
themselves to be supported
(M) through the transition
from functional independence
to functional dependence (M),
leading to improved diabetes
management (O)
28,43,59,61,62,64,66,79,83,84,87,116–119,124,128,130
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Context–mechanism–outcome 1: embedding positive attitudes towards people living
with dementia
Programme theory
If health and social care delivery systems propagate and reinforce positive attitudes towards people living
with dementia and diabetes and their families (C), through tailored SM support, then this fosters a belief in
staff that people living with dementia and diabetes have the potential to be involved in SM and the right to
access diabetes-related services (even when the trajectory is one of deterioration), (M) prompting treatment
confidence in people living with dementia and diabetes (M), which leads to engagement in SM practices by
people living with dementia and diabetes, their family carers and health-care professionals (HCPs) (O).
Stigma and barriers to care for people living with dementia
There is evidence that social stigma surrounds both dementia and diabetes not only in the general
population but also among HCPs.144 Stigma associated with dementia has an impact on the person living
with dementia and may lead to them having poorer access to care than people with similar comorbidities
but without dementia.39 Stigma is also felt by the family carer, for example through increased social
isolation. People with diabetes may also be stigmatised and blamed for their condition because of lifestyle
choices and/or obesity.144 Recent work by members of the team around community engagement and
dementia-friendly health care has argued that without a foundation of awareness about what it is like to
live with dementia, related initiatives will not succeed. A reliance, for example, on single initiatives such as
dementia champions is insufficient.145,146
People with dementia and comorbidity face many problems in accessing health care. This includes a lack of
services designed around the needs of people living with dementia, poor communication between services,
a lack of training on dementia care for health and social care staff and a reliance on others (such as family
carers) to recognise a need for services and seek help.39 A recent mixed-methods study, which included
qualitative interviews and focus groups with clinicians, highlighted deficiencies in access to care and
continuity of care for people with dementia and comorbidity. Access to care was affected by clinicians’
TABLE 4 The six CMO configurations (continued )
Title Context Mechanism and outcome Included evidence
5: family engagement If family carers are routinely
involved in care planning
and information sharing,
and are given the support
they need to take on the
tasks associated with
managing diabetes in
people living with
dementia (e.g. medicine
management, recognition
of hypoglycaemia) . . .
. . . then family carers will feel
supported and that their
contribution is recognised and
appreciated (M), leading to
the development of effective
SM strategies on the part of
the family carer (O)
39,42,63,64,69,72,79,82,95,107,108,115,124,130,142
6: usability of AT As the dementia trajectory
progresses, AT needs to be
tailored and adapted to the
needs and requirements of
people living with dementia
and diabetes and their
families (includes social,
environmental and cultural
needs), with the focus on
maintaining autonomy for
the people living with
dementia and diabetes . . .
. . . leading to people living
with dementia and diabetes
and their families gaining an
understanding (awareness) of
the usefulness of AT in their
management of dementia and
diabetes (M), leading to more
effective and sustained use of
AT to maintain autonomy and
diabetes SM strategies (O)
39,59,61,63,68,90,91,93,97,99,101,105,112,120,127,133,135
AT, assistive technology.
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previous experiences and their attitudes towards risk. For example, there were contrasting opinions about
the appropriateness of taking someone with dementia off insulin.39,142 Stakeholders also highlighted the
need to ensure that people living with dementia received equitable care:
. . . you shouldn’t be sort of swayed one way or the other, just because someone has dementia . . .
I think certainly when they first start on their journey I think it’s really important that we do everything
we can [of cross-disciplinary training to facilitate appropriate care].
Diab 1 (stakeholder interviews)
Involving people with dementia in self-management
We found 10 studies37,59,62,106,109,110,115,121,132,136 looking at SM interventions for people living with dementia
or cognitive impairment, only one of which included people with dementia and diabetes.59 This controlled
study evaluated the impact of personalised education sessions on people with diabetes and cognitive
impairment.59 In this US-based study, certified diabetes educators delivered personalised education sessions
over the internet to older adults with type 2 diabetes and cognitive impairment (mild cognitive impairment
or early-stage dementia). They found a significant increase in self-efficacy but no difference in glycated
haemoglobin (HbA1c) at 6-month follow-up. The authors say that the face-to-face nature of the contact
(via Skype) was beneficial for establishing good rapport with participants. Mountain37 suggests that the
lack of studies on SM for people living with dementia is a result of negative perceptions of the abilities of
people with early dementia, which ‘leaves them on the periphery of any benefits that can be derived from
the current focus of policies that support people with long term conditions’.37
Studies on SM for people with dementia are mostly qualitative or small pilot or feasibility studies, and most
do not report measurable health outcomes. They also tend to focus on couples or people who have a
partner, which excludes many who might potentially benefit.147 This literature does, however, provide
valuable insights into what needs to be in place to support independence and appropriate outcomes in
people living with dementia, much of which might form the basis for programmes for people with
dementia and diabetes. Potentially important components of such programmes include the need to focus
on the abilities and strengths of people with dementia rather than their disabilities,109,110 on emotions rather
than problems,109 on building confidence62,121 and on respecting participant autonomy and enhancing
empowerment.106 Social interaction may also be important.106,110,143 A small feasibility study121 suggested
that SM interventions may foster independence and reciprocity, and promote social and clinical support. A
larger RCT involving 136 people living with dementia–spouse dyads found that a group-based intervention
to promote SM in people newly diagnosed with dementia led to improvements in health-related quality of
life in spouses and in cognition in people living with dementia, although quality-of-life improvements in
spouses were not maintained at longer-term (9-month) follow-up.106 Further details of these studies can be
seen in Appendix 7 and an overview of some key potential aspects of context, mechanism and outcomes
can be seen in Figure 6.
Fostering confidence
The importance of confidence as a mechanism is underlined in a number of studies. For example, a
systematic review130 of self-care interventions for older adults with diabetes (not dementia) found that
interventions using concepts of self-efficacy, self-determination and proactive coping were effective in
influencing diabetes self-care behaviours, leading to improved health outcomes. For example, proactive
coping helped people to anticipate threats and act accordingly. In addition, work by Clare et al.86 and
Claire148 suggests that there is a link between independence, functional ability and self-care behaviour and
feelings of confidence or self-efficacy in people living with dementia and their family carers. Clare et al.86
argue that a loss of confidence can promote disability:
Negative influences can contribute to the development and maintenance of ‘excess’ disability – where
the extent of functional disablement is greater than would be predicted by the degree of impairment:
an example would be where an individual loses confidence.
Clare et al.86
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Therefore, interventions that promote confidence or self-efficacy may lead to increased engagement in SM
activities. This ties in with literature on enablement, in which the focus is on what the person with dementia
can do both cognitively and functionally to maintain their quality of life.148 The process of enablement has
been sponsored by the Department of Health in England in their 2010 guidance Nothing Ventured, Nothing
Gained,149 which made it clear that HCPs need to be proportionate in their assessment of risk with people
living with dementia and that a ‘safety first’ management perspective disempowers people living with
dementia. Although we found no literature on enablement for people living with dementia and diabetes,
there is some evidence that teaching goal-directed activities can improve the cognitive functioning of people
living with dementia.85,86 It has been suggested that the enablement philosophy can also be applied to
identifying and treating accompanying physical illness and providing information and support to caregivers,148
although this has not been tested in people living with dementia and diabetes.
We included several studies that focused on the functional abilities of older people with multimorbidity.
A case study138 of co-ordinated care for people with complex chronic conditions supported the idea that
care co-ordination programmes should focus on supporting service users and carers to become more
functional, independent and resilient. The authors suggested that this is preferable to a purely clinical
focus on managing or treating medical symptoms. Two studies58,65 involved occupational therapists (OTs)
delivering interventions aimed at improving the functional abilities of older people with multimorbidity.
One, which found improvements in activities of daily living, suggested that an important aspect of the
intervention was that OTs used motivational interviewing and goal-setting to understand patient priorities
and to negotiate solutions in partnership.58 In the other, a RCT of community OT for people living with
Current evidence base
• Programmes only evaluated in people with MCI or early-stage dementia
• Most include family carers
• Components include focus on skills such as problem-solving, self-efficacy, compensatory strategies, provision
   of education and information
• Only one study involving people with CI and diabetes
• Small studies, little measurement of outcomes, applicability to wider groups not clear
Context 
• Social support: either group based or face-to-face support from professional
• Trained facilitator
• Involve family carer but need to make sure that voice of person living with dementia is heard
• Ongoing support
• Partnership approach
• Factor in reaction to diagnosis (e.g. changing roles and responsibilities) and stigma
• Tailored approach (e.g. to personal routine and environment)
• Focus on strengths
Potential mechanisms
• Developing trust/connection with facilitator
• Confidence in self-care abilities
• Feeling in control
• Feeling ‘safe’
• Sense of belonging
• Sense of self
• Positivity and empowerment (still me)
Outcomes
• Increased self-efficacy
• More active role
• More engaged with SM
• Improved cognition
FIGURE 6 Summary of evidence around SM programmes for people living with dementia. CI, cognitive impairment;
MCI, mild cognitive impairment.
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dementia and their carers, the authors found that 10 sessions of OT led to improvements in mood, quality
of life and health status at the 12-week follow-up.65,95,96 The intervention involved the use of compensatory
strategies to adapt activities of daily living to the disabilities of patients and adapt environments to their
cognitive disabilities. Primary caregivers were trained to use effective supervision, problem-solving and
coping strategies to sustain both their own and the patient’s autonomy and social participation. A
potential mechanism was an increased sense of control.
Although these studies do not focus on SM for dementia and diabetes, and although they focused on
people living with mild or early-stage dementia, they may provide transferable learning for the development
of SM support for people living with dementia and diabetes, for example the focus on family relationships,
maintenance of an active lifestyle, psychological well-being and techniques for coping with memory
changes. Furthermore, they promote positive attitudes, with an emphasis on equality and collaboration
between participants and facilitators.106 Working with families is clearly key. However, studies highlight the
need to ensure that the voice of the person living with dementia is heard and that their needs are balanced
with those of the carer.115 Qualitative studies on SM support for people living with dementia found that
information provision may be aimed at carers, leaving people living with dementia feeling powerless,115 that
carers may inadvertently take control away from people living with dementia109 and that people living with
dementia can find support inappropriate or stifling.132 As one stakeholder put it:
. . . an intervention should work at a level that people . . . particularly early stages of dementia . . .
can be included . . . so it’s not decisions being made about them . . .
Dem 1
Further RCTs of SM support for people with diabetes and cognitive impairment are under way but these focus
on intellectual disability150 and learning disability151 rather than dementia. Although the results are not available,
the protocols do provide information about components of the intervention. For example, the intervention
being evaluated by Walwyn et al.151 involves establishing participants’ daily routines and lifestyles, identifying
all supporters and helpers and their roles, setting realistic goals for change and monitoring progress against
agreed-on goals, while the Taggart et al.150 study involves evaluating an adapted version of DESMOND
(The Diabetes and Self-Management for Ongoing and Newly Diagnosed patients with T2D programme).152
The adapted version includes longer sessions, increased use of pictures in the educational information, greater
involvement of carers, more repetition and interactive sessions, and a strong focus on celebration and fun,153
components that would appear appropriate for people living with dementia.
Context–mechanism–outcome 1 summary
Interventions for people with dementia and diabetes need to address the stigma that this group faces.
There is evidence that people living with dementia have the potential to be involved in SM, although most
research currently focuses on SM skills in people with mild or early-stage dementia, and there is little evidence
relating to SM in people with dementia and a comorbid condition such as diabetes. However, the literature
identified important components of interventions that are likely to be transferable to people with dementia
and diabetes; for example, focusing on strengths and abilities, being emotion focused rather than problem
focused, respecting autonomy and working to build confidence and empowerment. The involvement of
family carers in programmes is key, but it is important to balance the needs of the people living with dementia
with those of the carer to ensure that people living with dementia are not disempowered.
Context–mechanism–outcome 2: person-centred approaches to care planning
Programme theory
If delivery systems promote a person-centred and partnership approach to care, allowing HCPs to
understand the individual needs and abilities of people living with dementia and diabetes and their families
(C), then (1) HCPs feel confident that they are acting in the best interests of people living with dementia
and diabetes and their families (M), and (2) this generates trust between HCPs and people living with
dementia and diabetes and their families (M), leading to a better fit between care planning and patient
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and carer needs, and (potentially) a lessening of the burden of medicalisation experienced by people living
with dementia and diabetes and their families (O).
Identifying patient and carer priorities
People living with dementia and diabetes have two chronic conditions with different trajectories. Dementia
will generally ‘have a progressive or stepwise pattern of progression in illness severity, symptoms and
disability over time, which will require continual adaptation to new issues or limitations’,154 whereas
diabetes may have a more constant course with longer periods in which to adapt, but the trajectory of each
is likely to have an impact on the other. Supporting people living with dementia and diabetes, and their
families, with these ambiguous trajectories along the route from early-stage dementia to end-of-life care is
a difficult clinical enterprise. Delivering appropriate and sustainable care for people living with dementia and
diabetes requires a change from a curative, biomedical strategy to a more person-centred approach
whereby patient priorities are at the forefront.155 The Institute of Medicine defines patient-centred care as
being ‘respectful of and responsive to individual patient preferences, needs, and values, and ensuring that
patient values guide all clinical decisions’, and is a hallmark of high-quality care.156
Maintaining independence and engagement with day-to-day activities was a clear priority for participants
in all groups (e.g. people with dementia and diabetes, older people with diabetes, people with
dementia).59,70,100,113,114,132 For example, a qualitative study100 of older patients with type 2 diabetes found
that their primary goal in diabetes SM was engagement with their day-to-day activities, rather than
maintaining biomedical parameters. The authors concluded that HCPs have to prioritise each patient’s life
experience when providing advice about diabetes management. This was supported by our stakeholder
interviews, as seen in the following quotation from a general practitioner (GP):
But actually at this stage [referring to when people have complex health needs] people are interested
in autonomy, mobility you know, retaining as much function and independence as they can, being a
burden on their families you know, so all the normal things and they’re often much, much more
important than a lot of the medical stuff.
Diab 12
Person-centred approach to self-management in people living with dementia
and diabetes
A recognition of patient motivators and goals, and negotiation of a mutually agreed management plan, could
improve adherence to SM regimens.98,102,118,125,157 For example, in a qualitative study of older adults with
diabetes (aged ≥ 65 years), participants reported a variety of motivators for maintaining SM once a routine
had been established. HCPs needed to understand what these motivators were and work with patients
towards their SM goals. Feedback from participants included the observation that HCPs did not listen to,
or were dismissive of, their concerns and, as a result, this reduced the trust that they had in their HCP.118
A Cochrane review137 looked at SM interventions for people with diabetes and severe mental illness.
Searches, which were conducted in 2016, identified only one RCT that met the inclusion criteria. This was
a small study (n = 64) involving adults with type 2 diabetes and schizophrenia or schizoaffective disorder
(average age 54 years). The intervention, which involved a 24-week education programme, had no
significant impact on glycaemic control, although there were small improvements in diabetes knowledge
and self-efficacy. The authors suggested that the lack of impact could, in part, be explained by the lack of
a person-centred approach within the programme.
We found only limited evidence that evaluated the impact of our identified context on glycaemic control or
adverse events. Of the six included sources that focused on people with dementia and diabetes, only one59
evaluated an intervention. This was a controlled study evaluating the provision of personalised education
sessions for diabetes and cognitive impairment. The study showed an increase in self-efficacy and a short-term
effect on glycaemic control (HbA1c levels initially declined but had returned to baseline after 6 months).
RESULTS
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The authors suggested that this supported a need for long-term connection and maintenance programmes
for this group.
Trusting relationships
A key element of achieving a person-centred or partnership approach to care is building a long-term
trusting relationship with the people living with dementia and diabetes and their family69,70,72,73,79,102,125,142
that involves listening and valuing the patient’s subjective health experiences:
It’s allowing a two-way exchange of information, isn’t it, about how different conditions might
affect things.
Res 1
The impact that a trusting relationship between HCPs and people with dementia can have on patient care is
illustrated in a qualitative study87 exploring GPs’ perceptions of what is meant by a ‘timely’ diagnosis of
dementia and how this differs from an early diagnosis. The timely diagnosis was seen as requiring a more
patient-centred approach that recognises the issues that families go through in reconciling the stigma of
diagnosis and consequences for the future. The authors argue that a ‘diagnosis’ of dementia was not a
discrete act ‘. . . but a collective, cumulative, contingent process’.87 The GPs in this study saw the diagnosis as
a journey for both them and the patient and their family in reaching a nuanced and contingent resolution,
leading to a co-constructed diagnosis. This study, like others,39 highlights how vital relationship continuity
can be in creating trust and helping to secure appropriate and timely care for people living with dementia.
A feasibility study122 explored the use of patient-centred consultations for improving medication adherence
and management among older people with diabetes. The intervention included the use of dialogue tools
whereby the patient was asked to describe their day living with diabetes, to ‘. . . encourage participants to
reflect, engage in dialogue, and verbalize their experiences’.122 The findings showed that people living with
type 2 diabetes felt listened to, which generated a trusting relationship with their HCP. Participants also
reported feeling more capable of managing their diabetes, although, as this was a feasibility study, the
authors did not measure the impact of the intervention on glycaemic control. HCPs reported that the
process supported patient-centred partnership but the authors cautioned that the dialogue tools are, by
themselves, not enough to ensure patient-centeredness; adequate communication skills are also required
to prevent the process becoming a tick-box exercise.
We know that for people who have previously self-managed their diabetes (often for many years), the
transition to needing SM support can be difficult and distressing.39,142 Although we found some literature
on enablement for people living with dementia (see Context–mechanism–outcome 1: embedding positive
attitudes towards people living with dementia), we found no evidence about how (or whether or not)
a patient’s previous diabetes knowledge or SM strategies are acknowledged or used by HCPs.
Shared decision-making
The management of people living with dementia and diabetes represents a complex process with difficult
trade-offs to be made, so methods of involving patients and families in shared decision-making are important
aspects of achieving person-centred care. In a multicentre cluster RCT of older people with type 2 diabetes
(not dementia), Branda et al.71 introduced a decision aid that encouraged shared decision-making between
participants with diabetes and HCPs. There was no difference in glycaemic control between the decision-aid
intervention group and the control group. However, the decision aids did facilitate patient-centred practice
and co-construction of decision-making related to diabetes management. The participants also felt more
engaged in their diabetes management despite the lack of clinical outcomes. Similarly, Mathers et al.,111
in a RCT of a decision aid for patients with type 2 diabetes (adults aged between 42 and 87 years), found
no statistical effect on glycaemic control (HbA1c decreased in both intervention and control groups), but
decision-making by patients was more autonomous and promoted more realistic expectations and greater
knowledge. The authors suggested that this can lead to better long-term SM practices.
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Both of these studies involved the use of a decision aid in a single consultation between a clinician
and a person with diabetes. In the Mathers et al.111 study, the mean duration of the consultation was
15.31 minutes. People living with dementia and diabetes are likely to need interventions that involve more
frequent contact and include repetition and reinforcement. Decision-making involving people living with
dementia is likely to be complicated by issues of consent, concordance and the appropriateness of
treatment for people with dementia.
Context–mechanism–outcome 2 summary
Self-management of diabetes in people with dementia is likely to be contingent on the development of a
trusting relationship between the HCP and the person living with dementia and diabetes and their family,
involving understanding and incorporating patient priorities and how these may change over time. This in
turn facilitates a person-centred approach to care planning and diabetes management. There is currently
little research that looks at person-centred approaches to diabetes management in people living with
dementia, and further research is needed to develop interventions that support partnership working and
incorporate the consideration of the risk-benefit balance for different treatment options.
Context–mechanism–outcome 3: developing skills to provide tailored and flexible care
Programme theory
If HCPs are expected to develop skills that enhance the delivery of individualised and tailored care to
people with dementia and diabetes (e.g. enablement rather than management, listening/communication/
negotiation, shared decision-making), then this legitimises the work and creates the expectation in patients
and in HCPs that diabetic care for people living with dementia is important (M), leading to the provision
of more tailored diabetes care (O) and better engagement with SM by people living with dementia and
diabetes and their family carers (O).
Tailored and flexible
The importance of providing tailored care for older people with diabetes was emphasised in the literature.
In a meta-analysis of SM programmes in older people living with diabetes, Sherifali et al.126 concluded that
the strategies most effective at reducing HbA1c levels were those that involved tailored interventions or
psychological support. Tailored interventions consisted of patients receiving advice and support that met
their particular needs and goals for diabetes SM and the psychological support emphasised coping
strategies for depression and distress. The authors did not, however, unpick what it was about tailoring or
psychological support that might have triggered these different responses. A RCT to assess barriers to SM
experienced by older people with type 2 diabetes demonstrated the importance of assessing the specific
self-care barriers faced by this cohort and then individualising diabetes management.116 Individualisation
was aided by a diabetes educator making telephone contact between clinic visits.
Current clinical guidance also highlights the need for individualised and flexible care for older people
with dementia and diabetes. Clinical guidelines on diabetes recommend that target HbA1c levels be
relaxed for older people who are frail or have comorbidities and/or dementia.26,28,29,158 A summary of
recommendations for glycaemic control in older people (including those with dementia) can be seen in
Table 5.
For example, a best clinical practice statement28 by a multidisciplinary national expert working group
recommends that, for people with dementia, clinicians should aim to achieve fasting blood glucose of
6–9 mmol/mol (range HbA1c 53–64 mmol/mol; 7–8%). Although guidance for general diabetic populations
recommends levels of 6.5–7 mmol/mol, it also recommends that these targets be relaxed for those with
complex health needs or those who are frail.158 Despite this, evidence from observational studies suggests
that many older people with diabetes are potentially overtreated.25 This could be partly because these
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TABLE 5 Summary of best practice guidance on the management of diabetes in older people and those with dementia
Guidance
(author, year) Population
Summary of recommendations: glycaemic
control targets Summary of recommendations: medications
Sinclair et al., 201428 People with dementia Aim to achieve fasting blood glucose 6–9mmol/l
(range HbA1c 53–64 mmol/mol; 7–8%)
l People with dementia being treated with insulin, glucagon-like
peptide 1 or certain oral hypoglycaemic agents such as sulphonylureas
[gliclazide, glimepiride (Amaryl; Zentiva Group, Surrey, UK), glipizide]
and glinides [repaglinide (Prandin®; Novo Nordisk, Plainsboro, NJ,
USA) and nateglinide (Starlix®; Novartis Pharmaceuticals UK Ltd,
Surrey, UK)], which leave them at risk of hypoglycaemia, should have
regular blood glucose monitoring (at least once or twice daily)
In these circumstances, a review of glucose-lowering therapies is
needed to minimize the risk of hypoglycaemia
IDF, 201330 Older people but includes
recommendations for
people with dementia
A HbA1c target of up to 8.5%/70 mmol/mol may
be appropriate
l Begin oral glucose-lowering therapy when lifestyle interventions alone
are unable to maintain target blood glucose levels
Use the ‘start low and go slow’ principle in initiating and increasing
medication and monitor response to each initiation or dose
increase for up to a 3 month trial period
l When prescribing an oral glucose lowering agent, choose one with a
low potential for hypoglycaemia
l Use simplified insulin regimens with a low hypoglycaemic risk
l Avoid complex regimens and higher treatment burden to reduce the
risk of medication errors
l Consider benefit of treatment in relation to risks such as
hypoglycaemia, weight gain or loss, need for caregiver involvement,
impact of worsening renal or hepatic function, and
gastrointestinal symptoms
American Diabetes
Association, 201529
Older people but includes
recommendations for those
with complex health needs
such as people with CI
A1C goal
l Mild to moderate CI: < 8.0%
l Moderate to severe CI: < 8.5%
Looser glycaemic targets than this may expose
patients to risks
l Metformin may be contraindicated because of renal insufficiency or
significant heart failure
l Sulfonylureas, other insulin secretagogues, and insulin can
cause hypoglycaemia
l Insulin use requires that patients or caregivers have good visual and
motor skills and cognitive ability
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TABLE 5 Summary of best practice guidance on the management of diabetes in older people and those with dementia (continued )
Guidance
(author, year) Population
Summary of recommendations: glycaemic
control targets Summary of recommendations: medications
Sinclair et al., 201126 For people whose hypoglycaemia risk is high and
for whom symptom control and avoidance of
metabolic decompensation is paramount
(includes people with dementia), the target
HbA1c range should be 7.6–8.5%
The physician should aim to establish a contract between himself/
herself and the patient or principal carer in relation to treatment aims
and goals of care, designed to optimise patient empowerment at
all times
The decision to offer treatment should be based on the likely benefit/
risk ratio of the intervention for the individual concerned, but factors
such as vulnerability to hypoglycaemia, ability to self-manage, the
presence or absence of other pathologies, the cognitive status, and life
expectancy must be considered
CI, cognitive impairment; IDF, International Diabetes Federation.
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targets do not ‘fit’ with current performance measures159 (such as QOF targets in UK primary care), a factor
suggested by a number of our stakeholders and illustrated by this quotation from a diabetes specialist:
. . . we encourage people to set agreed targets with the patient . . . that may well be . . . higher than
the general population target which is a key message we get across to the GPs because they’re so
driven by QOF.
Diab 9
Flexible diabetes care is not just about adjusting target HbA1c levels. A case study117 involving the use of
continuous glucose monitoring to measure hypoglycaemia in older adults with diabetes found that simply
relaxing HbA1c goals may not be adequate to protect frail older adults against hypoglycaemia. They found
‘an unexpectedly high frequency of hypoglycaemic episodes in older adults with poor glycaemic control’;117
this was true of those with type 2 diabetes as well as of those with type 1 diabetes. The authors concluded
that there is a need for treatment regimens that better match patients’ self-care abilities, although they did
not explore further what such regimens might look like.117
Developing appropriate skills
Research suggests, however, that HCPs do not always have the skills needed to provide flexible
individualised care for people with diabetes and/or dementia.39 This was echoed by our stakeholders,
as the following quotation illustrates:
I’ve seen very very few examples where it’s done well, any of this, any of this sort of self-management,
shared decision-making, anything. It works well I think in a few types of situations where people feel
they have the autonomy to act in the interests of the patient and are able to make decisions that
might not necessarily follow the rules but they can see the patient as an individual and understands
their circumstances, otherwise I think health professionals are possibly becoming themselves much
more risk-averse and not wanting to suggest things that aren’t perceived as being healthy or might
not be the right answer.
Res 1
One consequence of this is that care is not tailored appropriately. In a RCT116 involving older people with
diabetes, the authors wrote that ‘the study team felt that many patients with multiple conditions were on
complex regimens that were clearly beyond their coping abilities’. In a qualitative study with older adults
with diabetes and other comorbidities (not dementia), participants reported that they felt overwhelmed
when dealing with their diabetes and other conditions and that they felt that their HCPs did not understand
the difficulties they experienced with balancing their comorbidities so that they could achieve a reasonable
quality of life.70 The following quotation from a GP highlights how ideas about assessing a patient’s abilities
to cope with treatment plans are not yet part of routine care. The GP is referring to the ‘choosing wisely’
initiative from the American Board of Internal Medicine Foundation,160 which aims to promote conversations
between clinicians and patients to prevent the use of unnecessary tests and procedures:
. . . choosing wisely American stuff you know, I think we’re all warming up to this agenda but I don’t
think anyone’s quite cracked you know, it’s not mainstream yet.
Diab 12
In addition, Kennedy et al.103 conducted a RCT of SM support for people with long-term conditions in
primary care in the UK. The results of the RCT103 and accompanying process evaluation104 and qualitative
study60 suggest that SM support did not fit with a biomedically focused ethos and, as a result, practices did
not give it the priority needed to embed it in the day-to-day work of primary care. A qualitative study
conducted in the USA also found that an overemphasis on biometrics and medicalisation by HCPs was a
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barrier to SM,100 and a study looking at SM pathways in primary care in the UK concluded that primary
care is currently failing to support SM.119 This is illustrated by the following stakeholder quotation:
. . . for the general population, self-management . . . is not working particularly effectively . . . translate
that to a much more delicate and fragile group . . . who have other comorbidities and have dementia
. . . then those types of responses are likely to be even less effective [of SM support strategies].
Diab 2
Several studies70,98,134 suggested that there is ‘goal divergence’ between patients, carers and HCPs,
particularly when there is medical uncertainty, as is generally the case with the dynamic nature of living
with multiple conditions. In a realist synthesis, Yardley et al.134 suggested that, to reconcile discrepancies
between the goals of patients, carers and HCPs, there is a need for less emphasis on a ‘diagnostic-cure
model’. Patient-centred communication and collaboration between HCPs and patients/families appear to
be key to achieving individualised care70,98,134 (see also Context–mechanism–outcome 2: person-centred
approaches to care planning).
Context–mechanism–outcome 3 summary
We found evidence that, to be able to provide flexible and individualised care for people living with
dementia and diabetes, HCPs need to prioritise communication, negotiation and partnership working. They
need to be provided with appropriate training and support so that they have the confidence to focus more
on quality of life and patient abilities and less on biometrics and clinical targets. However, currently the
evidence to link our proposed context with glycaemic control or a reduction in adverse diabetes-related
events is limited.
Context–mechanism–outcome 4: regular contact
Programme theory
If HCPs maintain regular contact over time (e.g. face to face, by telephone or by e-mail) with the person
living with dementia and diabetes and their family carer, monitoring and anticipating needs throughout the
dementia trajectory (C), then HCPs feel more equipped to meet patients’ needs (M), and people living with
dementia and diabetes and their families believe themselves to be supported through the transition from
functional independence to functional dependence (M), leading to improved diabetes management (O).
Anticipating needs
Regular contact between HCPs and the people living with dementia–carer dyad appears to be an important
contextual factor for HCPs to anticipate transitions and help people living with dementia and diabetes and
their family carers to manage changes in function and SM capabilities.142 This is particularly important for
people living with dementia for whom the dementia may progress in an uneven pattern of decline,92 and
for whom the transition from autonomy to delegation or caregiver-led management may be particularly
difficult.39,79,118 Regular contact may have particular advantages for people living with dementia, as illustrated
by this quotation from a stakeholder interview:
. . . if it’s set up on a regular basis, so the person knew, you know, like Tuesday afternoons when I
speak to my diabetic nurse, that can be put in their diary.
Dem 4
Penn et al.119 (looking at diabetes but not dementia) suggested that if SM support is offered at regular
points throughout a person’s trajectory, rather than just focusing on the point of diagnosis, then HCPs are
more likely to pick up problems with SM and be able to offer appropriate support. In a RCT116 focused on
improving diabetes management in older people, the authors found that older adults were reluctant to
make changes to their medication between clinic visits. However, regular telephone contact from a
diabetes educator encouraged people to adjust their insulin dosage, leading to better glycaemic control.
Regular contact is likely to be even more important for people with dementia, and guidance and commentary
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on the management of diabetes in people living with dementia recommends regular reassessment to identify
additional care needs.28,83 Older people with diabetes (including those with dementia) are particularly likely to
be in need of support during vulnerable periods, such as after a period of hospitalisation.116,142
Current care pathways, however, lack the capacity to consistently assess SM capabilities or provide SM
support.119 This is illustrated by the following quotation:
. . . since I’ve been in the care of the diabetic clinic everything else has gone out the window. When I
was in the care of the specialist nurse at the GP’s, I would have a regular sort of every 6-month check
on my feet . . . and the amount of protein in my urine, all those tests have now ceased, I’m now only
looked at from a point of view of sugar levels.
Person with type 2 diabetes
What sort of contact and with whom?
The quotation above also illustrates another important point. It is not just about having regular contact but
also about who that contact is with. The quotation suggests that care at the GP surgery, where the patient
was known, was preferable to the less personalised (and less comprehensive) care received at the diabetic
clinic. Clearly this is only one person’s experience; however, many of the studies we included39,59,62,64,66,116,130
support the link between regular contact with the same HCP, the development of a good relationship
and improved SM practices. For example, a controlled study59 of diabetes SM education for people with
cognitive impairment found that regular contact with a single diabetes educator led to the development of a
rapport, which was important in helping participants to develop strategies to improve SM (e.g. remembering
when to take their medication).
Of the studies we included, 38 described the development or evaluation of an intervention; two included
people living with dementia and diabetes, 16 included people living with dementia (not diabetes), 14 included
people with diabetes (not dementia) and six included other groups such as older people or those living with
long-term conditions. This includes a diverse range of interventions, although many were aimed at improving
SM. Interventions were delivered by a range of HCPs, most commonly GPs, nurses, OTs, psychologists and,
in US studies, certified diabetes educators. Regardless of who was delivering the intervention, studies
consistently highlighted the importance of the continuity and quality of the relationship. A number of studies
looked at the development and delivery of interventions delivered remotely using technology (e.g. text
messages). This is explored further in Context–mechanism–outcome 5: family engagement.
Although the quality of the relationship is important, people with dementia and diabetes need to be managed
by practitioners with appropriate expertise. Stakeholders highlighted the particular challenges HCPs face when
caring for people with dementia and diabetes, and the different skill sets that different specialists are likely
to have. Dementia as a comorbidity may challenge a diabetes specialist, and a dementia specialist may lack
appropriate diabetes knowledge. From our stakeholders we found examples of roles that involved someone
with expertise in both mental and physical health, although this was the exception rather than the rule:
. . . I have a very good colleague . . . who is a specialist physical health-care nurse and a mental health
nurse, and that is a, I’ve often thought of this person as a really interesting model for the future . . .
Dem 7
One paper described a programme that included embedding a psychiatrist within an integrated care pilot
for people with diabetes in inner London.123 The involvement of the psychiatrist raised awareness of
patient mental health problems among other team members and meant that the team was able to identify
if poor SM might be a result of mental health issues. The author said that clinicians became more engaged
when they were able to ‘really think about the person in their entirety’. However, the paper provided no
data on the impact of the intervention on patient outcomes.
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Context–mechanism–outcome 4 summary
Continuity of care and regular contact are important for both people with dementia and those with diabetes,
but it is likely to be even more critical for those with both dementia and diabetes. This is important so that
professionals can recognise times of transition (e.g. worsening symptoms of dementia having an impact
on diabetic control and increased risk of hypoglycaemia). At such times support may need to be ‘geared up’
but may be able to be ‘geared down’ once the transition has been successfully dealt with. Ensuring that all
professionals have expertise in dementia and diabetes would be difficult, and collaborative practice is likely to
be necessary for people with both conditions, particularly for more complex cases such as people who are
insulin dependent or those with advanced dementia.
Context–mechanism–outcome 5: family engagement
Programme theory
If family carers are routinely involved in care planning and information sharing, and are given the support
they need to take on the tasks associated with managing diabetes in people living with dementia
(e.g. medicine management, recognition of hypoglycaemia), (C) then family carers will feel supported
and that their contribution is recognised and appreciated (M), leading to the development of effective
SM strategies on the part of the family carer (O).
There is a great deal of evidence that family members often provide significant SM support for people with
long-term conditions such as diabetes,45,69 particularly when dementia has an impact on a person’s ability
to undertake self-care-related tasks.142 A mixed-methods study exploring the impact of dementia on access
to non-dementia services found that family members were often proactive in facilitating continuity of care
and negotiating access to services for their relatives with dementia and diabetes,39,142 and a review of
medicine use in people living with dementia found that administering medicines was a huge component
of being a caregiver of a person living with dementia.79 Managing the needs of a family member with
dementia and diabetes raises particular anxieties for carers because of the risk of hypoglycaemia and other
adverse advents associated with diabetes. People with dementia are likely to forget to eat (or to eat too
much), and ensuring that they eat appropriately and that this is co-ordinated with their medication is a
source of great concern for carers, particularly if they live at a distance.39 This is complicated by a lack of
flexibility in service provision, such as district nurses being able to go in only at certain times of the day, or
social services carers being unable to oversee medication administration for people with diabetes.39,142
Family carers may also play an important part in supporting or motivating their relatives in their SM activities.
A quasi-experimental study conducted in the USA (adults with diabetes but not dementia) found that involving
a care partner may make a person with diabetes more likely to participate in an automated telephone SM
system. The authors suggest that the mediating mechanisms were emotional support leading to improved
ability to regulate one’s own behaviour, direct assistance with diabetes problem-solving provided by the care
partner, and reinforcement of adherence.63
Despite this, family carers often feel undervalued or excluded from decision-making, and they may be
ill-prepared to take on responsibility for SM.39,42,64,79 The situation is often further complicated by the fact
that they may take on SM-related tasks only once there is a crisis or a failure to adhere to medication.42
The need for appropriate support for carers is highlighted by studies that found that problematic
medication management practices may persist despite the involvement of a family carer.79,107 For example,
a systematic review looking at challenges to optimal medicine use in people living with dementia found
that family carers may adopt strategies that are not always safe and effective, and that it was difficult
for them to make decisions about when to withhold or to give medicines.79 A tailored problem-solving
intervention to maximise medication management practices among caregivers of people with memory
loss found no significant difference between the intervention and control groups, although both groups
showed a significant reduction in the number of medication management problems.107 The authors
suggested that the lack of difference between the groups is because the caregivers in the control group
participated in a face-to-face baseline assessment by a study nurse or social worker, which included
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questions about their knowledge of medications and approaches to managing them, medication
reconciliation and medication-related resources.
Interventions aimed at supporting people with dementia to manage their diabetes should take into account
the education and support needs of family carers as well as those of the person living with dementia,39,64,79
support that needs to include the issues arising from both conditions and the impact that dementia is likely
to have on diabetes management.39 We found no studies evaluating structured interventions to provide
education and support to family carers of people with dementia and diabetes. Although stakeholders did
talk about involving family members in education, they also recognised that this was not done in a
structured or comprehensive way:
. . . I think we could probably do a lot more . . . supporting families and carers and to give them the
confidence, I think they’re so worried, it can be so . . . frightening . . . to have both conditions . . .
Diab 13
. . . patients are educated one to one or through diabetes-structured education, again I’ve never heard
of a patient education for carers and those with dementia to support them . . .
Diab 11
A number of studies linked support and education for carers to an improvement in SM. For example,
qualitative studies looking at SM for people living with dementia115 and for people with diabetes
(not dementia)69 argued that it is important to involve carers in the development of SM skills alongside
the person they care for. This was also highlighted in the stakeholder interviews. For example:
We need to sort of normalise the situation where it is completely normal and expected that close
family members will be involved in any decisions and there will be partnership.
Researcher: SM of long-term conditions
Context–mechanism–outcome 5 summary
Self-management for people with dementia and diabetes needs to be conceptualised as an activity that
frequently involves not just the person with dementia but also their family members. Interventions need to
take into account the needs and capabilities of family carers and the anxieties associated with managing
medication and diet and preventing adverse events such as hypoglycaemic attacks. Including the family
carers of people with dementia and diabetes should be the default option, and they should be included
early, when the people living with dementia still have the capacity to make decisions and before SM
breaks down.
Context–mechanism–outcome 6: usability of assistive technology
Programme theory
As the dementia trajectory progresses, assistive technology (AT) needs to be tailored and adapted to the
needs and requirements of people living with dementia and diabetes and their families (includes social,
environmental and cultural needs) with the focus on maintaining autonomy for the people living with
dementia and diabetes (C), leading to people living with dementia and diabetes and their families gaining
an understanding (awareness) of the usefulness of AT in their management of dementia (M) and to a
more effective and sustained use of AT to maintain autonomy and diabetes SM strategies (O).
The definition of AT used for this CMO is ‘any product or service designed to enable independence for
disabled and older people’.161 This broad definition has the merit of including both high- and low-technology
devices, ranging from objects that may not be considered ‘technological’, such as notice boards and calendar
clocks, to devices that are clearly technology based, such as GPS (Global Positioning System) locators,
blood-glucose monitors, reminders for medical management, and the internet.135 Gibson et al.91 further
subdivided AT into telecare and telemedicine. Telecare involves remotely monitoring people in their own
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homes and communicating with them at a distance via telephone and the internet, while telemedicine is
technology-supported medical or nursing tasks that assess biometrics sent from the patient and instructions
returned to the patient from their HCP. The use of AT in health and social care is seen as an important
element in enabling older people to live independently, and is part of the Department of Health’s Prime
Minister’s Challenge on Dementia.162 Despite this, a review of the use of AT for people living with dementia
suggested that the technology industry has limited awareness of the needs of people living with dementia
and their carers, and needs to view the ‘dementia market’ as an attractive option.105
We included 17 papers39,59,61,63,68,90,91,93,97,99,101,105,112,120,127,133,135 (five of which were reviews) in this section.
Two39,59 relate to people with dementia and diabetes, seven61,90,91,93,101,105,127 relate to the use of AT by
people with dementia, four97,120,133,135 concern the use of AT by older people and four63,68,99,112 involve people
with diabetes (not dementia). There is clearly a large body of literature relating to the use of AT by people
with diabetes (in particular telehealth and telecare), but most of this was beyond the remit of this review.
We found only one study59 that looked at the use of AT to help manage diabetes in people with cognitive
impairment, but there is a lot of evidence on the use of technology by people living with dementia.91,97,120,135
More details of the included studies can be seen in Table 6.
Assistive technology to maintain autonomy
For people living with dementia and diabetes, being able to remain in their own home and community is
very important to their quality of life. AT that can include the monitoring of biometrics, provide reminders
for medicine management and use sensors and alarms to track movement is seen as one way of
maintaining autonomy:135
. . . there’s electronic dosette boxes . . . linked to telecare, so if the person doesn’t take the medication,
telecare will come through the intercom and say, ‘Mr so-and-so, you need to take your tablets’, and
then if they don’t . . . [it] locks anyway so they can’t overdose.
Dem 2
TABLE 6 Usability of AT: details of included studies
Study (author, year) Study type
Condition
FocusDementia Diabetes Other
Aikens et al., 201563 Before-and-after study ✗ Investigating potential benefits
to medication adherence of
integrating a patient-selected
support person into an automated
diabetes telemonitoring and
SM programme
Boots et al., 201661 Qualitative ✗ Development and evaluation of
web-based SM program for
family caregivers of people with
early-stage dementia
Bunn et al., 201639 Mixed methods ✗ ✗ People living with dementia and
carer experiences of service
delivery, but refers to use of AT
Camp et al., 201559 Controlled study ✗ ✗ Evaluating a distance-based
education intervention for
people with both diabetes
and CI
Fleming and Sum, 201490 SR ✗ Assessing the empirical support
for the use of AT in the care of
people living with dementia
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TABLE 6 Usability of AT: details of included studies (continued )
Study (author, year) Study type
Condition
FocusDementia Diabetes Other
Gibson et al., 201591 Qualitative ✗ Exploring the everyday use of AT
by people with dementia and
their families
Gillespie et al., 201293 SR ✗ Examining the relationship
between AT for cognition and
cognitive function
Greenhalgh et al., 201397
(links to Procter et al.120)
Qualitative ✗ (older
people)
Defining quality in telehealth
and telecare, with the aim
of improving the proportion of
patients who receive appropriate,
acceptable and workable
technologies and services
Hsu et al., 201699 RCT ✗ Cloud-based diabetes
management programme for
insulin initiation and titration
Jekel et al., 2015101 SR ✗ (CI) Focuses on performance of
patients with MCI in specific
IADL (sub)domains but refers to
problems with use of technology
Knapp et al., 2015105 Rapid review ✗ Cost–benefit analysis to consider
the hypothesis that accelerated
investment in technology could,
over a series of different time
frames, deliver savings on the
overall cost of care
Mayberry et al., 201168 Mixed methods ✗ Exploring the role of patient
health literacy, numeracy and
computer literacy on the usage
of health IT
Mayberry et al., 2016112 Qualitative ✗ Developing and testing a
telephone coaching system to
improve self-care for people with
T2DM from low-SES groups
Procter et al., 2014120 Qualitative ✗ (older
people)
Exploring the experiences of
older people living with
assisted-living technologies
and care services
Span et al., 2013127 SR ✗ Gaining insight into the
involvement of people with
dementia in developing
supportive IT applications
Wherton et al., 2012133 Qualitative ✗ (older
people)
Understanding the assisted living
needs of older people in
domestic settings and methods
to support their involvement in
the coproduction of assisted
living technologies
CI, cognitive impairment; IADL, instrumental activities of daily living; IT, information technology; MCI, mild cognitive
impairment; SES, socioeconomic status; SR, systematic review; T2DM, type 2 diabetes mellitus.
DOI: 10.3310/hta21750 HEALTH TECHNOLOGY ASSESSMENT 2017 VOL. 21 NO. 75
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Bunn et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
37
Simple technology, such as dosette boxes, can also be used to maintain independence, as this
stakeholder suggests:
I was familiar with the sort of dosette box, if that’s what you’re talking about, which is a great idea
and does really help people.
Dem 1
However, such strategies become less successful as the dementia progresses,142 and even people with mild
cognitive impairment are likely to have problems with the everyday use of technology, such as telephone
and television, that limit their independence and autonomy.101 These problems are also likely to apply to
technology for the management of diabetes, as this stakeholder points out:
But, I mean some of the insulin pens are really fiddly as well, like they’ve got really tiny numbers and
you have to dial it up and all that kind of thing, I don’t know how well they’re adapted for people
with visual problems or cognitive problems.
Dem 6
A systematic review90 of AT for people living with dementia (n = 41 studies) found that there is currently
little evidence to suggest that AT has an impact on the independence, safety or security of people living
with dementia. There was some evidence to support the use of AT to facilitate communication and provide
access to support and information for carers. The authors say that the research is characterised by the poor
performance of the technology, small samples and high drop-out rates, and that some AT (e.g. that to
improve safety and security) may not be acceptable to users. Furthermore, they suggest that ‘there is quite
a short span of time during which the person with dementia is able to use the technology’.90
Tailoring assistive technology to the needs of people living with dementia
In the UK, AT for people living with dementia is provided by a variety of sources, including health and social
care services and the private sector and AT that has been adapted by users for their own particular needs.
Qualitative research suggests that the bulk of provision involves the direct purchase of ‘off-the-shelf’
technology, which, if not specific to user needs, is adapted by family carers.91,97 A review of AT for people
living with dementia found that family carers were most likely to use technology that is not specific to caring
or to dementia, such as tablets, baby monitors, smart phones and light sensors.105 Health and social care
services appear to provide inadequate support because they have limited provision of appropriate technology
and/or they do not have the requisite knowledge base.91,118 Moreover, provision may be variable:
In one local authority, we went to one recently, a dementia kind of carers group and sat with them
and showed them a list from somewhere else and some of the devices on that weren’t on theirs, you
know? It’s not equitable . . .
Res 2
A number of commentators argue that it is important to involve people living with dementia in the
development of supportive technology. A systematic review127 examining the involvement of people living
with dementia in developing information technology (IT) applications found that people living with dementia
wanted to, and could, contribute to IT design. The authors argued that the involvement of people living
with dementia and their family carers can help to ensure the development of appropriate AT that is ‘fit for
purpose’ and that it can also enhance feelings of empowerment in people living with dementia.127 However,
even when included in the design of AT, people living with dementia are likely to need ongoing support. In
an ethnographic study133 looking at methods to support the involvement of older people in the coproduction
of AT, participants suggested that they would need ongoing support and assistance once the technology
had been provided and that family members would need to be involved throughout the provision process.
Coproduction involves the sharing of power between professionals and members of the public, working
together in equal partnership.163
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Support in the use of assistive technology
One of the ways in which AT needs to be tailored to people living with dementia and diabetes is to ensure
that interventions include appropriate support, for example from a family carer or a health or social
care professional:
. . . technologies are great but you need to think is it the right thing for the patient . . . is there enough
support around it to implement it and respond to it . . .
Res 2
The role of support in the use of AT, most often from family members, was a common theme.68,90,91,112,120,133,142
For example, a mixed-methods study68 on older people with diabetes and a qualitative study91 on people living
with dementia highlight the importance of family carer assistance in the use of AT. Family carers were found
to invest a substantial amount of effort in embedding AT to help their relatives to maintain independence and
reduce potential risks, which in turn minimises carer anxiety.91 Family support was also thought to increase
motivation to use, and participation in the use of, automated SM support.63 However, a feasibility study of
diabetes self-care support suggested that family ties are complex and family involvement in SM is not
always helpful.112
Technology in itself is unlikely to solve the problem of independent living for older people,97 particularly
those living with dementia.105 Knapp et al.105 write that ‘successful interventions need to recognise the
high value that many PLWD [people living with dementia] and their carers place on face-to-face service
contacts . . . technologies that seek to reduce these contacts are unlikely to be acceptable or used (or, if they
are, could exacerbate problems associated with social isolation and loneliness)’. AT, such as telehealth or
telecare, appears to be most effective when technology augmented or involved face-to-face contact.59,90 For
example, a controlled study59 evaluated the impact of a tailored educational intervention, delivered via Skype
on an iPad (Apple Inc., Cupertino, CA, USA), for older people with both type 2 diabetes and mild cognitive
impairment. There was an initial decrease in HbA1C levels post intervention but this was not sustained at
6 months. The authors account for this through the fact that contact with the HCPs ended, and that their
input had been instrumental in sustaining participant adherence. Participants in this study had few problems
using their iPads and wanted to continue using them after the trial to maintain social networking, retrieve
information and communicate via e-mail. The authors suggest that using such AT with trained volunteers over
the longer term may enable people living with dementia and diabetes to receive effective and efficient
medication management. However, it should be noted that participants were paid to take part in the study
and were given the iPads (neither of which is likely to be possible outside a research setting).
The importance of contact with a HCP was supported by a qualitative study61 exploring the use of a SM
programme for carers of people living with dementia; participants preferred blended care (face-to-face
and online modules) as they valued personal contact with a professional. As one participant said, ‘people
experience emotions, whilst a computer is just an object’.61 The assumption was that personal contact
could increase motivation and adherence, although the mechanism for achieving this was not identified
in the paper. This is supported by an evaluation of web-based appointments for people with diabetes in
Newham, East London. Older people were less likely to have broadband at home and only 11% of those
aged 70–79 years agreed to participate in Skype consultations, compared with 82% of those aged
< 50 years.164 In addition, a RCT of a cloud-based diabetes management programme aimed at improving
SM (not dementia) suggested that connectivity with a coach helped people to feel less anxious and
more motivated.99
Context–mechanism–outcome 6 summary
Evidence suggests that, in order to make AT usable for people living with dementia and diabetes and their
families, AT needs to be focused on the needs of the user (e.g. maintaining autonomy), involve people
living with dementia and their carers in its development and include family carers in installation and
training. Telehealth and telecare should be designed to involve (as the default option) care partners such
as other members in the family network. Appropriate support in the form of face-to-face contact appears
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to be an important contextual factor that may lead to improved motivation and adherence. Service
providers need to recognise the high value that people living with dementia and their family carers place
on face-to-face contacts.
Conclusions
The CMO configurations outlined in this chapter require changes in individual or organisational behaviour
or understanding, and in many cases both. For example, CMO 3 – which focuses on skills development –
requires the development of skills at an individual level but also organisational changes which legitimise
the importance of those skills and allows the time for them to be acquired and practised. The outcomes we
specified in the protocol for this synthesis included a number of clinical outcomes, such as the prevention of
hypoglycaemia, the management of cardiovascular risk factors and the identification and management of
long-term complications such as neuropathy.1 However, the outcomes that emerged from the evidence
available are primarily experiential rather than clinical, focusing on the need to trigger mechanisms such as
trust, confidence and empowerment. A general metamechanism that emerges is that there is some form
of synergy between an intervention strategy, disease progression and social and environmental factors
(in particular the involvement of family members). A flexible service model for people with dementia and
diabetes would enable this synergy in a way that would lead to the improved management of diabetes in
people living with dementia. These ideas are explored further in Chapter 4.
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Chapter 4 Discussion
The overall aims of this study were to identify key features or mechanisms of programmes and approachesthat aim to improve the management of diabetes in people with dementia, to understand how those
mechanisms operate in different contexts to achieve particular outcomes for this population and to identify
the areas needing further research. We used an iterative four-stage approach that optimised the knowledge
and networks of the research team and that was guided by the RAMESES criteria for realist review.47 In this
chapter we start by giving an overview of the findings and their implications; we then go on to discuss the
limitations of the study, and finish by outlining our suggestions for practice and future research.
Summary of findings
We included 89 papers, 10 of which focused directly on our target group of people living with dementia
and diabetes. The majority of the evidence related to people with dementia or diabetes or other long-term
conditions and was included because of the opportunities it provided for transferable learning. Our review
has resulted in an explanatory account of how interventions might work to improve the management of
diabetes in people living with dementia. We have generated six CMO configurations that explain the
importance of:
l embedding positive attitudes towards people living with dementia
l person-centred approaches to care planning
l developing skills to provide tailored and flexible care
l regular contact
l family engagement
l usability of AT.
These CMO configurations are summarised in Figure 7 and are grounded in evidence from the literature
and stakeholder perspectives. Although designed to be specific to people with dementia, the configurations
are also likely to be transferable to other groups who experience problems with diabetes management,
for example older people with complex health and social care needs.
Each CMO configuration involves a contingent change in individual or organisational behaviour or
understanding, and the programmes draw on a range of theoretical traditions and perspectives, some of
which come through in the analysis more strongly than others. Some key mid-range theories that relate to
the CMO configurations identified in the synthesis are summarised in Table 7. These mid-range, more
abstract theoretical perspectives provide a further resource that can be drawn on by people designing and
delivering interventions to manage diabetes in people living with dementia.
Explanatory framework
An overarching metamechanism emerges from the data. This relates to the convergence between an
intervention strategy, disease progression and social and environmental factors. Although this framework
(Figure 8) takes into account the trajectory of both dementia and diabetes, the dementia trajectory dominates.
This is because the progressive nature of most dementia means that people living with dementia, and their
family members, have to adapt continually to new issues or limitations,75,154 which may include adaptations in
the way in which diabetes is managed. Environmental factors include physical, cultural and economic elements,
the most important of which is the availability of support from informal carers, particularly family members.173
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The framework in Figure 8 represents a ‘dial’, whereby the arrows turn in relation to the dementia trajectory.
In the early stages, when people living with dementia and diabetes can still retain some functionality to make
decisions about their diabetes management, ‘personalisation’ and ‘relationship-building’ are key components
of care that involve the person living with dementia and diabetes, their family carer and their HCPs. This
requires a reorientation of staff capabilities towards a more patient-centred care perspective, prioritising
people living with dementia and diabetes and family perspectives over biomedical directives. As the dementia
trajectory moves towards increased cognitive difficulties, and independent functioning becomes more
problematic for the person living with dementia and diabetes, the dial moves towards greater ‘monitoring’
by the HCP and family carer as risks of poorer memory or behaviours have an impact on diabetes SM.
This risk-management perspective may increasingly use technology as a way of maintaining diabetes SM.
Types of interventions identified
in literature
•   SM support
•   Support for family carer
•   AT (often delivered remotely)
•   Training and support for HCPs
     (e.g. appropriate communication)
•   Shared decision-making
•   Case management
•   Integrated care
Potential mechanisms
(HCPs)
•   Confidence to deliver
     individualised care
•   Belief that PLWD have
     potential to be involved in SM
•   Empowered to act in best
     interest of PLWD rather than
     target driven
Potential mechanisms
(PLWD and family carer)
•   Trust in HCPs
•   Confidence to undertake SM
•   Awareness (e.g. of use of AT)
•   Feel supported and involved
•   Empowered
Outcomes (from literature)
•   Engagement in SM
•   Better fit between patient and carer
     needs and care planning
•   Greater use of AT
•   Patient and carer satisfaction
Potentially leading to
(but currently lack of evidence)
•   Fewer adverse events such as
     hypoglycaemic attacks, falls,
     hospitalisation (because
     appropriate support leads to better
     SM and health services able to
     anticipate and manage transitions)
•   Lessening of burden of medicalisation
Context
•   Embed positive attitudes towards
     PLWD
•   Person-centred approaches to
     care planning
•   Skills (HCPs) to provide tailored
     and flexible care
•   Regular contact
•   Family engagement
•   Usability of AT
FIGURE 7 Summary of CMO configurations. PLWD, people living with dementia.
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TABLE 7 Illustrative theories relating to CMO configurations
CMO configuration
Illustrative (mid-range)
theories Explanation
Embedding positive
attitudes towards people
living with dementia
Enablement148 Enablement theory emphasis what the person living with
dementia can do rather than what they cannot. In the early
stages of dementia the focus may be on functionality and
personal choice (e.g. involvement in SM) and then, as the
dementia progresses, the focus shifts towards
maintaining dignity148
Person-centred approaches
to care planning
Agency and personhood38 A person living with dementia should continue to be
recognised and respected as an individual and, when
applicable, as one member of a trusting relationship or
relationships.38 Supportive person-centred caregiving from
HCPs who know the individual’s biography and focus on
their assets rather than their losses will lead to resources
being used to support people living with dementia in
managing their diabetes
Developing skills to provide
tailored and flexible care
RCC165 To practise enablement with people living with dementia
and diabetes, HCPs need to acquire skills related to
RCC.165 RCC is the process by which the HCP achieves
patient-centred care through the relationships that they
build over time with the patient, family and other
professional colleagues.166 RCC theory has three aspects:
1. relationship between the patient and the HCP, through
which the practitioner develops knowledge and skills
that include the patient’s experience of health and
illness, developing and maintaining relationship with
the patient, and communicating clearly and effectively
2. relationship between the community and the HCP, in
particular the impact that the illness has on
family relationships
3. relationship between professional colleagues, requiring
skills in group dynamics and team-building165
Regular contact Continuity of care This refers to how contact, co-ordination of care,
information and shared decision-making is achieved and
sustained over time between patients and practitioners.
Continuity of care is particularly important for those
with complex health needs, such as people with dementia
and diabetes167 Continuity has moved to a partnership
paradigm in which continuity of care is recognised to be
constructed by patients, families and professionals, all of
whom have a part to play in its accomplishment168,169
Family engagement Therapeutic quadrangle154,170 The therapeutic quadrangle considers not just the
interconnectedness of the patient, main family carer and
HCPs in a ‘triangle of care’ model, but also the type of
chronic disease(s) that the patient suffers from. Within this
model, the interaction between the HCPs, patient and
family will vary according to the level of ‘technological’
care required at any given time through the disease
trajectory. In people living with dementia and diabetes,
there are two conditions that have different characteristics,
necessitating a flexible approach to the management of
care between family carer and HCP, taking into account
the preferences of the person living with dementia and
diabetes. The HCP needs to be alert to the progression
of dementia with its impact on diabetes and vice versa.
In addition, the HCP needs to consider how treatment
regimens might increase the burden of care on patient and
family, leading to the unintended consequence of people
disengaging from SM practices because they are too
difficult or because they feel overwhelmed
continued
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TABLE 7 Illustrative theories relating to CMO configurations (continued )
CMO configuration
Illustrative (mid-range)
theories Explanation
Usability of AT Coproduction97 Coproduction, and ‘ageing in place’, positions the person
living with dementia at the centre of the design process for
health technologies. It is a social process involving family
and HCPs and the customisation of technology for
individual use97
Activity theory171 Activity theory is a framework for understanding
human–computer interaction.171 Consciousness is located
in everyday actions and embedded in social interactions
between people and artefacts. These may be physical,
such as a smart phone, or phenomena, such as human
language. Understanding the way in which people living
with dementia and diabetes, carers, HCPs and artefacts
interact in everyday activity provides a basis for achieving
useable AT.172 As a consequence, people living with
dementia are enabled to use AT through a ‘scaffolding’
process as others (carers and HCPs) adjust their help and
support to match the abilities of the people living
with dementia
RCC, relationship-centred care.
Monitoring
Role of the
family
Staff
capabilities
(skills/
attitudes)
Relationships
Personalisation
(for people living
with dementia 
and family
carer)
Dementia
progresses
Early dementia
Ta
ilo
re
d
 A
T
In
d
ivid
u
al an
d
 o
rg
an
isatio
n
al ch
an
g
es
Flexib
ility
Managing diabetes in people living with dementia
Dementia
trajectory
FIGURE 8 Diagrammatic representation of explanatory framework.
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The relationship and personalisation perspectives are still essential but are adapted through the trajectory,
requiring HCPs to anticipate the needs of people living with dementia and diabetes and their family carers by
‘gearing up’ interventions during periods of cognitive decline and, when functionality has stabilised, ‘gearing-
down’ support, thus maintaining a personalised management approach to the uneven cognitive decline.
Context
The CMOs highlight a number of contextual factors that are likely to impact on the success, or otherwise,
of interventions or programmes to manage diabetes in people with dementia. These would include the
following.
l The broader organisational strategy and goals: to what extent do systems legitimise and prioritise SM
support and person-centred approaches for people with complex needs? Do current pathways meet
the needs of people with dementia and diabetes? Evidence from this review suggests that significant
changes are necessary at an organisational level.
l The specific requirements of the workforce: ordered so that they can provide individualised care to
people with dementia and diabetes. This may relate to individual development needs (e.g. necessary
knowledge of dementia and diabetes, appropriate communication skills) or to organisational or team
issues (e.g. appropriate skill mix, interprofessional working).
l Service organisation and delivery: the extent to which services are organised to engage with and
support family carers, provide continuity of care and anticipate changing needs (e.g. through regular
contact/monitoring).
Mechanisms
A realist approach argues that exposing the resources and reasoning within mechanisms and their
relationship to the context of their implementation is key to the evaluation of a complex programme of
change.174 Our review suggests that the design and delivery of programmes or services for people living
with dementia and diabetes will have a greater chance of ‘working’ (i.e. reducing feelings of powerlessness,
increasing independence and, potentially, improving glycaemic control) by paying attention to those
activities, or contexts, that engender the following mechanisms.
l Assets: stigma and negative assumptions about the capabilities of people living with dementia may
adversely affect their access to appropriate care. Systems need to foster the expectation in individuals
(patients and professionals) that people with dementia have the right to receive diabetes-related services
and that they (and their family carers) should be involved in the management of their condition.
l Inclusion/engagement: family carers need to feel valued and supported. Support may come through
one-to-one contact with professionals or from peers via group-based activities. Systems need routinely
to promote the involvement of family carers (e.g. information-sharing with family carers is the
default option).
l Confidence of HCPs: HCPs need to feel confident that they are acting in the best interests of the
people living with dementia and diabetes and that they are equipped to meet the patient’s needs.
For example, to change treatment goals or simplify medication regimens, they need to feel that it is
the ‘right’ thing to do. They also need to feel confident that the system supports them to deliver
personalised care.
l Confidence/empowerment of patients and carers: people living with dementia and diabetes and their
family carers need to feel confident in the treatment/care they are receiving and in their own abilities
to undertake SM-related tasks. Resources to create confidence in maintaining SM practices in the early
stages of the dementia trajectory might include diabetes-related education, programmes to teach
compensatory strategies to cope with memory changes, continuity of contact with specialist staff
(in both dementia and diabetes) and enablement-focused activities.
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l Trust: the evidence suggests that relationship continuity175 (e.g. a continuous therapeutic relationship
with one or more HCPs over time) is an important resource for triggering trust and the related
mechanism of confidence. Face-to-face contact is important in facilitating trust and encouraging the
person to participate in their care.
l Resonance: programmes and initiatives need to be cognitively, emotionally and physically relevant and
meaningful to people living with dementia and their family carers. For example, AT for people living
with dementia needs to focus on promoting independence and care plans need to ‘fit’ with the needs
and priorities of patients and their family carers.
Mechanisms are dynamic and may be interacting with each other;176 for example, in our programme
theory, trust is likely to operate in parallel to confidence. In addition, what is seen as a mechanism or
outcome in one CMO, such as a belief that people living with dementia have the right to diabetes care,
may, in turn, become a context in a subsequent CMO.177
Implications of the findings
Engaging with family carers
The need to engage with, and support, family carers of people living with dementia and diabetes is an
overarching theme throughout the CMOs. This review highlights the way in which the emotional support
and practical assistance provided by families is key in the management of long-term conditions and of
particular importance for those with complex needs such as dementia and diabetes. Despite this, carers
often feel undervalued or ill-prepared to take on caring responsibilities. A survey of carers of older people
with diabetes found that 40% of family carers had never received any information about diabetes from
professionals.41 Many of the support needs of family carers identified in this review are not specific to
people caring for a family member with dementia and diabetes; they could equally apply to those caring
for people with dementia and other comorbidities. However, there are clearly some concerns that are
particularly pertinent to family members of people living with dementia and diabetes. Although many
carers may find medication management stressful, this is often exacerbated for family carers of people
with dementia and diabetes owing to their concerns about the prevention of adverse events associated
with either hypoglycaemia or hyperglycaemia.39,64,142
To generate carers’ confidence in their ability to undertake diabetes-related care, we argue that they are
likely to need education combined with ongoing support from a specialist in diabetes about timing of
medication, diet, how to recognise the common signs and symptoms of hypoglycaemia and how to
distinguish between symptoms of dementia and diabetes.28 They may also have needs related to the
dementia, such as how to manage behaviours that challenge. Support needs to be individualised and
adapted over time to reflect the changing needs of the person living with dementia and diabetes–carer
dyad, and to create opportunities to review priorities.
How best to support carers of people living with dementia and diabetes is unclear. Caregivers often report
high level of satisfaction with interventions178 but the evidence of effectiveness for most interventions is
weak.157 The lack of effectiveness may be due, in part, to methodological problems with the outcomes
used in these studies. Although depressive symptoms are one of the most widely used outcomes in
caregiver intervention studies, not all carers will have depressive symptoms.179 Zarit and Femia179 argue that
caregiving should not be viewed as if it were a psychiatric disorder like major depression. In addition, they
argue that there is heterogeneity in caregivers’ experiences of a relative’s dementia and not all will react
to stressors and resources in the same way. Interventions need to be adaptive or tailored,180 but for
interventions to be tailored appropriately we need to better understand what caregivers want.181
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Minimally disruptive medicine
The complex needs of people with dementia and diabetes require new ways of looking at how we organise
and deliver care for this patient group. Minimally disruptive medicine is focused on achieving patient goals
for life and health while imposing the smallest possible burden on patients’ lives.182,183 It is an approach that
recognises that people living with multiple chronic conditions are likely to be overwhelmed by the work
involved in being a patient183 and suggests that there is a need to move away from targets to practices that
foster trust and care. For someone with dementia and diabetes, rather than intensifying treatment in the
face of poor outcomes, it may be that clinicians needs to focus on ‘can you really do what I’m asking you to
do?’.184 Minimally disruptive medicine for someone with dementia and diabetes might involve changing or
simplifying medication regimens, for example by reducing the total number of tablets prescribed and/or
giving tablets once per day if possible.28 Fostering trust, for example through a continuous therapeutic
relationship between a professional and the patient–carer dyad, is likely to make this easier.185
People living with dementia without family carers or support
There is very little evidence on which to base any recommendations for practice for people living with
dementia and diabetes who live alone and have very limited networks of support from family or friends.
The focus on the role of the carer highlighted in this work is clearly very significant, not just because of
what it indicates about the support needs of family carers but also because of the implications for service
provision for people who do not have family support. Research suggests that people with dementia who
live alone are at an increased risk of having unmet social, environmental, psychological and medical
needs.39,186 Our CMO on person-centred approaches to care planning identified the generation of trust
between the HCPs and the people living with dementia as necessary to improve care planning and SM.
Building trusting relationships with HCPs may be particularly important for those who live alone as they do
not have a family member to facilitate access and continuity of care39 and are likely to be more dependent
on HCPs to perform this role.187 However, a qualitative study188 reported that people living with dementia
who lived alone found it difficult to trust others and admit to their mistakes or challenges, because they
feared being placed in long-term care.
Tailoring and person-centred care
Running through our programme theory are ideas about person-centred care, tailoring and individualised
care. These are identified as resources necessary to trigger mechanisms such as trust, empowerment and a
belief that SM is achievable and worthwhile. These ideas are not new189 and have been applied to both
those with dementia38 and those with diabetes.190 Guidance for both conditions recommends person-
centred care.30,191,192 What this synthesis does is begin to identify what some of the key components of
person-centred care or tailoring would be and what changes this might entail in individual practice and
organisational approaches. For example, the instigation of individualised (possibly simplified) diabetes
regimens requires that the person living with dementia and diabetes sees an appropriate specialist(s) or
that generalists such as GPs and practice nurses have appropriate knowledge about how to tailor diabetes
care. It also relies on HCPs knowing that such actions are legitimised, for example through less focus on
biomedical targets and time allocation to establish an understanding of the individual’s story and priorities.
This is, inevitably, linked to continuity and having a practitioner who both understands the dementia
trajectory and can respond as care needs alter.39
Collaboration and communication
Poor communication and collaboration between different specialties have been identified as significant
barriers to continuity of, and access to, care for people with dementia and comorbidities such as
diabetes.39,142,193 This also emerged very strongly from our stakeholder interviews. Many of our stakeholders
talked about the problems caused by poor communication between disciplines, an inability to share records
across different sectors and specialties, and a lack of understanding of each other’s roles and responsibilities.
We considered developing this theme as one of our CMOs. However, although this issue was clearly of great
importance, we felt that it was generic rather than specific to dementia and diabetes and, as such, that it fell
outside the remit of this review. Nevertheless, future initiatives for people with dementia and diabetes will
need to consider how to improve communication and collaboration between individual health and care
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professionals and between organisations; perhaps through the co-location of different specialties. This will
include the need for better documentation and communication of decisions around treatment burden and
risk (e.g. decisions to deprescribe).
Care pathways
One of the questions that arose throughout the review was the extent to which ‘good care’ for people
with dementia and diabetes required specific diabetes interventions and how much related more generally
to interventions for the management of older people with complex health and social care needs. A UK
study194 found that, on average, people living with dementia had 4.6 chronic illnesses in addition to their
dementia. Therefore, people with dementia and diabetes are likely to have other conditions, such as
hypertension or arthritis,195 that may further complicate management and create clinical uncertainty.
A Cochrane review looked at managing multimorbidity in primary and community care settings.196 The
review, which includes 18 studies, found some evidence to suggest that interventions targeted at specific
risk factor management (e.g. the management of vascular risk factors and depression in people with
comorbid vascular disease and depression) or focused on areas where people have difficulties, such as with
functional ability or medicines management, were effective. Initiatives also need to be integrated into
health-care systems.196 Our review would add to this by suggesting that building confidence in medicines
management and promoting functional ability in people living with dementia and their carers is reliant on
multiple contexts that allow clinicians to base assessment on familiarity with the patient’s (and carer’s)
story, priorities and needs. Longer consultations are needed for patients with the ‘cumulative complexity’
of multiple chronic conditions and for those less able to articulate their priorities and needs,197 both of
which apply to people with dementia and diabetes.
Strengths and limitations
One of the main limitations of this synthesis was the lack of evidence relating to the management of
diabetes in people living with dementia. The qualitative and observational evidence detailed some of the
individual and organisational challenges involved in managing diabetes in people living with dementia,
but there was a paucity of discussion about the underlying assumptions of the research or interventions
tested for this group. However, in realist methodology the unit of analysis is the programme theory, or
underpinning mechanism of action, rather than the intervention;50 as such, we were able to draw on a wider
literature that provided opportunities for transferable learning. This enabled us to develop a theory-driven
explanation, in the form of six CMO configurations that make up a programme theory, to inform the care of
people living with dementia and diabetes. The programme theory that we have developed can be used to
guide future initiatives and interventions.
The outcomes in our CMOs are largely experiential rather than clinical. This reflects the evidence available.
Outcomes such as increased engagement in SM are potential surrogates for better clinical management
of diabetes, but this is not proven. We included a number of clinical outcomes such as the prevention of
hypoglycaemia, the management of cardiovascular risk factors and the identification and management
of long-term complications such as neuropathy. Although these outcomes may be important, the literature
suggests that key goals for this group are maintaining independence and creating treatment regimens that
‘fit’ with the needs and abilities of people living with dementia and their family carers. However, literature
in this area is scarce, and further work is needed to identify what it is that people living with dementia and
diabetes and their family carers want from interventions.180
Much of the evidence we included related to either people living with dementia or people with diabetes,
rather than people with both conditions. Inevitably, the aims, focuses and outcomes of these two sets of
studies are very different. Moreover, because we drew on this larger literature, there were many more
potentially relevant sources of information than we could possibly cover. However, the nature of realist
synthesis means that there is not a finite set of relevant papers that can be found. Rather, the reviewer
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takes a more purposive approach to sampling,50 with the aim of reaching conceptual saturation rather
than identifying an exhaustive set of studies.74 In this review, conceptual saturation was reached in relation
to findings about the need to address stigma, personalise care, increase patient and practitioner trust and
confidence, and to identify what supports independence. Owing to the limited nature of the evidence,
we felt that including further studies would not add anything new to the programme theory.
A realist review takes a particular position on how the quality of evidence is judged.50,198 The traditional
hierarchy of evidence is rejected in favour of an approach that prioritises the way in which studies contribute
to the development of the programme theory. For example, ‘do the inferences made in a study gel with
those from other studies?’.198 A realist review is concerned with theoretical depth and transferability rather
than with developing statements or recommendations that have statistical certainty about questions of
effectiveness or cost-effectiveness.50 In line with this approach, we assessed evidence on how it contributed
to our theory development. We did not undertake formal quality assessment, but in our data extraction
process we included questions that allowed us to assess the relevance and rigour of the evidence. This
included an appraisal of whether or not the evidence linked to the theory areas, whether or not it provided
valuable information, if it could be relied on and if it contributed to the review.
The use of a realist approach allowed us to develop a plausible programme theory about what works in
the management of diabetes in people with dementia. However, the lack of directly relevant evidence
means that the extent to which our CMOs could be tested using empirical studies was limited. In addition,
in developing our CMOs we found it much easier to describe the context or resources that were needed
than either the mechanisms or the outcomes. Most studies did not report the outcomes specified in our
protocol and few were explicit about what they thought the mechanisms were that explained their study
outcomes. However, the plausibility of our programme theory was refined through extensive consultation
with experts in dementia and diabetes and with service user representatives. This included one-to-one
interviews, a consensus meeting at the end of the study, workshops with the project team and
consultation with the experts on our advisory committee.
Conclusions
Dementia and diabetes mellitus are common long-term conditions that coexist in a large number of older
people.2,3 The cognitive and physical consequences of dementia have an impact on the ability of people
living with dementia to manage their diabetes and puts them at risk of complications such as hypoglycaemic
episodes, cardiovascular conditions and amputations,4–6 which place a huge burden on health and social care
economies.7 Moreover, the impact of dementia and diabetes on patients and their families is considerable.
The priority for HCPs is how to accommodate the challenges of living with dementia as a long-term
condition with the minimum requirements of good diabetic control, recognising that perceptions of ‘good’
are situation specific, differ for people living with dementia and diabetes and for family carers and will
change over time. The dearth of literature on people living with dementia and diabetes and, as importantly,
their supporters and family carers is mirrored in the wider literature. This review suggests that there is a
need for further work to establish a shared understanding of what needs to be in place to engage
effectively with people living with dementia including those with diabetes and their supporters to establish
how ‘good support’ is operationalised and measured.
The role of family carers in managing the health-care conditions of people living with dementia, and their
contribution in facilitating continuity of, and access to, care, are indisputable.39 It is important, therefore,
that HCPs conceptualise the provision of care for people with dementia and a comorbidity as a complex
phenomenon that affects not just individuals but also dyads and families.45 The challenges of being a carer
have been exhaustively documented; legislation and staff training to ensure that carers are recognised and
supported has been in place for some time. What is not so well understood is how to involve and support
family carers at different stages of the trajectory for people with dementia and diabetes.39
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Although both hyperglycaemia and hypoglycaemia can have adverse effects for people living with dementia
and diabetes, the prevention of hypoglycaemia seems to be particularly important.25 Despite this, evidence
suggests that older people with diabetes are often overtreated and given inappropriate medications.25
Moreover, the ability of people living with dementia and diabetes and their family carers to cope with
medication regimens is not taken into account. This review suggests that there is a need to prioritise quality
of life, independence and patient and carer priorities over a more biomedical, target-driven approach. Much
of the research included in this review, particularly that specific to people living with dementia and diabetes,
identifies deficiencies and problems with current systems. Although we have highlighted the need for
personalised care, continuity and family-centred approaches, there is much evidence to suggest this is not
currently happening. Future research on the management of diabetes in older people with complex health
needs, including those with dementia, needs to look at how organisational structures and workforce
development can be better aligned to the needs of people living with dementia and diabetes.
Implications for practice
The following implications for practice have emerged from the review.
l The evidence suggests that SM for people with dementia and diabetes needs to be conceptualised
as an activity that frequently involves not just the person with dementia but also family members.
Therefore, SM should include the identification of family carers, appropriate training in carer
engagement for staff, and protocols regarding confidentiality and information sharing.
l Self-management support needs to be seen by HCPs as a legitimate activity, and pathways should be
adapted to enable the regular assessment of SM capabilities and to provide appropriate SM support for
people living with dementia and diabetes and their family carers.
l Family carers are likely to require diabetes-specific education and advice (e.g. about the appropriate
timing of medication and access to food, how to recognise the common signs and symptoms of
hypoglycaemia and how to distinguish between symptoms of dementia and those of diabetes).
l Staff caring for people with diabetes need appropriate training on dementia and the impact that this
might have on the management of diabetes. This applies to staff at all levels, including those more senior.
l HCPs caring for people living with dementia and diabetes need education in enablement approaches
to SM.
l HCPs caring for people with dementia and diabetes need regularly to assess a patient’s ability to
self-manage and to identify when they, or their family carer, may need additional support.
l HCPs caring for people with dementia and diabetes may need training or guidance on how to
incorporate ideas about deprescribing and minimally disruptive medicine (e.g. the management
of uncertainty).
l There is a need for better integration of physical and mental health-care systems, that is, old-age
psychiatry teams and geriatric teams working together and community-based geriatric and frailty teams
having specialist mental health staff as an integral part of the team.
l People with dementia and diabetes who live alone, or who do not have family support, may be
particularly disadvantaged and may need additional help and monitoring from HCPs and care staff.
l People living with dementia and diabetes are likely to benefit from longer appointments in both
primary and secondary care, and booking systems should allow for this.
l People living with dementia and diabetes, particularly those who live alone, are likely to need regular
(preferably face-to-face) contact with HCPs who are familiar with their needs and problems.
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Suggestions for future research
A number of potential areas for future research were identified by the review. These are listed in order of
priority and include the following.
l What is the impact of SM interventions for people with dementia and diabetes that involve family carers?
l What interventions can be used to improve medication management in people with dementia and
diabetes and their family carers; for example, what is the impact of pharmacist-led interventions?
l What sort of care pathway is most appropriate and effective? For example, a specific dementia and
diabetes pathway or a pathway for older adults with complex needs (vulnerability pathway)?
l What sort of support do family caregivers of people with dementia and diabetes want and how can
interventions be designed to reflect this?
l How can professionals caring for people with dementia and diabetes be helped to recognise when a
person is no longer able to self-manage, or when there is a need to ‘gear-up’ or ‘gear-down’ support?
l What are important outcomes and goals for people with dementia and diabetes and their family carers?
l How can AT support SM for people with dementia and diabetes and how do their needs change as the
dementia trajectory progresses?
l What impact does the stage/extent of cognitive and physical impairment have on the uptake and
outcomes of interventions?
l Are interventions that take an assets-based approach to the care of people with dementia and diabetes
(e.g. promoting confidence, empowerment and independence) more effective?
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Dr Charles Fox Consultant Physician with Expertise in Diabetes
Professor Yoon Loke Professor of Medicine and Pharmacology, Norwich Medical School (interest in the
harms of hypoglycaemia)
Dr Ana Manzano-Santaella Lecturer in Health and Social Policy, University of Leeds (expertise in evaluation of
complex health-care interventions using realist approaches)
Dr Paul Millac Member of University of Hertfordshire Patient and Public Involvement Group
Ms Diane Munday Member of University of Hertfordshire Patient and Public Involvement Group
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Appendix 2 Search strategy
Search strategy
Search terms were devised by Frances Bunn and Peter Reece Jones and then discussed with other team
members and with an information scientist (Beth Hall). The search terms were chosen to reflect our three
main theory areas.
The searches were split into three categories: A, dementia and diabetes; B, dementia only; and C, diabetes
only. Each category was then divided into three to reflect each of the programme theories. For example,
A1 is the category of dementia and diabetes plus theory area 1 (clinically based approach).
The main searches are A1, A2 and A3, which include terms for both dementia and diabetes. However,
because there was little that covered both, we also looked at literature that focused on either dementia
only (B1, B2 and B3) or diabetes only (C1, C2 and C3). An overview of the search strategy can be seen in
Table 8. This is followed by details of the full search terms for PubMed. The terms were adapted as
appropriate for other databases.
PubMed: first searches were run on 8 March 2016 (all searches were limited to 1990 onwards to coincide
with some of the early papers from Alan Sinclair).
Updated searches around tailored care, individualised care
and multimorbidity
A new search was run on 27 April 2016 as a result of discussions at the project workshop. The suggestion
was that we should be looking at care for people with comorbidity.
TABLE 8 Overview of search strategy
Focus of search
Theory area 1: clinically
based approach
Theory area 2:
collaborative
partnerships Theory area 3: coproduction
Dementia
and diabetes
A1 A2 A3
Theory area 3 produced very
few hits, so all searches
(A, B and C) were combined
Dementia only B1 B2 B3
Diabetes only C1 C2 C3
Large area so was agreed
could use clinical guidelines
(e.g. recent Sinclair
guidelines26,28,30) as these
provide up-to-date evidence
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BOX 3 Details of search terms: dementia and diabetes
A1
#1 ((((((“diabetes”[Title/Abstract]) OR “insulin”[Title/Abstract]) OR “hypoglycaemia”[Title/Abstract]) OR
“hyperglycaemia”[Title/Abstract]) OR “glycaemic control”[Title/Abstract]) OR “glycemic control”[Title/Abstract])
OR “hba1c”[Title/Abstract]) OR (diabetes[Title/Abstract] OR insulin[Title/Abstract] OR (glycaemic control)[Title/
Abstract] OR (glycemic control)[Title/Abstract] OR hypoglycaem*[Title/Abstract] OR hypoglycemi*[Title/Abstract]
OR hyperglycaem*[Title/Abstract] OR hyperglycem*[Title/Abstract] OR Hba1C[Title/Abstract] – includes both
MeSH and free text
#2 (“dementia”[Title/Abstract]) OR “alzheimer”[Title/Abstract]) OR “alzheimers”[Title/Abstract]) OR “mild
cognitive impairment”[Title/Abstract]) OR “cognitive impairment”[Title/Abstract]) OR (dement*[Title/Abstract]
OR alzheimer*[Title/Abstract] OR MCI[Title/Abstract] OR cognitive impairment[Title/Abstract])
#3 = #1 AND #2
#4 (((manage*[Title/Abstract] OR treat*[Title/Abstract] OR intervention*[Title/Abstract] OR programme*[Title/
Abstract] OR program*[Title/Abstract] OR controlled[Title/Abstract] OR randomized[Title/Abstract] OR randomised
[Title/Abstract] OR interview*[Title/Abstract] OR qualitative[Title/Abstract] OR trial[Title/Abstract])) OR “randomised
controlled trial”) OR “intervention study”
#5 = #3 AND #4
Not
((((“cross sectional study”) OR “epidemiological studies”) OR “case control”) OR “cohort study”) OR “cross
sectional studies”
N = 2868
A2
#1 ((((((“diabetes”[Title/Abstract]) OR “insulin”[Title/Abstract]) OR “hypoglycaemia”[Title/Abstract]) OR
“hyperglycaemia”[Title/Abstract]) OR “glycaemic control”[Title/Abstract]) OR “glycemic control”[Title/Abstract])
OR “hba1c”[Title/Abstract]) OR (diabetes[Title/Abstract] OR insulin[Title/Abstract] OR (glycaemic control)[Title/
Abstract] OR (glycemic control)[Title/Abstract] OR hypoglycaem*[Title/Abstract] OR hypoglycemi*[Title/Abstract]
OR hyperglycaem*[Title/Abstract] OR hyperglycem*[Title/Abstract] OR Hba1C[Title/Abstract] – includes both
MeSH and free text
#2 (“dementia”[Title/Abstract]) OR “alzheimer”[Title/Abstract]) OR “alzheimers”[Title/Abstract]) OR “mild
cognitive impairment”[Title/Abstract]) OR “cognitive impairment”[Title/Abstract]) OR (dement*[Title/Abstract]
OR alzheimer*[Title/Abstract] OR MCI[Title/Abstract] OR cognitive impairment[Title/Abstract])
#3 = #1 AND #2
#4 (((“self care”[Title/Abstract]) OR “self management”[Title/Abstract]) OR “self medication”[Title/Abstract])
OR “self administration”[Title/Abstract]) OR “minimally disruptive medicine”[Title/Abstract]) OR “adherence”
[Title/Abstract]) OR “shared decision making”[Title/Abstract]) OR “patient preference”[Title/Abstract]) OR
“patient participation”[Title/Abstract]) OR “patient involvement”[Title/Abstract]) OR “patient centred care”
[Title/Abstract]) OR “personalised care”[Title/Abstract]) OR “individualised care”[Title/Abstract]) OR (partnership
[Title/Abstract] OR collaboration[Title/Abstract]) Filters: Publication date from 1990/01/01
#5 = #3 AND #4
N = 113
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A3
#1 ((((((“diabetes”[Title/Abstract]) OR “insulin”[Title/Abstract]) OR “hypoglycaemia”[Title/Abstract]) OR
“hyperglycaemia”[Title/Abstract]) OR “glycaemic control”[Title/Abstract]) OR “glycemic control”[Title/Abstract])
OR “hba1c”[Title/Abstract]) OR (diabetes[Title/Abstract] OR insulin[Title/Abstract] OR (glycaemic control)[Title/
Abstract] OR (glycemic control)[Title/Abstract] OR hypoglycaem*[Title/Abstract] OR hypoglycemi*[Title/Abstract]
OR hyperglycaem*[Title/Abstract] OR hyperglycem*[Title/Abstract] OR Hba1C[Title/Abstract] – includes both
MeSH and free text
#2 (“dementia”[Title/Abstract]) OR “alzheimer”[Title/Abstract]) OR “alzheimers”[Title/Abstract]) OR “mild
cognitive impairment”[Title/Abstract]) OR “cognitive impairment”[Title/Abstract]) OR (dement*[Title/Abstract]
OR alzheimer*[Title/Abstract] OR MCI[Title/Abstract] OR cognitive impairment[Title/Abstract])
#3 = #1 AND #2
#4 (((((“co production”) OR “co design”) OR “codesign”) OR “coproduction”) OR “co creation”) OR
(co-produc* OR coproduc* OR co-design* OR codesign* OR co-creat* OR cocreat* OR co-commission* OR
cocommission) Filters: Publication date from 1990/01/01 (MeSH and free text)
#5 = #3 AND #4 = 0
BOX 4 Details of search terms: dementia only
B1
#1 ((((“dementia”[Title/Abstract]) OR “alzheimer”[Title/Abstract]) OR “alzheimers”[Title/Abstract]) OR “mild
cognitive impairment”[Title/Abstract]) OR “cognitive impairment”[Title/Abstract]) OR (dement*[Title/Abstract]
OR alzheimer*[Title/Abstract] OR MCI[Title/Abstract] OR cognitive impairment[Title/Abstract])
#2 (diet[Title/Abstract] OR exercise[Title/Abstract] OR blood glucose[Title/Abstract] OR blood pressure[Title/Abstract]
OR medication[Title/Abstract] OR adherence[Title/Abstract] OR self management[Title/Abstract]) Filters: Publication
date from 1990/01/01
#3 = #1 AND #2
#4 (((manage*[Title/Abstract] OR treat*[Title/Abstract] OR intervention*[Title/Abstract] OR programme*
[Title/Abstract] OR program*[Title/Abstract] OR controlled[Title/Abstract] OR randomized[Title/Abstract] OR
randomised[Title/Abstract] OR interview*[Title/Abstract] OR qualitative[Title/Abstract] OR trial[Title/Abstract]))
OR “randomised controlled trial”) OR “intervention study”
#5 = #3 AND #4
#6 Not
((((“cross sectional study”) OR “epidemiological studies”) OR “case control”) OR “cohort study”) OR “cross
sectional studies”
N = 4767
BOX 3 Details of search terms: dementia and diabetes (continued)
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B2
#1 ((((“dementia”[Title/Abstract]) OR “alzheimer”[Title/Abstract]) OR “alzheimers”[Title/Abstract]) OR “mild
cognitive impairment”[Title/Abstract]) OR “cognitive impairment”[Title/Abstract]) OR (dement*[Title/Abstract]
OR alzheimer*[Title/Abstract] OR MCI[Title/Abstract] OR cognitive impairment[Title/Abstract])
#2 (self care[Title/Abstract] OR self management[Title/Abstract] OR self medication[Title/Abstract] OR self
administration[Title/Abstract] OR minimally disruptive medicine[Title/Abstract] OR adherence[Title/Abstract] OR
shared decision making[Title/Abstract] OR patient preference[Title/Abstract] OR patient participation[Title/
Abstract] OR patient involvement[Title/Abstract] OR patient centred care[Title/Abstract] OR patient Centered
care[Title/Abstract] OR personalised care[Title/Abstract] OR individualised care[Title/Abstract] OR individualized
care[Title/Abstract] OR personalized care[Title/Abstract]) Filters: Publication date from 1990/01/01
#3 = #1 AND #2
N = 1257
B3
#1 ((((“dementia”[Title/Abstract]) OR “alzheimer”[Title/Abstract]) OR “alzheimers”[Title/Abstract]) OR “mild
cognitive impairment”[Title/Abstract]) OR “cognitive impairment”[Title/Abstract]) OR (dement*[Title/Abstract]
OR alzheimer*[Title/Abstract] OR MCI[Title/Abstract] OR cognitive impairment[Title/Abstract])
#2 ((((“co production”) OR “co design”) OR “codesign”) OR “coproduction”) OR “co creation”) OR
(co-produc* OR coproduc* OR co-design* OR codesign* OR co-creat* OR cocreat* OR co-commission* OR
cocommission) Filters: Publication date from 1990/01/01
#3 = #1 AND #2
N = 20
BOX 5 Details of search terms: diabetes only
C1
Use clinical guidelines.
C2
#1 ((((((“diabetes”[Title/Abstract]) OR “insulin”[Title/Abstract]) OR “hypoglycaemia”[Title/Abstract]) OR
“hyperglycaemia”[Title/Abstract]) OR “glycaemic control”[Title/Abstract]) OR “glycemic control”[Title/Abstract])
OR “hba1c”[Title/Abstract]) OR (diabetes[Title/Abstract] OR insulin[Title/Abstract] OR (glycaemic control)[Title/
Abstract] OR (glycemic control)[Title/Abstract] OR hypoglycaem*[Title/Abstract] OR hypoglycemi*[Title/Abstract]
OR hyperglycaem*[Title/Abstract] OR hyperglycem*[Title/Abstract] OR Hba1C[Title/Abstract] – includes both
MeSH and free text
#2
(((“frailty”) OR “older”) OR “elderly”) OR “geriatric”) OR “elder”) OR “aged” Filters:Publication date from
1990/01/01 – all MeSH
BOX 4 Details of search terms: dementia only (continued)
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PubMed
#1 Tailored care OR tailoring OR individualised care OR individualized care OR personalised care OR
personalized care or needs based care (all MESH)
#2 (tailored[Title/Abstract] OR tailor*[Title/Abstract] OR individualised[Title/Abstract] OR individualized[Title/
Abstract] OR personalised[Title/Abstract] OR personalized[Title/Abstract] OR “needs based”[Title/Abstract])
#3 #1 OR #2
#4 multimorbidity OR multimorbid Or comorbidity OR comorbid OR frailty (all MESH)
#5 #3 AND #4
#6 (manage*[Title/Abstract] OR treat*[Title/Abstract] OR intervention*[Title/Abstract] OR programme*
[Title/Abstract] OR program*[Title/Abstract] OR controlled[Title/Abstract] OR randomized[Title/Abstract]
OR randomised[Title/Abstract] OR trial[Title/Abstract])) OR “randomised controlled trial”) OR
“intervention study”)
#7 #5 AND #6
N = 162
#3 (self care[Title/Abstract] OR self management[Title/Abstract] OR self medication[Title/Abstract] OR self
administration[Title/Abstract] OR minimally disruptive medicine[Title/Abstract] OR adherence[Title/Abstract]
OR shared decision making[Title/Abstract] OR patient preference[Title/Abstract] OR patient participation[Title/
Abstract] OR patient involvement[Title/Abstract] OR patient centred care[Title/Abstract] OR patient Centered
care[Title/Abstract] OR personalised care[Title/Abstract] OR individualised care[Title/Abstract] OR individualized
care[Title/Abstract] OR personalized care[Title/Abstract]) Filters: Publication date from 1990/01/01
#4 = #1 AND #2 AND #3
N = 4670
C3
#1 ((((((“diabetes”[Title/Abstract]) OR “insulin”[Title/Abstract]) OR “hypoglycaemia”[Title/Abstract]) OR
“hyperglycaemia”[Title/Abstract]) OR “glycaemic control”[Title/Abstract]) OR “glycemic control”[Title/Abstract])
OR “hba1c”[Title/Abstract]) OR (diabetes[Title/Abstract] OR insulin[Title/Abstract] OR (glycaemic control)
[Title/Abstract] OR (glycemic control)[Title/Abstract] OR hypoglycaem*[Title/Abstract] OR hypoglycemi*[Title/Abstract]
OR hyperglycaem*[Title/Abstract] OR hyperglycem*[Title/Abstract] OR Hba1C[Title/Abstract] – includes both MeSH
and free text
#2 ((((“co production”) OR “co design”) OR “codesign”) OR “coproduction”) OR “co creation”) OR
(co-produc* OR coproduc* OR co-design* OR codesign* OR co-creat* OR cocreat* OR co-commission*
OR cocommission) Filters: Publication date from 1990/01/01
#3 = #1 AND #2
N = 57
BOX 5 Details of search terms: diabetes only (continued)
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Appendix 3 Data extraction form
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Abdelhafiz et al., 201625 NA Review To explore the relationship
between hypoglycaemia, frailty
and dementia and the
implications for clinical practice
NA Dementia
AND diabetes
Older people with frailty
diabetes and/or dementia
Aikens et al., 201563 USA Before-and-after study To investigate the potential
benefits of integrating a
patient-selected support person
into an automated diabetes
telemonitoring and
SM program
Automated telemonitoring
service for diabetes that used
interactive voice response
telemonitoring in which
patients respond to
prerecorded queries using
their telephone keypad.
System then provided tailored
SM messages and notified
clinical team about problems
that might require additional
follow-up
Diabetes
NOT dementia
People with T2DM who
are non-adherent to
medication. Majority of
care partners were
adult children
Alsaeed et al., 201679 NA Literature review To investigate the facilitators of
optimal medicines use from the
perspectives of people living
with dementia and their
caregivers
NA Dementia
NOT diabetes
People living with
dementia and/or
care partners
Anderson et al., 201573 USA Opinion/discussion To shift focus from symptoms
to symptoms and the
challenges that they pose for
patients/families
NA Other Relates to people with
chronic illness
Bahar-Fuchs et al., 201380 NA SR To evaluate the effectiveness
and impact of cognitive training
and/or rehabilitation for people
with mild Alzheimer’s disease
or vascular dementia in relation
to important cognitive and
non-cognitive outcomes for the
person and their primary
caregiver in the short, medium
and long term
Cognitive rehabilitation or
training for people with
dementia (interventions that
directly or indirectly target
cognitive functioning as
opposed to those that focus
on behavioural, emotional or
physical functions)
Dementia
NOT diabetes
People with Alzheimer’s
disease or vascular
dementia
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Bailey et al., 201681 USA RCT To determine the impact of
a PDA for decisions about
antihyperglycaemic medications
on key elements of shared
decision-making
The interactive diabetes
decision aid for T2DM:
presented on computer,
designed to help people
understand T2DM, and the
full range of treatment
options
Diabetes
NOT dementia
English-speaking
participants with T2DM
receiving metformin with
persistent hyperglycaemia
who were recommended
to consider
medication intensification
Baxter, 201457 UK Opinion/discussion To improve standards of
diabetes care
NA Diabetes
NOT dementia
Article relates to people
with diabetes
Bergdahl et al., 201372 Sweden Qualitative To explore planned home care
nursing encounters in
palliative care
NA Other Older people with cancer
and comorbidities, family
carers and nurses
Beverly et al., 201470
(same study as
Beverly 2011199)
USA Qualitative To explore how older adults
manage and cope with T2DM
and self-care and other
chronic conditions
NA Diabetes
NOT dementia
Older adults diagnosed
with T2DM and at least
one other chronic
health condition
Boots et al., 201482 NA SR To provide an overview of the
evidence for the effectiveness,
feasibility and quality of
internet interventions for
informal caregivers of people
with dementia
A variety of internet
interventions for carers of
people living with dementia
are reviewed (e.g. website
or website and support,
workshop sessions, online
training)
Dementia
NOT diabetes
Informal carers of people
living with dementia
Boots et al., 201661 Netherlands Qualitative To (1) develop an online SM
programme for early-stage
dementia carers to increase
self-efficacy and goal
attainment, and (2) evaluate
the programme’s feasibility and
report preliminary data
on effectiveness
Face-to-face meeting with an
appointed ‘coach’ (always the
same HCP) followed by
completion of the online tool
to ‘skill up’ informal carers of
people living with dementia
and improve their coping
strategies; during this stage
the coach is available to help
with any issues and a final
meeting with the coach
occurs after completion
Dementia
NOT diabetes
Spousal carers of people
living with mild to
moderate dementia
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Branda et al., 201371 USA RCT To evaluate the impact of
patient decision aids vs. usual
care on decision making
measures, metabolic control
and medication adherence
Diabetes medication choice
decision aid vs. statin choice
decision aid. Clinicians
received minimal training
Diabetes
NOT dementia
HCPs: physicians, nurses,
nurse practitioners and
physician assistants who
cared for patients with
T2DM. Patients: adults
with T2DM of a duration
> 1 year and a reason,
identified by a clinician,
to consider changing
their antihyperglycaemic
or lipid-lowering
regimens
Brown et al., 201583 UK Opinion/discussion To inform nursing staff about
current practice for managing
diabetes for people living
with dementia
NA Dementia
AND diabetes
Relates to people living
with dementia and
diabetes, their carers
and family
Bunn et al., 201639 UK Mixed methods To explore the impact of
dementia on access to
non-dementia services and
identify ways of improving the
integration of services for
this population
NA Dementia
AND diabetes
Older people living with
dementia and comorbid
conditions, including
diabetes, stroke and
vision impairment
Camp et al., 201559 USA Non-randomised
controlled study
To determine whether or not a
distance-based education
intervention would result in
positive health outcomes for
people with both diabetes
and CI
PRIDE: providing resources
for independence through
diabetes education. Certified
diabetic educators were
linked with older adults with
diabetes and CI. Provided
personalised education
sessions over the internet.
Initial focus was on
medication adherence and an
additional goal selected by
participant–certified diabetes
educator dyad (e.g. diet,
blood glucose testing). A
subset of participants also
received a cognitive
intervention called
spaced retrieval
Dementia
AND diabetes
Older adults with T2DM
and CI (MCI or early-
stage dementia) living
independently in
their homes
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Care Quality
Commission, 2016139
UK Thematic review Improve understanding of
people’s experiences of
diabetes care across England,
and consider how well different
care services work together
Diabetes care in England Diabetes
NOT dementia
Adults aged 18–65 years
with type 1 and type 2
diabetes. Particular focus
on people from black
and minority ethnic
populations
Chrvala et al., 201684 NA SR To assess the effect of diabetes
SM education and support
methods, providers, duration
and contact time on glycaemic
control in adults with T2DM
Diabetes SM education
interventions including
elements and activities
intended to improve
participants’ knowledge,
skills, and ability to perform
SM activities that had the
potential to improve
glycaemic control
Diabetes
NOT dementia
Studies involving people
aged > 18 years with any
HbA1C level and all
intervals of diabetes
duration with a comorbid
health condition. Sample
to include > 50% of
participants with T2DM
Clare et al., 201086 UK RCT To provide evidence of the
clinical efficacy of cognitive
rehabilitation in early-stage
Alzheimer’s disease
Eight weekly 1-hour individual
sessions of cognitive
rehabilitation, personalised to
address individually relevant
goals; also techniques for
learning new information,
practice maintaining attention
and concentration, and
techniques for stress
management. Two control
groups: one treatment as
usual and the other with eight
weekly 1-hour sessions
of relaxation
Dementia
NOT diabetes
People with dementia
and informal carers
Clare et al., 201385 UK Study protocol To establish whether or not
cognitive rehabilitation is a
clinically effective and
cost-effective intervention
for people with early-stage
dementia and their carers
Ten sessions of cognitive
rehabilitation over 3 months
followed by four
maintenance sessions over
6 months
Dementia
NOT diabetes
People with early-stage
dementia
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Davis et al., 201262 USA RCT To test the effect of a targeted
intervention on self-care,
heart failure knowledge and
30-day readmissions in people
with MCI
Intervention focused on
environmental manipulations
(by simplifying tasks and
providing external cues or
prompts to initiate action)
and training in compensatory
strategies for working with
impairments in memory
Other People hospitalised for
exacerbation of heart
failure who screened
positive for MCI
De Vriendt et al., 201558 Belgium RCT To investigate the effectiveness
of a client-centred, activity-
orientated intervention on ADL
for frail older people
Client-centred goal-setting:
OT trained to clarify older
persons’ prioritised goals in
self-care, leisure activities, etc.
Other Community-dwelling frail
older adults
Dhedi et al., 201487 UK Qualitative To explore GPs’ perspectives on
the meaning of ‘timeliness’ in
dementia diagnosis
NA Dementia
NOT diabetes
Practising GPs in an
academic department of
primary care and public
health
Donald et al., 201388 Australia/
New Zealand
Observational To assess the impact of
complications and comorbidities
on diabetes-specific quality of
life in a large population-based
cohort of type 2 diabetic patients
NA Diabetes
NOT dementia
Adults with diabetes
Dugmore et al., 201589 NA SR To explore
[W]hat existing qualitative
studies reveal about the
implementation, effects and
processes of psychosocial
interventions for dementia
Any non-pharmacological,
clinical intervention for
people with dementia
Dementia
NOT diabetes
Six out of 16 studies
on people living with
dementia, 5/16 studies
on people living with
dementia and family/
professional carers,
and 5/16 studies on
professional carers only
Feil et al., 200942 USA Observational To examine the role of CI and
caregiver support in diabetes
care adherence and glycaemic
control
NA Dementia
AND diabetes
Older adults with T2DM
and CI
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Feil et al., 201164 USA Qualitative To explore caregivers’
challenges and quality-of-life
issues managing diabetes in
patients with dementia
NA Dementia
AND diabetes
Family carers, but no
details of their
relationship with people
living with dementia
Fleming and Sum, 201490 NA SR To assess the empirical support
for the use of AT in the care
of people with dementia as
an intervention to improve
independence, safety,
communication, well-being
and carer support
Any intervention utilising AT
and focused on the care of
people with dementia aged
> 50 years
Dementia
NOT diabetes
People with dementia
Gibson et al., 201591 UK Qualitative To explore the everyday use of
AT by people with dementia
and their families
NA Dementia
NOT diabetes
Total of 39 participants:
13 people with dementia
and 26 carers
Giebel et al., 201592 UK Observational To investigate which activities
are impaired at each stage of
dementia and to what extent
this is associated with variations
in quality of life across the
different stages
NA Dementia
NOT diabetes
People with dementia
aged ≥ 65 years and
their carers
Gillespie et al., 201293 NA SR To examine the relationship
between AT for cognition and
cognitive function
AT for cognition is defined as
‘any technology which
compensates for cognitive
deficit during task
performance’. One of the
categories is around reminders
and time management
Dementia
NOT diabetes
People of all ages with
CI of any aetiology,
including acquired brain
injury, neurodevelopment
disorder, psychiatric
disorder, dementia and/or
intellectual disability
Goeman et al., 201694 Australia/
New Zealand
Other: mixed methods To improve the approach to
diabetes education and give
better SM support to clients
Training nurses to identify
learning styles and deliver
prescribed information in an
appropriate way and confirm
the patient’s understanding
Education of people with
diabetes by the specially
trained nurses to improve
health literacy and
understanding of diabetes
and so improve SM
Diabetes
NOT dementia
People aged > 50 years,
with diabetes
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Goodwin et al., 2013138 UK Case study To examine key lessons and
markers for success in the
‘how’ of care co-ordination
that might be transferable to
different contexts and settings
Care co-ordination, covering
a variety of conditions
including palliative care and
advanced dementia service.
The dementia intervention is
about supporting carers to
provide palliative care for
people with advanced
dementia
Dementia
NOT diabetes
People with advanced
stage dementia and their
family carers
Graff et al., 200665
(linked to Graff 200896)
Netherlands RCT To determine the effectiveness
of community based
occupational therapy on daily
functioning of patients with
dementia and the sense of
competence of their caregivers
Ten sessions of occupational
therapy over 5 weeks,
including cognitive and
behavioural interventions, to
train patients in the use of
aids to compensate for
cognitive decline and
caregivers in coping
behaviours and supervision
Dementia
NOT diabetes
People with dementia
and their informal carers
Graff et al., 200896
(linked to Graff et al., 200665)
Netherlands RCT To assess the cost-effectiveness
of community-based
occupational therapy, compared
with usual care, in older
patients with dementia and
their care givers from a
societal viewpoint
Ten sessions of occupational
therapy over five weeks,
including cognitive and
behavioural interventions, to
train patients in the use of
aids to compensate for
cognitive decline and care
givers in coping behaviours
and supervision
Dementia
NOT diabetes
People with dementia
and their informal carers
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Graff et al., 200795 Netherlands RCT To investigate the effects of
community occupational
therapy on quality of life, mood
and health status in dementia
patients and their caregivers
Occupational therapists
trained in collaborative
assessment (80 hours) and
familiar with dementia
patients provided 10 × 1-hour
sessions to people living
with dementia and carers.
The first four sessions were
assessment and goal-setting
through collaborative
techniques. The remaining
six sessions implemented
compensatory strategies
to adapt patients’ ADL;
caregiver supervision skills
were also monitored
Dementia
NOT diabetes
People with dementia
and family carers
Greenhalgh et al., 201397
(part of Athene study and
related to Procter et al.,
2014120)
UK Qualitative To define quality in telehealth
and telecare with the aim of
improving the proportion
of patients who receive
appropriate, acceptable and
workable technologies
and services
NA Other People aged ≥ 60 years
with multimorbidity
AT/telecare
service providers
AT designers
Hackel, 201366 USA Opinion/discussion . . . to apply and compare
aspects of person centred
care and recent consensus
guidelines to two cases of
older adults with poorly
controlled diabetes in the
context of relatively
similar multimorbidity
NA Dementia
AND diabetes
Older adults with T2DM
and complex
multimorbidities
Heisler et al., 200398 USA Survey To assess the extent to which
patients with T2DM agree with
their primary care providers on
diabetes treatment goals and
strategies, the factors that
predict agreement, and
whether or not greater
agreement is associated with
better patient SM of diabetes
NA Diabetes
NOT dementia
Adults with diabetes
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Hsu et al., 201699 USA RCT To help patients develop
improved self-efficacy and
more accurate management
models for diabetes
Training in the use of a
software interface for glucose
monitors and a cloud-based
system to track HbA1c level
in order to self-administer
insulin more accurately
Diabetes
NOT dementia
Independent adults
with T2DM
Huang et al., 2005100 USA Qualitative To explore
. . . self-reported healthcare
goals, factors influencing
these goals, and self-care
practices of older patients
with diabetes mellitus
NA Diabetes
NOT dementia
Older people with T2DM
Iliffe et al., 200667 UK Qualitative If the job categories cannot
expand as fast as is needed,
the tasks of dementia care
will have to be redistributed,
suggesting that skills will
have to be shared and
transferred between
different disciplines. The
question for service
commissioners and providers
is: how can smarter working
be achieved? This article
attempts to answer this
question . . .
NA Dementia
NOT diabetes
HCPs
Institute of Diabetes in
Older People, 201330
UK (and
International)
Guidance International group of diabetes
experts considered the key
issues that require attention in
supporting the highest quality
of diabetes care for older
people
NA Dementia
AND diabetes
Older people with
diabetes, including those
with dementia
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Jekel et al., 2015101 NA SR To summarise the research
results regarding the
performance of patients with
MCI in specific IADL (sub)
domains compared with
persons who are cognitively
normal and/or patients
with dementia
NA Dementia
NOT diabetes
People with MCI
Jowsey, 201469 Australia/
New Zealand
Qualitative To describe motivation towards
or away from SM in diverse
group of older Australians with
T2DM, COPD and CHF
NA Diabetes
NOT dementia
Older people with T2DM,
COPD or CHF
Jowsey et al., 2016102 Australia/
New Zealand
Qualitative To explore how patients with
chronic illness (COPD, CHF or
T2DM) manage their condition
in the absence of health
organisation continuity of care
NA Diabetes
NOT dementia
People with T2DM,
COPD or CHF
Kennedy et al., 2013103 UK RCT To determine the effectiveness
of an intervention to enhance
SM support for patients with
chronic conditions in UK
primary care
Practice-level training in a
whole-systems approach to
SM support. Practices were
trained to use a range of
resources: a tool to assess the
support needs of patients,
guidebooks on SM, and a
web-based directory of local
SM resources. Training
facilitators were employed by
the health management
organisation
Other People with LTCs
Kennedy et al., 2014104 UK Survey and interviews To identify influences affecting
the implementation of an
intervention of a SM support
approach (WISE) at patient,
clinical and organisational levels
SM support intervention (this
is a process evaluation of the
intervention; see Kennedy
et al.103)
Other Organisational
stakeholders, practice
staff and trial participants
Kennedy et al., 201460 UK Qualitative To evaluate the implementation
and embedding of SM support
in a UK primary care setting
SM support intervention (this
is a qualitative study linked to
the intervention; see Kennedy
et al.103)
Other Practice nurses
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Knapp et al., 2015105 UK Rapid review To undertake a cost–benefit
analysis to consider the
hypothesis that accelerated
investment in technology
could, over a series of different
time frames, deliver savings on
the overall cost of care (for
people with dementia)
IT Dementia
NOT diabetes
Academics, managers
and telecare
representatives
Laakkonen et al., 2016106 Finland RCT To investigate the effects of SM
group rehabilitation for people
with dementia and their
spouses on their health-related
quality of life
SM group intervention in
which SM capabilities such as
problem-solving, self-efficacy
and mastery were built
gradually
Dementia
NOT diabetes
People with a recent
diagnosis of dementia
and their spouses
Lingler et al., 2016107 USA RCT To develop and examine the
efficacy of a tailored problem-
solving intervention on informal
caregivers’ management of
medications for community-
dwelling persons with
memory loss
The intervention was
delivered by either a nurse or
a social worker and included
two or three home visits,
2 weeks apart, followed by
two or three telephone
sessions, 7–10 days apart.
Sessions always included
discussion of issues that the
caregiver was experiencing.
Carers received a copy of the
intervention ‘manual’ for
reference between sessions
and after the trial. The
intervention addressed seven
basic aspects of the caregiver’s
role in managing medications
(e.g. ‘preventing errors’ and
‘contingency planning’)
Dementia
NOT diabetes
People with memory loss
and their informal carers
Markle-Reid et al., 2016108 Canada Before-and-after study To investigate the feasibility
of a RCT to examine the
effectiveness of the ACHRU
Partnership Program, an
interprofessional nurse-led
programme for community-
living older adults with T2DM
and other multimorbidities
Home visits by a nurse and a
dietitian from the diabetes
education centre, monthly
group sessions for
participants, monthly nurse-led
case conferences for team
members and nurse-led care
co-ordination
Diabetes
NOT dementia
Older people with T2DM
and at least two
comorbid conditions
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Martin et al., 2013109 UK Qualitative To explore barriers to SM
among people living
with dementia
NA Dementia
NOT diabetes
People with dementia,
carers, service providers
Martin et al., 2015110 UK Qualitative To evaluate the experiences
of attending a novel SM
programme and initial process
evaluation. The programme
was designed with and for
people with dementia
Six sessions, each lasting
2.5 hours, held weekly, and
covering, practical, emotional,
physical and physiological and
lifestyle aspects of managing
the issues encountered by
people in the early stages of
living with dementia
Dementia
NOT diabetes
People in the early stages
of dementia
Mathers et al., 2012111 UK RCT To test the PANDA decision
aid, which facilitates decision-
making between people with
T2DM and clinicians, when the
patient is taking at least two
oral glucose-lowering drugs at
maximum tolerated dose and
has a high HbA1c level, and for
whom the introduction of
insulin is being considered
Brief training of clinicians and
use of PDA with patients in a
single consultation. The
development of the
intervention was based on the
UK MRC framework for the
development and evaluation
of complex interventions
Diabetes
NOT dementia
People with T2DM aged
≥ 21 years
Mayberry et al., 201168 USA Mixed methods, focus
groups and survey
To explore the role of patient
health literacy, numeracy and
computer literacy on usage of a
different patient web portal
and other forms of health IT
NA Diabetes
NOT dementia
Adults with T2DM
Mayberry et al., 2016112 USA Qualitative To develop and test a
telephone coaching system to
improve self-care for people
with T2DM from low-SES
groups
Two weeks of tele-health
coaching, a discussion to set
personal goals and follow-up
individualised text messaging
to encourage participants to
achieve the goals
Diabetes
NOT dementia
People with T2DM and
family members, from
low-SES backgrounds
McBain et al., 2016137 NA SR To assess the effects of
diabetes SM interventions
specifically tailored for people
with T2DM and severe
mental illness
Diabetes SM interventions
designed for people with
mental health problems
Diabetes
NOT dementia
Adults with T2DM and
severe mental illness
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
McBain et al., 2016140 UK Qualitative Explore the barriers and
facilitators HCPs experience
when managing T2DM in
people with severe
mental illness
NA Diabetes
NOT dementia
Adults with T2DM and
severe mental illness
Metzelthin et al., 2013113
(linked to Metzelthin
et al., 2013114)
Netherlands Process evaluation To examine the extent to which
the interdisciplinary care
approach is implemented as
planned and gain insight into
HCPs’ and frail older people’s
experiences regarding the
benefits, burden, stimulating
factors and barriers
Nurse-led interdisciplinary
care approach (care
management approach).
Called Prevention of Care, it
involves screening for frailty,
care planning and a ‘flexible
toolbox of interventions’
(e.g. enhancing meaningful
activities, stimulating health).
A nurse acts as case
manager. The intervention
is based on the ‘5 As’
behaviour change model
(Assess, Advise, Agree,
Assist, Arrange)
Other Frail older people
Metzelthin et al., 2013114
(linked to Metzelthin
et al., 2013113)
Netherlands RCT To evaluate whether an
interdisciplinary primary care
approach for community-
dwelling frail older people is
more effective than usual care
in reducing disability and
preventing (further) functional
decline
Nurse-led interdisciplinary
care approach (care
management approach).
Called Prevention of Care, it
involves screening for frailty,
care planning and a ‘flexible
toolbox of interventions’
(e.g. enhancing meaningful
activities, stimulating health).
A nurse acts as case
manager. The intervention
is based on the ‘5 As’
behaviour change model
Other Frail older people
Mountain, 200637 NA Scoping review To describe the concept of SM
and how it is being promoted
and consider how people with
early dementia might be
enabled to SM
NA Dementia
NOT diabetes
People with
early dementia
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Mountain and
Craig 2012115
UK Qualitative To identify priority topics for a
potential SM programme and
to explore the relevance of
the identified topics with a
consultation group of people
living with dementia and their
carers to inform the creation of
a draft SM programme
NA Dementia
NOT diabetes
People with
early dementia
Munshi et al., 2011117 US Case study To evaluate hypoglycaemia in
older people with HbA1c levels
of ≥ 8% with continuous
glucose monitoring
NA Diabetes
NOT dementia
People aged ≥ 69 years
with HbA1c values
of ≥ 8%
Munshi et al., 2013116 US RCT To evaluate whether or not
assessment of barriers to
self-care and strategies to cope
with these barriers in older
adults with diabetes is superior
to usual care with attention
control
Geriatric diabetes team
(a geriatric diabetologist, a
diabetes educator and a
nutritionist) identified
strategies to help patients
cope with barriers. Strategies
were designed to optimise
patients’ self-care, leading to
better treatment adherence.
Patients were given
individualised strategies either
in person or by telephone
Diabetes
NOT dementia
Community-dwelling
adults aged ≥ 69 years
with T2DM
Newton et al., 2016118 UK Qualitative To examine the motives that
people living with T2DM have
for SM and the methods they
use to assess their success
NA Diabetes
NOT dementia
People with T2DM
Penn et al., 2015119 UK Case study To explore and illuminate the
processes and points where
people struggle to find
SM support
NA Diabetes
NOT dementia
Staff from primary care
general practices in
the UK
Piette and Kerr, 200643 NA Opinion/discussion To examine the effectiveness of
diabetes care when diabetes
mellitus is one of several
long-term health problems
and to identify pathways for
improvement
NA Diabetes
NOT dementia
People with diabetes
and comorbidities
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Procter et al., 2014120 (part of
Athene study and related to
Greenhalgh et al., 201397)
UK Qualitative To explore the experiences of
older people who use assisted
living technologies and care
services
NA Other Older adults
Quinn et al., 2016121 UK RCT To explore the feasibility of SM
intervention for people with
early-stage dementia compared
with treatment as usual
Each session began with time
for social interaction, then a
discussion. Each session
focused one of the following:
information about dementia,
enjoying favourite activities,
staying well, managing
memory difficulties, coping
skills, maintaining relationships
and planning for the future.
Sessions ended with a
5-minute mindfulness exercise.
Caregivers attended the first
and last sessions and could join
each session at the end for a
summary of what had
been discussed
Dementia
NOT diabetes
People with dementia
or MCI
Quinn et al., 2016136 International Review Identify group-based
psychosocial interventions for
people with dementia or MCI
that incorporate significant
elements of SM
Group-based
psychosocial interventions
Dementia
NOT diabetes
People with dementia
or MCI
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Reinhardt Varming
et al., 2015122
Denmark Feasibility study To explore the feasibility of a
research-based programme for
patient-centred consultations to
improve medical adherence
and blood glucose control in
patients with T2DM
Patient-centred empowerment,
motivation and medical
adherence consultation
programme. Intervention
developed by the action
learning process. Three one-
to-one consultations with the
same HCP (nurse or physician)
to ensure continuity. The main
focus of the programme is to
explore and resolve challenges
patients may have with
implementing prescribed
medication and in obtaining
good glycaemic control
Diabetes
NOT dementia
People with T2DM aged
49–85 years
Ryan and Sawin, 200945 USA Qualitative To clarify the concept of SM,
comment on the divergence of
research, theoretical and
conceptual thinking, present
the individual and family
SM theory and identify
opportunities for future study
of SM
The study evaluated multiple
SM interventions aimed at
improving various health
outcomes
Other People with LTCs
Sachar, 2012123 UK Opinion/discussion Aim not stated: describes
the service
Integrated diabetes care
(Inner North West London
Integrated Care Pilot).
Integrates diabetes care and
mental health care
Dementia
AND diabetes
People with diabetes and
mental health problems
that could involve CI
or dementia
Schaller et al., 2016124 Germany Before-and-after study To assess the usefulness and
impact of the European
eHealth Monitor project
Dementia Portal service in the
dementia care setting from two
user perspectives: informal
caregivers and professionals
A web portal for informal
caregivers and professionals
was tested for a 12-week
period
Dementia
NOT diabetes
Family carers of people
living with dementia and
community HCPs in
Germany
Schulman-Green et al.,
2016125
NA SR To identify factors that are
facilitators and barriers to SM
by adults with chronic illness
NA Diabetes
NOT dementia
Of 53 included studies, 28
reported on diabetes, and
a remaining 20 reported
on cardiovascular disease
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Sinclair et al., 201428 UK Guideline To provide guidance for the
care of people with dementia
and diabetes
NA Dementia
AND diabetes
People with dementia
and diabetes
Span et al., 2013127 NA SR To gain insight into the
involvement of people with
dementia in developing
supportive IT applications
Computer applications
involving people with
dementia
Dementia
AND diabetes
People with dementia
Suh et al., 2004128 Other Observational To measure rates of decline in
cognition and function in
patients with Alzheimer’s
disease and to investigate their
accelerating risk factors in
Republic of Korea
NA Dementia
NOT diabetes
People with a diagnosis
of Alzheimer’s disease
Sun and Guyatt, 2013129 NA Opinion/discussion NA NA Diabetes
NOT dementia
People with LTCs
including diabetes
Tan et al., 2015130 NA SR To evaluate the effectiveness of
diabetes self-care interventions
for older adults with diabetes
and identify the factors
influencing self-care behaviours
Diabetes self-care
interventions for older adults
Diabetes
NOT dementia
Older adults
with diabetes
Taylor et al., 2014131 NA SR To evaluate the evidence on
SM support for people with
one or more LTCs in order to
inform commissioners and
health-care providers about
what works, for whom and in
what contexts
SM support interventions Other People with LTCs
Taylor et al., 2016141 UK Evaluation To evaluate the pilot of an
evidence-based care quality
improvement intervention for
diabetes in primary care
Quality improvement
programme for diabetes in
primary care
Diabetes
NOT dementia
General practices in
the UK
Toms et al., 2015132 UK Qualitative To explore:
. . . the views of people with
dementia and family
caregivers on the use of
self-management in
dementia
NA Dementia
NOT diabetes
People with dementia
and carers
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Study (author, year) Country Research type Aim/purpose Description of intervention Participants Type of participants
Wherton et al., 2012133 UK Qualitative To discuss the challenges of
understanding the assisted
living needs of older people in
domestic settings and methods
to support their involvement in
the coproduction of assisted
living technologies
NA Other People with LTCs
including heart disease,
stroke, COPD, diabetes,
Alzheimer’s disease,
falls, visual impairment
and osteoarthritis
Yardley et al., 2015134 Other Realist synthesis To investigate how primary
health-care delivery and
professional experiential
learning interact to generate
outcomes valued by patients
with multimorbidity and HCPs
NA Other People
with multimorbidity
ACHRU, Aging, Community and Health Research Unit; ADL, activities of daily living; CHF, chronic heart failure; CI, cognitive impairment; COPD, chronic obstructive pulmonary disease;
HbA1c, indicator of blood glucose level; IADL, instrumental activities of daily living; LTC, long term condition; MCI, mild cognitive impairment; MRC, Medical Research Council;
NA, not applicable; PANDA, Patients ANd Decision Aids; PDA, patient decision aid; SES, socioeconomic status; SR, systematic review; T2DM, type 2 diabetes mellitus; WISE, Whole system
Informing Self-management Engagement.
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Appendix 5 Evidence supporting context–
mechanism–outcome configurations from the
literature
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TABLE 9 Evidence supporting CMO 1: embedding positive attitudes towards people living with dementia
Study (type)
Condition
EvidenceDementia Diabetes Other
Stigma and barriers
Bunn et al., 201639
(mixed methods)
✗ ✗ l Evidence that care provision for people living with dementia and comorbidity
is not equitable
l Study recommends that to improve access and continuity for people living with
dementia and comorbidity, a significant change in the organisation of care is
needed. This involves coproduction of care whereby professionals, people living
with dementia and their family carers work in partnership; recognition of the
way a patient’s diagnosis of dementia affects the management of other long-
term conditions; flexibility in services to ensure that they are sensitive to the
changing needs of people living with dementia and their family carers over
time; and improved collaboration across specialities and organisations
Iliffe et al., 200667 (qualitative) ✗ l Study suggests that HCPs should think of dementia in terms of disability not
disease, as the former encourages them to focus on the strengths and abilities
of the person living with dementia and the latter emphasises the degenerative
nature of the condition
Kennedy et al., 201460 (RCT) ✗ ✗ l Implementation of a SM support approach (WISE), a process evaluation
l Interventions or tools that are considered to disrupt QOF tasks are less likely to
be used by practice staff (e.g. the tool designed to elicit patients’ needs and
priorities was not taken up for regular use; nurses were less likely than GPs to
use it)
Knapp et al., 2015105 (review) ✗ l A barrier to the development of appropriate AT is limited awareness of the
needs of people living with dementia and their carers. They suggest that the
technology industry needs to see the ‘dementia market’ as an attractive option
A
PPEN
D
IX
5
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
104
Study (type)
Condition
EvidenceDementia Diabetes Other
Metzelthin et al., 2013113 and
Metzelthin et al., 2013114
(RCT and process evaluation)
✗ l A RCT of case management for frail older people showed no impact on
disability or HADS. With regard to the intervention protocol, authors say that,
despite an extensive development period and a comprehensive training
programme:
[W]e probably failed in providing professionals with the necessary
competencies and feasible tools to apply rather complex concepts, such as
interdisciplinary collaboration, tailor made care, and self-management
l Accompanying process evaluation: the authors found that frail older people
were satisfied as they felt acknowledged by HCPs and experienced support in
handling their problems and fulfilling their needs
Sinclair et al., 201428
(best practice statement)
✗ ✗ l Advanced age and dementia should not be barriers to good diabetes care
l An annual diabetes review is recommended
Yardley et al., 2015134
(realist synthesis)
✗ (LTC) l Primary care organisations should seek to create contexts in which patients,
GPs and trainees can discuss challenges related to multimorbidity, concepts of
success and failure and develop shared goals
Reinforce positive attitudes (e.g. focus on abilities rather than disabilities)
Bahar-Fuchs et al., 201380 (SR) ✗ l Cognitive training was not associated with positive or negative effects in
relation to any reported outcomes. The overall quality of the trials was low to
moderate. The single RCT of cognitive rehabilitation found promising results in
relation to a number of participant and caregiver outcomes, and was generally
of high quality
l The RCT of individualised cognitive rehabilitation (Clare et al.86): benefits
related to self-related competence and satisfaction in performing meaningful
personal goals, memory capacity and general quality of life
l More recent literature seems to be focusing on those with MCI rather
than dementia
Camp et al., 201559
(non-randomised controlled)
✗ (CI) ✗ l Evaluated personalised education sessions for people with diabetes and CI.
HbA1c initially declined after the intervention but returned to baseline after 6
months. There was a significant increase in self-efficacy that was maintained
at 6 months
continued
D
O
I:10.3310/hta21750
H
EA
LTH
TECH
N
O
LO
G
Y
A
SSESSM
EN
T
2017
VO
L.21
N
O
.75
©
Q
ueen
’s
Printer
and
C
ontroller
of
H
M
SO
2017.
This
w
ork
w
as
produced
by
Bunn
et
al.
under
the
term
s
of
a
com
m
issioning
contract
issued
by
the
Secretary
of
State
for
H
ealth.
This
issue
m
ay
be
freely
reproduced
for
the
purposes
of
private
research
and
study
and
extracts
(or
indeed,
the
fullreport)
m
ay
be
included
in
professionaljournals
provided
that
suitable
acknow
ledgem
ent
is
m
ade
and
the
reproduction
is
not
associated
w
ith
any
form
of
advertising.
A
pplications
for
com
m
ercialreproduction
should
be
addressed
to:
N
IH
R
Journals
Library,
N
ationalInstitute
for
H
ealth
Research,
Evaluation,
Trials
and
Studies
C
oordinating
C
entre,
A
lpha
H
ouse,
U
niversity
of
Southam
pton
Science
Park,
Southam
pton
SO
16
7N
S,
U
K
.
105
TABLE 9 Evidence supporting CMO 1: embedding positive attitudes towards people living with dementia (continued )
Study (type)
Condition
EvidenceDementia Diabetes Other
Clare et al., 201385
(protocol for RCT)
✗ Negative influences can contribute to the development and maintenance of
‘excess’ disability – where the extent of functional disablement is greater than
would be predicted by the degree of impairment [e.g. through loss
of confidence]
l A series of studies (single-care designs or small-group pre/post comparisons)
demonstrated that it was possible to identify meaningful personal goals and
use evidence-based restorative or compensatory rehabilitation methods to
bring about behaviour change for people with early-stage dementia
Davis et al., 201262 ✗ (CI) ✗ l An intervention for people with heart failure and MCI (not dementia), learning
in a hospital environment, could not be translated into self-care management
on their return home. Self-care behaviours may not improve as a function of
increased knowledge, but more as a function of confidence
Graff et al., 200665 (RCT)
(links to Graff et al., 200795
and Graff et al., 200896)
✗ l Ten sessions of OT improved quality of life, mood and health status in carers
of people with dementia and diminished the burden of care
l The intervention was delivered in a collaborative and patient-centred way and
included individualised support for caregivers
l Intervention involved the use of compensatory strategies to adapt ADL to the
disabilities of patients and environmental strategies to adapt the patients’
environment to their cognitive disabilities
l Primary caregivers trained to use effective supervision, problem-solving and
coping strategies to sustain their own and the patient’s autonomy and
social participation
l Potential mechanism – sense of control over life
Laakkonen et al.,
2016106 (RCT)
✗ l SM group-based intervention for people living with dementia–carer dyads
(newly diagnosed with dementia)
l Intervention delivered by trained facilitators (specialists in gerontology)
l Outcomes: better health-related quality of life for carers at 3 months but not
at 9 months; cognition of people living with dementia in SM group improved;
no increase in health and social service costs
Martin et al., 2013109
(qualitative)
✗ l If health-care services maintain a deficit focus, this creates dependence and
discourages SM. The authors suggest a need to focus on abilities rather than
disabilities and promote meaningful positive experiences and an outlook with
an emotional focus rather than a problem focus
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Study (type)
Condition
EvidenceDementia Diabetes Other
Martin et al., 2015110
(qualitative)
✗ l Important aspects of a SM programme for people living with dementia:
flexibility, social interaction, focus on strengths and make information simple
l The authors suggest that the use of simplified implementation intentions helps
people to achieve a desired goal, leading to a feeling of achievement and a
reminder that life still holds pleasures
Mountain 200637 (review) ✗ Neglect of the potential of self-management can be attributed to the gap that
exists between the commonly held interpretations of self-management and the
prevailing understandings of the abilities of people with early dementia
l Disclosure of a diagnosis of dementia and a person-centred approach are
necessary for SM
l The authors conclude:
[W]ithout a concerted effort from a range of stakeholders, including policy
makers and advocacy organizations, people with dementia will continue to
remain on the periphery of any benefits that can be derived from the
current focus of policies that support people with LTC
Mountain and Craig, 2012115
(qualitative)
✗ l Highlight the importance of identifying methods of working with families and
carers so that the voice of the person living with dementia is heard and their
needs balanced with those of the carers
l The majority of people living with dementia considered that information
provided following diagnosis was aimed predominantly at their carers. This
had increased feelings of powerlessness and helplessness
Quinn et al., 2016121
(feasibility study)
✗ l Suggests that SM interventions are acceptable to people living with dementia
and may foster independence and reciprocity and promote social and clinician
support. However, numbers were small and only 17% of those approached
to take part consented. Findings from qualitative interviews suggest that
increased self-efficacy may be related to increased confidence and the
widening of social support opportunities
continued
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TABLE 9 Evidence supporting CMO 1: embedding positive attitudes towards people living with dementia (continued )
Study (type)
Condition
EvidenceDementia Diabetes Other
Taylor et al., 2016141 (SR) ✗ l Review of SM support for people with LTC: group discussions to talk about
dementia, future plans and personal relationships did not significantly improve
patients’ quality of life
Toms et al., 2015132
(qualitative)
✗ l Study of perspectives on SM from people living with dementia and their
caregivers suggests that a diagnosis of dementia can facilitate supportive
behaviour but could also trigger stigmatisation. Support may be inappropriate
or ‘stifling’, and consultation is often absent
l Can be disparity between people living with dementia and carers in terms
of independence
ADL, activities of daily living; CI, cognitive impairment; HADS, Hospital Anxiety and Depression Scale; LTC, long-term condition; MCI, mild cognitive impairment; SR, systematic review;
WISE, Whole system Informing Self-management Engagement.
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TABLE 10 Evidence supporting CMO 2: person-centred approaches to care planning
Study (type)
Condition
EvidenceDementia Diabetes Other
Identifying patient and carer priorities
Alsaeed et al., 201679 (SR) ✗ l Caregivers felt that they were not being involved by the GP in discussions and
decisions about the person living with dementia’s medication, such as when
medications were changed or new ones were prescribed, and felt that HCPs
did not fully comprehend the role that caregivers had taken on and the
burden and stress involved with it. This can lead to caregivers not expressing
their medication-related concerns. The study recommended that both
caregivers and people living with dementia are involved in decisions and
encouraged to voice their concerns
Anderson et al., 201573
(review)
✗ l Propose a framework derived from Heifetz et al.’s200 adaptive leadership
framework (ability to distinguish between technical and adaptive challenges)
l Importance of trusting relationships – encourages individuals to become active
in the management of chronic health conditions, patients feel that they are
heard and empathetically understood by providers. When this occurs the
patient/family and providers develop a shared meaning of the patient/family
responses to challenges (they propose this as part of their framework but do
not support with evidence)
Bergdahl et al., 201372
(case study)
✗ l A warm relationship between nurse and patient encourages dialogue and
relevant practical support
Branda et al., 201371 (RCT) ✗ l Decision aid may make it more likely that a clinician will have a conversation
with a patient about the discussion to start or change a medication but impact
on actual medication use is unclear (did not appear to impact on glycaemic
control) decision aid often not used as intended
Jowsey et al., 201469
(qualitative)
l HCPs need to build up a relationship with patient and family to trigger trust
and rapport to optimise the motivation of service users to continue with SM
l Families have significant role as external motivators
l Interventions that increase family members knowledge and skills enhance
patient’s sense of being cared for – potentially having an impact on SM
Jowsey et al., 2016102
(qualitative)
l When HCP allow patients and family to develop patient-initiated management
strategies that fit into their own daily life-patterns then patients and families
feel empowered and enabled to self-manage the illness
continued
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TABLE 10 Evidence supporting CMO 2: person-centred approaches to care planning (continued )
Study (type)
Condition
EvidenceDementia Diabetes Other
Dhedi et al., 201487
(qualitative)
✗ l Looks at GP experiences of diagnosing dementia:
Our research supports the recommendations of other researchers that more
attention be paid to supporting GPs in the management of complexity and
uncertainty, and specifically the dilemmas involved in meeting families’
needs for support over long periods
l The taken-for-granted benefits of early diagnosis cannot be assumed, but
need to be ‘worked through’ on an individual case-by-case basis
Heisler et al., 200398 (survey) ✗ l Patients who reported sharing responsibility with their providers in making
treatment decisions agreed with their providers on significantly more
treatment strategies in bivariate analyses
l The authors say:
Our findings support the hypothesis that greater concordance between
patients and their providers on goals and strategies may be a mechanism
by which better patient-provider communication and collaboration
contribute to improved patient outcomes
Mathers et al., 2012111 (RCT) ✗ l Patient autonomy many be strengthened by the use of a decision aid.
Study showed a reduction in HbA1c in both intervention and control groups
(no significant difference between groups), but knowledge was better in the
intervention group
Newton et al., 2016118
(qualitative)
✗ l Co-management entailed participants being able to discuss the ramifications
of certain treatment options and SM activities with HCPs, but many people felt
that HCPs did not listen to or were dismissive of their concerns, or that there
was a lack of continuity of care
Schulman-Green et al.,
2016125 (SR)
l HCPs need to provide time for patients to discuss and take account of their
preferences, which leads patients to feel confident in, and supported by, their
HCP, leading to better SM strategies
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Study (type)
Condition
EvidenceDementia Diabetes Other
Person-centred approaches
Anderson et al., 201573
(review)
✗ l Study found that patients view as difficult what clinicians deem to be easy
Bailey et al., 201681 (RCT) ✗ l Personalised and active educational package enhanced patient engagement
with treatment and increased knowledge (however, the study did not involve
people living with dementia)
l Helping patients to make explicit value judgements may support decision-
making processes through fuller understanding and buy-in, which is integral
to self-confidence
Bergdahl et al., 201372
(case study)
✗ l A co-creative process helping patients to reach their goals can be seen as a
way to plan a path through a landscape of uncertainty
Huang et al., 2005100
(qualitative)
✗ l Patients were frustrated when their personal preferences were not taken
into account
De Vriendt et al., 201558 (RCT) ✗ l A RCT investigated the effectiveness of a client-centred, activity-orientated
intervention aimed at frail older people. OTs were trained to clarify older
people’s prioritised goals. The intervention had a positive effect on ADL as
measured on basic ADL. The authors say that this intervention may have
been successful because the OTs were trained in motivational interviewing,
goal-setting and working with the older person to find solutions
Goeman et al., 201694
(uncontrolled before-and-
after study)
✗ l Small positive impact on clients’ diabetes knowledge and behaviour after an
intervention to assess their health literacy. The mean age was 75 years but
people with CI were excluded
Heisler et al., 200398 (survey) ✗ l Goals of HCP and patient/carer may not be the same, so need to discuss goals
Our findings support the hypothesis that greater concordance between
patients and their providers on goals and strategies may be a mechanism
by which better patient-provider communication and collaboration
contributed to improved patient outcomes
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TABLE 10 Evidence supporting CMO 2: person-centred approaches to care planning (continued )
Study (type)
Condition
EvidenceDementia Diabetes Other
Markle-Reid et al., 2016108
(feasibility study)
l Examines feasibility of a community-based SM intervention for older adults
with T2DM
l Programme enabled HCPs to better understand the health status and
challenges facing clients as a result of the multiple opportunities for
interprofessional collaboration, the synergistic effects of different programme
components, and the unique insights gained from seeing clients in their
home environment
McBain et al., 2016137 (SR) ✗ ✗ l A SR of SM interventions for people with diabetes and severe mental illness
found no significant effects on glycaemic control – authors suggest this may
be explained in part by lack of a person-centred approach. An improvement in
diabetes knowledge was found at long-term follow-up
Munshi et al., 2011117
(case study)
l Simplified treatment regimens are needed that better match patients’
self-care abilities
Munshi et al., 2013116 (RCT) ✗ l A RCT that found better management of T2DM through the assessment of
self-care barriers and the application of individualised strategies
Reinhardt Varming et al.,
2015122 (feasibility study)
✗ l A feasibility study explored the use of patient-centred consultations to improve
adherence and glycaemic control. The intervention included the use of
dialogue tools where the patient was asked to describe their day, their use of
medication and their challenges. HCPs felt that tools supported patient-centred
consultations by facilitating dialogue, reflection and patient activity
Ryan and Swain, 200945
(description of development
of model)
✗ ✗ l Describes a new descriptive theory of SM: individual and family SM theory.
SM is a multidimensional, complex phenomenon that can be conceptualised
as affecting individuals, dyads or families across all developmental stages.
SM includes condition-specific risk and protective factors, the physical and
social environment, and unique characteristics of individuals and family
members. Need to use ‘individual’ and ‘family lens’
Schulman-Green et al.,
2016125 (SR)
✗ l Identifies a number of HCP behaviours that facilitate SM in patients with
chronic illness. Includes active listening, valuing patients’ subjective experience,
investing time to get to know the patient as an individual, offering practical
advice and anticipatory guidance, regular visits and recommending culturally
sensitive SM strategies
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Study (type)
Condition
EvidenceDementia Diabetes Other
Sherifali et al., 2015126 (SR) ✗ l Meta-analysis found that although diabetes SM programmes utilise a variety
of strategies, the most effective strategies for older adults were tailored
interventions or psychological support, with a reduction in HbA1c levels of
approximately –3mmol/mol (0.2%). Although reduction was statistically
significant, a reduction of –3mmol/mol (0.2%) may not be clinically significant
in isolation from other diabetes interventions
Span et al., 2013127 (SR) ✗ ✗ l A SR looking at the involvement of people living with dementia in developing
supportive IT applications showed that people living with dementia wanted to,
and could, contribute to IT design. Involvement in the development enabled
people living with dementia to participate as equal partners
Yardley et al., 2015134
(realist synthesis)
✗ (LTC) l ‘Primary care organisations should seek to create contexts in which patients,
GPs and trainees can discuss challenges related to multimorbidity, concepts of
success and failure and develop shared goals’
Functional abilities
Camp et al., 201559
(controlled study)
✗ (CI) ✗ l Evaluation of distance-based education for people with diabetes and CI. The
intervention led to an increase in self-efficacy. The intervention was framed as
a programme to promote independence rather than as an admission of a
need for assistance. HbA1c initially declined after treatment but returned to
baseline levels after 6 months
De Vriendt et al., 201558
(qualitative)
l Study of an OT-delivered client-centred and activity-orientated intervention
found improvement in ADL measure but no difference in physical functioning.
OTs were trained in goal-setting and motivational interviewing
Goodwin et al., 2013138
(case study)
✗ l Supports the idea that care co-ordination programmes should focus on
supporting service users and carers to become more functional, independent
and resilient – preferable to a purely clinical focus on managing or treating
medical symptoms
Graff et al., 2006,65
Graff et al., 200795 (RCT)
✗ l Ten sessions of OT improved quality of life, mood and health status in carers
of people with dementia. The intervention was delivered in a collaborative and
patient-centred way
Huang et al., 2005100
(qualitative)
✗ l For older people with diabetes, SM goals are related to maintaining
independence
continued
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TABLE 10 Evidence supporting CMO 2: person-centred approaches to care planning (continued )
Study (type)
Condition
EvidenceDementia Diabetes Other
Iliffe et al., 200667 (qualitative) ✗ l Suggests that HCPs should think of dementia in terms of disability, not disease
as the former focus on strengths and abilities of the person living with
dementia and not the degenerative nature of the condition
Metzelthin et al., 2013113 ✗ l Interventions need to be designed to take into account the importance to
older people of independence, making their own decisions and finding their
own solutions
Tan et al., 2015130 (SR) ✗ l A SR of diabetes self-care interventions for older adults with diabetes found
that interventions using concepts of self-efficacy, self-determination and
proactive coping were effective in influencing diabetes self-care behaviours
Toms et al., 2014132
(qualitative)
✗ l For older people with dementia, independence is seen as very important
Yardley et al., 2015134
(realist synthesis)
l Patients identified their proactive behaviour as key to coping with multimorbidity.
Mechanisms used by patients (their own ‘freestyle’ interventions) included
maintaining a social role and/or meaningfulness, choice in the contact of support
when needed, achieving goals, understanding diseases and having autonomy to
prioritise medication
ADL, activities of daily living; CI, cognitive impairment; LTC, long-term condition; SR, systematic review; T2DM, type 2 diabetes mellitus.
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TABLE 11 Evidence supporting CMO 3: developing skills to provide tailored and flexible care
Study (type)
Condition
EvidenceDementia Diabetes Other
Appropriate skills (e.g. enablement, listening, communication, negotiation)
Branda et al., 201371 (RCT) ✗ l A RCT of a patient decision aid for people with diabetes found no impact on
glycaemic management. However, the authors suggest that decision aids have
an important role in promoting patient-centred practice and patient
engagement
l Barriers to use of decision aid: infrequent opportunities to use the aid and
minimal training of clinicians
l Need to train and support clinicians in the use of decision aids
Iliffe et al., 200667 (qualitative) ✗ l Dementia care is labour intensive; tasks of dementia need to be redistributed,
suggesting that skills will have to be shared and transferred between
disciplines
l Identified five skills that appear key in primary care: (1) pattern recognition,
(2) deductive synthesis to reduce uncertainty, (3) dialogue and disclosure,
(4) disability perspectives and (5) case management with shared care
Kennedy et al., 2013103
(qualitative)
✗ ✗ l An evaluation of SM support for people with LTCs in primary care
l Study finds that:
Embedding self-management support into routine primary care practice
cannot be achieved within existing educational structures and may require
considerable additional incentives
Kennedy et al., 2014104 and
Kennedy et al., 201460 (RCT)
✗ ✗ l An evaluation of SM support for people with LTCs in primary care in the UK
found that SM support was not prioritised by practices and did not fit with a
biomedically focused ethos so was not given the priority needed to embed it
in the day-to-day work of primary care
l For SM support to be implemented in primary care practices, it needs to be
viewed as a legitimate activity or professional priority
Mathers et al., 2012111 (RCT) ✗ l A decision aid to facilitate decision-making between clinicians and their
patients reduced HbA1c levels in intervention and control groups, although
there was no significant between-group difference
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TABLE 11 Evidence supporting CMO 3: developing skills to provide tailored and flexible care (continued )
Study (type)
Condition
EvidenceDementia Diabetes Other
Metzelthin et al., 2013113 and
Metzelthin et al., 2013114
(RCT and process evaluation)
✗ l Case management for frail older people showed no impact on disability or
HADS. Authors say that this could be because they failed to provide
professionals with the necessary competencies and feasible tools to apply
rather complex concepts, such as interdisciplinary collaboration, tailor-made
care and SM
Penn et al., 2015119
(modelling pathways)
✗ l Primary care is currently failing to support SM
l Support for SM may not ‘fit’ with existing work
Reinhardt Varming et al.,
2015122 (feasibility study)
✗ l A patient-centred empowerment, motivation and medical adherence
programme that involved individual consultations and telephone follow-up:
63% of participants reported feeling more capable to manage their diabetes.
Feasibility study that did not measure glycaemic management
Sachar, 2012123
(opinion/discussion)
✗ ✗ l Many professionals lack confidence about their skills in assessing capacity
Sun and Guyatt, 2013129
(editorial on Kennedy trial)
✗ One might seriously question doctors’ awareness of the importance of
patient SM of chronic conditions
l The authors suggest that ‘considerable incentives will probably be needed to
change doctors’ behaviours with respect to SM support practices’
Tailored and flexible
Abdelhafiz et al., 201625
(review)
✗ l The study presents evidence that many older people with diabetes are
overtreated (the authors cite a number of observational studies to support this)
Alsaeed et al., 201679
(SR, qualitative)
l Abilities and knowledge of carers should be taken into account (e.g. they may
adopt unsafe or ineffective medication strategies, and the responsibility
involved in managing medicines negatively affects the caregiver’s quality of life)
Donald et al., 201388
(observational)
l The freedom to eat as desired was the most negatively affected aspect of
quality of life among the study participants (people with diabetes and mental
illness); this finding supports the idea of relaxing diabetes control in favour of
enjoying life for people living with dementia and diabetes
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Study (type)
Condition
EvidenceDementia Diabetes Other
Dugmore et al., 201589 (SR) ✗ l A review of qualitative studies of psychosocial interventions for dementia
found that the prioritisation of task-orientated or outcomes-focused
approaches to care impeded the delivery of the intervention
l In some studies, psychosocial interventions were not seen as ‘real work’ by
staff in care homes
l Some of mechanisms triggered by interventions were ‘feeling useful’ and
feeling included
Heisler et al., 200398 (survey) ✗ l Patients who reported sharing responsibility with their providers in making
treatment decisions agreed with their providers on significantly more
treatment strategies in bivariate analyses
Jowsey et al., 201469 ✗ l Families play a significant role as external motivators (relates to diabetes SM)
so interventions should increase family member knowledge and skills
Munshi et al., 2011117
(case study using continuous
glucose monitoring)
✗ l Results suggest that simply relaxing HbA1c goals may not be adequate to
protect frail older adults against hypoglycaemia. Simplified treatment regimens
are needed that better match patients self-care abilities
Munshi et al., 2013116 (RCT) ✗ l The study team felt that many patients with multiple comorbidities were on
complex regimens that were clearly beyond their coping abilities
Taylor et al., 2016141
(case study)
✗ l Some success for a train-the-trainer model in improving quality of diabetes
care in primary care. Several contextual and process factors were identified as
common drivers for quality improvement activity (e.g. good teamwork, clear
leadership, a simple well-defined intervention) or constraints hindering such
activity (e.g. high workload, staffing changes, lack of data gathering and
poorly defined interventions). The results of the evaluation support a model of
disseminated quality improvement in diabetes care using a train-the-trainer
approach with mentoring and practice-based support
Yardley et al., 2015134
(realist synthesis)
l Personal concepts of success were not always compatible with measurable
clinical markers. Recommended a reduced emphasis on index condition and
diagnosis–cure models in LTCs
HADS, Hospital Anxiety and Depression Scale; LTC, long-term condition; SR, systematic review.
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TABLE 12 Evidence supporting CMO 4: regular contact
Study (type)
Condition
EvidenceDementia Diabetes Other
Communication and regular contact (allows one to anticipate needs)
Alsaeed et al., 201679 (SR) ✗ l Literature review on medication management in people living with dementia:
the transition to caregiver-led management may not go smoothly and this
could be a time when carers need extra support
l Suggest that regular medication reviews are useful
Boots et al., 201661
(mixed methods)
l SM programme for carers of people living with dementia: participants
preferred blended care (face to face and online modules) as they valued
personal contact with a professional. May increase adherence and
effectiveness. Small but positive effects on caregiver self-efficacy and
goal attainment
Brown et al., 201583
(opinion/discussion)
✗ ✗ l Highlight importance of regular monitoring and discussion of diabetes care in
order to know the person living with dementia and their preferences and to
spot when changes occur in either condition
Bunn et al., 2017142
(qualitative) (and Bunn et al.,
201639)
✗ ✗ l People living with dementia and their family carers valued continuity, in terms
of relationships with practitioners but also in terms of encounters that factored
in the impact of dementia, that built on earlier conversations and
appointments and that included people with dementia and their carers in
decision-making
Camp et al., 201559
(controlled study)
✗ ✗ l Controlled study of diabetes SM education showed an improvement in
self-efficacy and short term improvements in HbA1c. Authors stress the
importance of regular contact and the development of rapport. The
programme was tailored to the needs of people with CI
l Suggest that as clinicians and participants were able to maintain contact using
iPads and the internet this approach lends itself to long-term connection
l Need long-term connection and maintenance programmes for this group
Chrvala et al., 201684 (SR) ✗ l A SR of SM education and support for people with T2DM suggests that
diabetes SME has a significant impact on glycaemic control. There was
evidence to suggest that contact hours exceeding 10 were more often
associated with diabetes SME interventions resulting in additional, statistically
significant, decreases in HbA1C
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Study (type)
Condition
EvidenceDementia Diabetes Other
Davis et al., 201262 (RCT) ✗ (MCI) ✗ (heart failure) l Tailored education has to be continued into the community over time to
improve self-care behaviours
Dhedi et al., 201487
(qualitative)
✗ l Study exploring what is meant by ‘timely’ diagnosis of dementia. The authors
suggest that there is a ‘need for ongoing dialogue’ as ‘diagnosis is not a
discrete act but a collective, cumulative contingent process’
Feil et al., 201164 (qualitative) ✗ ✗ l Study suggests that active provider–caregiver communication is essential to
improving quality of care for the patient
Giebel et al., 201592
(qualitative)
✗ l IADL functions are affected in people with MCI and mild dementia (getting
worse as dementia progresses) – but at uneven rates. The early detection of
dementia in people with diabetes may be important so that adaptations can
be made to the diabetes routine
Hackel, 201366 (case report) ✗ l Older people with diabetes require comprehensive co-ordinated care to ensure
that the management of all their multimorbidities does not increase their risk
of hypoglycaemia (e.g. the use of beta-blockers may increase the risk of
hypoglycaemic unawareness)
Munshi et al., 2013116 (RCT) ✗ ✗ l In older adults regular telephone contact from a diabetes educator
encouraged people to adjust insulin dosage, leading to better glycaemic
control. There is a need for greater support during vulnerable periods such as
after hospitalisation. Potential mechanism: people felt encouraged/enabled
l Older adults were reluctant to make changes to medication between
clinic visits
l Better management of T2DM through the application of individualised
strategies: improvement on measures of self-care
Newton et al., 2016118
(qualitative)
✗ l Exploration of motivation to SM and style of SM among people with T2DM.
Found that the transition to a different style of SM (e.g. autonomy to
delegation) may be particularly difficult
l Many people felt that HCPs did not listen to, or were dismissive of, their
concerns, or that there was a lack of continuity of care
Penn et al., 2015119
(case study)
✗ l Capacity to consistently assess SM capabilities, provide SM support or enhance
patient-led self-care activities is missing from current diabetes pathways.
Authors say that if SM support is offered at regular points through a person’s
condition trajectory (rather than focusing around the point of diagnosis of
diabetes), then HCPs are more likely to pick up problems with SM and provide
SM support
continued
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TABLE 12 Evidence supporting CMO 4: regular contact (continued )
Study (type)
Condition
EvidenceDementia Diabetes Other
Piette and Kerr, 200643
(opinion/discussion)
✗ l Telephone care may increase patients’ resources for SM between visits, as well
as help identify important priorities during encounters
Sinclair et al., 201428
(guidelines)
✗ ✗ l Key principles of care have been established for people with both dementia and
diabetes, including regular reassessment to identify additional care needs,
consideration of problems of adherence to therapy, use of ‘safer’ glucose-lowering
medications, and the recognition of when ‘severe’ dementia supervenes and
priorities of management may need revision
Suh et al., 2004128
(observational)
✗ l Patients with Alzheimer’s disease can have quite severe CI before they show
substantial deficits in basic ADL, which then decline very rapidly, while IADL
begin to be impaired in the early stage of Alzheimer’s disease
Tan et al., 2015130 (review) l If HCPs provide knowledge and support that anticipates future issues, then
patients and family carers feel greater confidence and self-efficacy, leading to
sustained SM behaviours
l Interventions using concepts of self-efficacy, self-determination and proactive
coping were effective in influencing diabetes self-care behaviours with
improved health outcomes
HbA1c, indicator of blood glucose levels; ADL, activities of daily living; CI, cognitive impairment; IADL, instumental activities of daily living; MCI, mild cognitive impairment;
SME, self-management education; SR, systematic review; T2DM, type 2 diabetes mellitus.
A
PPEN
D
IX
5
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
120
TABLE 13 Evidence supporting CMO 5: family engagement
Study (type)
Condition
EvidenceDementia Diabetes Other
Engaging with families
Aikens et al., 201563
(before-and-after study)
✗ l Involving a care partner may make a person with diabetes more likely to
participate in an automated telephone SM system. The authors suggest several
mediating mechanisms: emotional support leading to improved ability to
regulate one’s own behaviour, direct assistance with diabetes problem-solving
provided by care partner, reinforcement of adherence by care partner
Alsaeed et al., 201679 (review) ✗ l Important to involve both the person living with dementia and the caregiver
l Literature review on medication management in people living with dementia:
the transition to caregiver-led management may not go smoothly, and this
could be a time when carers need extra support. However, studies showed
that caregivers lacked medication-related support
l Better communication can assist in building trust and shed light on the
problems experienced to allow them to be addressed appropriately. The
authors stress the importance of maintaining a good relationship between
caregiver–person living with dementia dyad and HCPs
Bergdahl et al., 201372
(qualitative case studies)
l Authors suggest that when nurses adopt a family-focused perspective,
then relatives can experience the situation as meaningful; this fosters
partnership working
Boots et al., 201482 (SR) ✗ l Internet interventions for carers of people living with dementia that include
relevant information, tailored caregiving strategies and contact with other
caregivers increase confidence, sense of competence, decision-making skills
and self-efficacy, leading to improvement of the caregivers’ well-being
l Multicomponent programs that combined information, tailored caregiving
strategies and contact with other caregivers resulted in positive effects on
confidence, self-efficacy, stress, burden and depression
continued
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TABLE 13 Evidence supporting CMO 5: family engagement (continued )
Study (type)
Condition
EvidenceDementia Diabetes Other
Boots et al., 201661
(mixed methods)
l A SM programme for carers of people living with dementia. Participants
preferred blended care (face to face and online modules) as they valued
personal contact with a professional; this strategy may increase adherence to,
and effectiveness of, the intervention. Small but positive effects on caregiver
self-efficacy and goal attainment were noted
Bunn et al., 201639
(mixed methods)
✗ ✗ l Recommends coproduction of care whereby professionals, people living with
dementia, and family carers work in partnership
Bunn et al., 2017142
(qualitative) (related to
Bunn et al., 201639)
✗ ✗ l Family members were often proactive in facilitating continuity and negotiating
access to services for their relatives with dementia. This included acting as an
advocate for their family member with dementia, noticing when something
was wrong and seeking help
l Family carers felt undervalued or excluded from decision-making about their
relative’s care
l The availability of a family carer to act as a proxy, and provide consent,
information and postdischarge support impacted on a person living with
dementia’s access to care. HCPs recognised that people living with dementia
who lived alone, or did not have support from a family carer or advocate,
were particularly vulnerable and may have poorer access to care
Graff et al., 200665 (RCT) ✗ l It is important to recognise the significance of family. Personalised and active
education should include family members. Skills were taught to both partners
in the dyad
Graff et al., 200795 (links to
Graff et al., 200665) (RCT)
✗ l Evaluation of community occupational therapy
l Potential mechanisms identified include enhanced sense of competence
(for family carer) and greater sense of independence (for people living
with dementia)
Feil et al., 201142 (qualitative) ✗ ✗ l As people living with dementia lose the ability to make health-care decisions,
caregivers enter into the patient–provider encounter to take part in shared
decision-making, help set diabetes treatment goals and establish a diabetes
care plan that supports the person’s quality of life
l Study suggests that active provider–caregiver communication is essential to
improving quality of care for the patient
l In this study, caregivers expressed a lack of access to providers and a lack of
recognition of their caregiver role. This undermined their sense of self-efficacy
in managing patients’ diabetes care
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Study (type)
Condition
EvidenceDementia Diabetes Other
Lingler et al., 2016107 (RCT) ✗ l A tailored problem-solving intervention to maximise medication management
practices among caregivers of people with memory loss; there was no
significant difference between intervention and control, although both groups
showed a significant reduction in the number of medication management
problems. But the difference may be because caregivers in usual care group
had face-to-face baseline assessment that may have had an impact on
medicine management
l The authors suggest that medication management deficiencies on the part of
caregivers are modifiable and can decrease over time
Markle-Reid et al., 2016108
(feasibility study)
✗ ✗ (older people) l Providers and participants requested increased family caregiver involvement
Mountain and Craig,
2012115 (qualitative)
✗ l Authors suggest that it is important to appropriately involve carers in the
development of SM skills alongside the person they care for
Feil et al., 200942
(cross-sectional)
✗ ✗ l Caregivers may take on SM only when patient has already failed to adhere;
this may make the transition more difficult. Caregivers taking on management
of diabetes may not be informed or prepared and may lack sufficient
education or skills. It is difficult to acquire the right skills because of the
complexity of managing both conditions
Jowsey et al., 201469
(qualitative)
✗ l Suggest that interventions need to increase knowledge and skill building in
family members to contribute to care
Schaller et al., 2016124
(before-and-after study)
✗ l Evaluated a tailored e-health service for informal carers of people living with
dementia. It appeared to improve communication between caregivers and
professionals and 83% of carers thought that the concept was good, but it
had no impact on quality of life
Tan et al., 2015130 (review) l If HCPs provide knowledge and support that anticipates future issues, then
patients and family carers feel greater confidence and self-efficacy, leading to
sustained SM behaviours
l Interventions using concepts of self-efficacy, self-determination and proactive
coping were effective in influencing diabetes self-care behaviours with
improved health outcomes
SR, systematic review.
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TABLE 14 Evidence supporting CMO 6: usability of AT
Study (type)
Condition
EvidenceDementia Diabetes Other
Tailored and adapted
Aikens et al., 201563
(before-and-after study)
✗ l Involving a care partner may make a person with diabetes more likely to
participate in automated telephone SM system (and improve medication
adherence) – but this needs to take into account preference for privacy and
autonomy vs. social connectedness
Boots et al., 201661
(qualitative)
✗ l SM programme for carers of people living with dementia: participants
preferred blended care (face to face and online modules), as they valued
personal contact with a professional
Camp et al., 201559
(controlled study)
✗ ✗ l Tailored education programme delivered via Skype improved self-efficacy for
people with T2DM and CI – participants were orientated to the use of the
technology involved (iPad and Skype) – but connection with the educator
delivering the intervention was seen as important. However, there was no
long-term impact on cholesterol, HDL or triglycerides
Fleming and Sum, 201490 (SR) ✗ l A SR of AT for the care of people living with dementia found that evidence for
the effective use of AT to improve the safety and security of people living
with dementia is very weak. There is some support for the use of AT to
facilitate communication and access to support and information for caregivers
of people living with dementia but not much evidence of any impact on
independence. The best results appear to come when the technology
augments face-to-face contact
Gibson et al., 201591 (SR) ✗ l A qualitative study exploring the use of AT supports the idea that AT is most
easily introduced and assimilated into daily life if it is introduced early in the
dementia trajectory. People buy/adapt readily available AT because social care
services are not providing what they need
Gillespie et al., 201293 (SR) ✗ l A SR of the use of AT for people with CI (all ages and aetiologies) found that
there is moderate support for the effectiveness of AT for cognition devices in
supporting organisation and planning functions (63% of studies included
report reminding and prompting interventions)
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Study (type)
Condition
EvidenceDementia Diabetes Other
Greenhalgh et al., 201397
(qualitative)
✗ l A qualitative study on the assisted living needs of older people found that
installed AT met few participants’ needs; some devices had been abandoned
and a few had been deliberately disabled. Successful technology arrangements
were often characterised by ‘bricolage’ (pragmatic customisation, combining
new with legacy devices) by the participant or by someone who knew and
cared about them
Hsu et al., 201699 (RCT) ✗ l A RCT of a cloud-based diabetes management programme aimed at
improving SM found a positive effect on glycaemic control and patient
satisfaction. The coach was also important for this group: connectivity with the
coach helped people to feel less anxious and more motivated. However,
people living with dementia would need support with the technology
Jekel et al., 2015101 (SR) ✗ (CI) l IADL deficits (such as problems with medication intake, telephone use,
keeping appointments, finding things at home and using everyday technology)
were documented in patients with MCI
Knapp et al., 2015105
(review, economic evaluation)
✗ l The review suggests that successful interventions need to recognise the high
value that many people living with dementia and their carers place on
face-to-face service contacts; technologies that seek to reduce these contacts
are unlikely to be accepted or used (or, if they are, could exacerbate problems
associated with social isolation and loneliness)
l Found some evidence of increased independence, but more studies reported
carer outcomes than outcomes for people living with dementia. The authors
recommend that for the successful adoption of AT, assessments should be
user, rather than technology, based, integrated within usual assessment
processes, include carers and introduce people to technology-based
possibilities before they reach current eligibility thresholds for local authority
support. Carers were most likely to use technology not specific to caring or to
dementia (e.g. tablets, baby monitors, smart phones and light sensors)
l Passive technology is often the most appreciated because people living with
dementia/carer do not have to remember to programme or interact with it
continued
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TABLE 14 Evidence supporting CMO 6: usability of AT (continued )
Study (type)
Condition
EvidenceDementia Diabetes Other
Mayberry et al., 201168
(mixed methods)
✗ l People with limited health, numeracy or computer literacy were no less likely
to access a patient web portal or other forms of health IT, but often relied on
assistance from family members
Mayberry et al., 2016112
(qualitative)
✗ l Feasibility study of diabetes self-care support ‘mHealth’ intervention for
low-income adults. Participants reported that the intervention increased
self-care and improved support for, and communication about, diabetes. But
family ties are complex and although some behaviours may be unhelpful,
criticism of them is not always welcome
l Authors suggest that their iterative design process ‘reduced technical bugs
and problems with content, functionality, and study processes’
Procter et al., 2014120
(qualitative)
✗ l A qualitative study exploring the experiences of older people using AT found
that support from ‘knowledgeable’ family/friends was important. Rather than
more ‘advanced’ technologies, the success of ageing-in-place programmes will
depend on effortful alignments in the technical, organisational and social
configuration of support
Span et al., 2013127 (SR) ✗ l A SR looking at the involvement of people living with dementia in developing
supportive IT applications showed that people living with dementia wanted to,
and could, contribute to IT design. Involvement in the development enabled
people living with dementia to participate as equal partners
Wherton et al., 2012133
(qualitative)
✗ l An ethnographic study looking at methods to support the involvement of
older people in the coproduction of assisted living technologies. Participants
suggested that they would need ongoing support once the technology had
been provided. They also felt that family members would need to be involved
throughout (e.g. decision to use telehealth, installation and training), and that
the design should allow some flexibility to share health measurement data
with other people within their family network
ADL, activities of daily living; CI, cognitive impairment; HADS, Hospital Anxiety and Depression Scale; HDL, high-density lipoprotein; IADL, instrumental activities of daily living; LTC, long-term
condition; MCI, mild cognitive impairment; SR, systematic review; T2DM, type 2 diabetes mellitus.
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Appendix 6 Evidence supporting context–
mechanism–outcomes from the stakeholder
interviews
TABLE 15 Evidence from stakeholder interviews supporting CMO 1: embedding positive attitudes towards people
living with dementia
CMO name Context Mechanism and outcome
Interview
endorsements
1: embedding positive
attitudes towards people
living with dementia
If health and social care delivery
systems propagate and reinforce
positive attitudes towards people
living with dementia and
diabetes and their families
through tailored SM support . . .
. . . then this fosters a belief in
staff that people living with
dementia and diabetes have the
potential to be involved in SM
and the right to access diabetes-
related services (even when the
trajectory is one of deterioration)
(M), prompting treatment
confidence in people living with
dementia and diabetes (M),
which leads to engagement in
SM practices by people living
with dementia and diabetes,
their family carers and HCPs (O)
Dem (n = 46)
Diab (n= 28)
Res (n= 3)
Total (N= 77)
. . . people with dementia . . . will go to all sorts of different wards, so I guess it’s just that we need to continue with
that work to help people [staff] to understand, you know, how we can support people with dementia . . .
Dem 1
. . . we still have this thing where if you’ve got dementia, and everything you display is because of your dementia
Dem 2
. . . not just the education of the staff that go in, but that’s engaging with the heads of councils I guess really, who have
the money, who are responsible for the funding of home carers
Dem 2
. . . part of the CQC guidelines are that, in terms of dementia, the guidelines are part of the training . . . but we [nurses]
get . . . a 45-minute slot . . . health-care assistants, because it’s part of this new certificate . . . they get 5 hours, so that’s
a bit better. So how do you incorporate all the NICE guidelines into that?
Dem 2
So people with dementia aren’t even allowed to make cups of tea. I think we’ve got better at that, you know, care
homes now don’t have locks on kitchens, and you know, there’s tea and coffee available for people, but we are still I
think quite risk averse
Dem 2a
. . . she missed four memory clinic appointments and they phoned me and said they were discharging her for
non-compliance . . .
Dem 4
I’ve not come across many in the diabetic team who can really get their heads around what’s happening with the
person and that, you know, the person isn’t deliberately non-compliant . . .
Dem 6
. . . the Getting To Know Me project here in [XXXX] we trained over 600, or 700, frontline practitioners about dementia,
just a general aspects of dementia, what it is, how to communicate, what to look for, what people might be saying
when they maybe can’t tell you through words . . .
Dem 7
continued
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TABLE 15 Evidence from stakeholder interviews supporting CMO 1: embedding positive attitudes towards people
living with dementia (continued )
CMO name Context Mechanism and outcome
Interview
endorsements
. . . all of our diabetes specialist nurses have subspeciality . . . I’m hoping that the two DSNs that are now the dementia
champions will become exactly that . . .
Diab 1
I think the main points are getting policy changed around targets and making it OK for people that are frail elderly with
dementia to have a higher HbA1c target . . .
Diab 9
. . . one of my profound frustrations is that you can have people talking about multiple long-term conditions and they’re
excluding mental health diagnoses, and yet we know that you know, 30% to 40% of people with diabetes will have
anxiety and depression you know, and often early unrecognised memory issues . . .
Diab 12a
CQC, Care Quality Commission; dem, interviewees with expertise in dementia care; diab, interviewees with expertise in
diabetes; DSN, diabetes specialist nurse; NICE, National Institute for Health and Care Excellence; res, researchers.
Also relevant to:
a Person-centred approaches to care planning.
TABLE 16 Evidence from stakeholder interviews supporting CMO 2: person-centred approaches to care planning
CMO name Context Mechanism and outcome
Interview
endorsements
2: person-centred
approaches to
care planning
If delivery systems promote a
person-centred and partnership
approach to care, allowing HCPs
to understand the individual
needs and abilities of people
living with dementia and
diabetes and their families . . .
. . . then (1) HCPs feel confident
that they are acting in the best
interests of people living with
dementia and diabetes and
their families (M) and (2) this
generates trust between HCPs
and people living with dementia
and diabetes and their families
(M), leading to a better fit
between care planning and
patient and carer needs and
(potentially) a lessening of the
burden of medicalisation
experienced by people living
with dementia and diabetes and
their families (O)
Dem (n = 44)
Diab (n= 80)
Res (n= 11)
Total (N= 135)
. . . what’s in their best interests and does it really matter if we don’t have perfectly tight diabetic control if they’re
enjoying what they’re eating
Dem 6
I would want people with dementia to be able to eat anything that they want, no diabetes diet, normal food
Diab 6
Where the client is fully able to contribute [to a care plan], that usually goes very well because we can then discuss the
likes and dislikes, their routines, how they manage their diabetes themselves . . .
Dem 4
. . . I’m not an expert on dementia, but for me it seems logical . . . that you try and keep it as normal as possible for
them, it’s what they’re familiar with isn’t it, you know, so even if it was a case of for example their wife bringing in the
blood glucose meter that they use at home . . .
Diab 1
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TABLE 16 Evidence from stakeholder interviews supporting CMO 2: person-centred approaches to
care planning (continued )
CMO name Context Mechanism and outcome
Interview
endorsements
I inject twice a day and I try to eat to match the insulin . . . It was the only thing I was offered so, you know, at that
point and I thought well I can manage that . . .
Diab 3a
. . . in some places where perhaps they’re doing very good personalised care for that patient, they’ll bring the carers in
and they’ll be part of that personalised care process, because they’ll recognise the importance of that carer with
somebody with dementia
Diab 4b
. . . they’re now working much more towards outcomes . . . so that gives you flexibility to do different things with
different people . . .
Diab 4
. . . since I’ve been in the care of the diabetic clinic everything else has gone out the window. When I was in the care of
the specialist nurse at the GP’s, I would have a regular sort of every 6-month check on my feet, you know, yeah,
sensitivity in my feet, my kidney and the amount of protein in my urine, all those tests have now ceased, I’m now only
looked at from a point of view of sugar levels
Diab 8a,c
. . . how could I help this person? What’s their network of support and is that going to be enough? Who would I need
to get involved? So you’re really breaking it down like that
Diab 9
I think different targets for certain groups of people you know, and quality of life targets rather than all about number
crunching . . .
Diab 13
. . . educate the GPs that the targets might not need to be so strict for these people [with dementia and diabetes]
Diab 13
I think health professionals are possibly becoming themselves much more risk averse and not wanting to suggest things
that aren’t perceived as being healthy or might not be the right answer
Res 1
. . . you go and get your monthly prescription . . . and you have to do it for numerous medications that are often out of
sync and then pharmacy doesn’t have things in stock, and it’s just, you know, a huge burden of work involved, which is
invisible to care providers
Res 3
Dem, interviewees with expertise in dementia care; diab, interviewees with expertise in diabetes; res, researchers.
Also relevant to:
a Developing skills for tailored and flexible care.
b Family engagement.
c Regular contact.
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TABLE 17 Evidence from stakeholder interviews supporting CMO 3: developing skills to provide tailored and
flexible care
CMO name Context Mechanism and outcome
Interview
endorsements
3: developing skills to
provide tailored and
flexible care
If HCPs are expected to develop
skills that enhance the delivery
of individualised and tailored
care to people with dementia
and diabetes (e.g. enablement
rather than management,
listening/communication/
negotiation, shared
decision-making) . . .
. . . then this legitimises the
work, creating the expectation in
patients and HCPs that diabetic
care for people living with
dementia is important (M),
leading to the provision of more
tailored diabetes care (O) and
better engagement in SM by
people living with dementia and
diabetes and family carers (O)
Dem (n = 46)
Diab (n= 44)
Res (n= 6)
Total (N= 96)
. . . we’ve had very little training about the management of diabetes, so, and I’m imagining that a lot of my, you know,
my ideas about diabetes management are quite old-fashioned and if I’m trying to educate other people then that’s not
a great position . . .
Dem 1
I don’t think we’re supporting people with diabetes [and dementia] as well as we could, because of this training issue
and where responsibility lies . . .
Dem 4
. . . we don’t tend to think of dementia as a kind of life-limiting condition which we need to perhaps change that and
to think a little bit more . . .
Dem 1
You tailor around maximising the possibility the person will be able to access that treatment . . .
Dem 5a
. . . if somebody’s not doing something at all and you can get them doing something a little bit, it’s really noticeable
what a difference that makes to their cognition . . .
Dem 5
. . . you can conceptualise it as tailoring, but I suppose in the way that I see it in my mind is there’s probably a checklist
of about 10 or 15 things that we think about, and you sort of run through them and you think what’s most relevant to
that person
Dem 5
. . . in the memory clinic we try to do shared decision-making and thinking about what people wanted . . . we’d talk to
them about various options for management of their dementia . . . I’m not sure I even said to people . . . let’s think
about how we manage your other health problems, like I’m just thinking now, that’s probably something that we didn’t
address . . .
Dem 6
. . . it’s about having . . . different levels of intervention or help or support or enablement that are actually needed, given
the scenarios in which people find themselves . . .
Dem 7
. . . there’s national guidance, isn’t there, in terms of what the target HbA1c is per se, but as I say when we’re actually
seeing individuals we certainly do tailor that to their needs, to their comorbidities, to the situation at the time and for
their safety ultimately
Diab 1
NICE has released five guidelines . . . the one on type 2 diabetes . . . does suggest goals for glucose, but it does say very
clearly that these may need to be modified in people on an individual basis in people who are older who have got
significant comorbidities
Diab 6
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TABLE 17 Evidence from stakeholder interviews supporting CMO 3: developing skills to provide tailored and
flexible care (continued )
CMO name Context Mechanism and outcome
Interview
endorsements
. . . I don’t know if they have QOF indicators for dementia, but there are QOF indicators for diabetes, and often they can
see that as a tick box . . . health-care professionals will just look at what’s happening with the diabetes now, instead of
thinking . . . what could happen in 3 or 4 years?
Diab 4
. . . people shouldn’t be running high . . . let’s say 15 or 12 . . . but much more important is avoiding hypoglycaemia
which affects them in all sorts of ways, it makes their dementia worse, it makes them more likely to fall . . .
Diab 5
. . . the diabetes needs expert attention but it needs expert attention to simplify the regime . . .
Diab 6b
Dem, interviewees with expertise in dementia care; diab, interviewees with expertise in diabetes; NICE, National Institute for
Health and Care Excellence; res, researchers.
Also relevant to:
a Person-centred approaches to care planning.
b Embedding positive attitudes towards people with dementia.
TABLE 18 Evidence from stakeholder interviews supporting CMO 4: regular contact
CMO name Context Mechanism and outcome
Interview
endorsements
4: regular contact If HCPs maintain regular contact
over time (e.g. face to face, by
telephone or by e-mail) with the
person living with dementia and
diabetes and their family,
monitoring and anticipating
needs throughout the dementia
trajectory . . .
. . . then HCPs feel more
equipped to meet patients’
needs (M), and people living
with dementia and diabetes and
their family believe themselves to
be supported (M) through the
transition from functional
independence to functional
dependence (M), leading to
improved diabetes
management (O)
Dem (n = 6)
Diab (n = 6)
Res (n = 1)
Total (N= 13)
. . . it’s a kind of a whole-system approach really, so you know, it’s having the district nurses on board . . .
Dem 2
. . . once a year for a formal annual review as it were and whenever I’ve needed it, if there’s been any problems I’ve
always been able to be seen and there’s a very good nurse who’s the diabetes person . . .
Diab 3a,b
. . . if you have one health-care person who you know is almost like your keyworker, your key contact, you build up a
relationship, which is very important . . .
Diab 4
. . . our local GPs are pretty well bogged down and you can’t get an appointment with them just to see a doctor in less
than a month . . .
Diab 8
. . . the ideal thing would be to have a mobile team of nurses who would visit people in their homes very frequently to
keep an eye on things and maybe to educate the carers if there are carers . . .
Diab 8a,b,c
Dem, interviewees with expertise in dementia care; diab, interviewees with expertise in diabetes; res, researchers.
Also relevant to:
a Person-centred approaches to care planning.
b Developing skills for tailored and flexible care.
c Family engagement.
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TABLE 19 Evidence from stakeholder interviews supporting CMO 5: family engagement
CMO name Context Mechanism and outcome
Interview
endorsements
5: family engagement If family carers are routinely
involved in care planning and
information sharing, and are
given the support they need to
take on the tasks associated with
managing diabetes in people
living with dementia (e.g.
medicines management,
recognition of
hypoglycaemia) . . .
. . . then family carers will feel
supported and that their
contribution is recognised and
appreciated (M), leading to the
development of effective SM
strategies on the part of the
family carer (O)
Dem (n = 23)
Diab (n= 33)
Res (n= 4)
Total (N= 60)
I wouldn’t say most of the patients I look after are managing their diabetes really themselves, it’s managed by those
around them . . .
Dem 1
. . . more communication between families and people like diabetic nurses . . . a diabetic nurse . . . is going to want to
manage diabetes . . . the relative’s going to have to manage the dementia . . .
Dem 2
It’s very difficult to learn new things, I understand as in this case, [he’s] also got Parkinson’s and Lewy body, so she’s at
a breaking point . . .
Dem 4
. . . you’ve got someone with diabetes who used to perfectly manage their diabetes well themselves, suddenly can’t and
now the wife has taken it over, she’s chosen to continue to support him . . . it must be really hard for her . . . she’s gone
from being a partner to a carer . . .
Diab 1
Big responsibility [taking on the management of diabetes], yeah, and I think, yeah, we shouldn’t take that for granted,
yeah, it could be a bit daunting for a relative
Diab 7
. . . you need to think about the whole care network and that’s where you start thinking about how much can we ask
carers to undertake, who have never been in a caring role . . .
Diab 10
. . . carers are almost always very conscious of the need to help that person to be as independent as possible . . .
Dem 5
. . . I’ve had this conversation with carers saying, ‘Yes, he has always throughout his life made a decision to drink, but
now the decision’s different because now when he drinks, he punches walls, wanders off, makes himself very unsafe,’
and so actually the nature of the decision has changed
Dem 5a
. . . it’s common for families to disagree. Particularly around whether somebody should be allowed to live at home in a
risky situation rather than go to a care home
Dem 5
. . . it’s really hard then [for families] working with that person because they don’t think they’ve got dementia or any
memory problems, they may even still be off driving, you’ve got all those issues to deal with as well . . .
Dem 6b,c
. . . for the family, how lovely would it be for them to just speak to one person who knew about diabetes and the
dementia . . .
Diab 1c,d
. . . dementia is a terminal illness . . . and that relatives very often don’t know that . . .
Diab 6
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TABLE 19 Evidence from stakeholder interviews supporting CMO 5: family engagement (continued )
CMO name Context Mechanism and outcome
Interview
endorsements
. . . as a carer, you are faced with an uphill struggle to actually understand the coherence of the care offered to your
loved one with dementia and diabetes
Diab 10
. . . it’s relationships and it’s negotiating that and making sure that it’s in place and for health professionals to recognise
when that’s really fragile and what can be done to just sort of sure things up a bit
Res 1a,c
Dem, interviewee with expertise in dementia care; diab, interviewee with expertise in diabetes; res, researchers.
Also relevant to:
a Developing skills for tailored and flexible care.
b Embedding positive attitudes towards people with dementia.
c Person-centred approaches to care planning.
d Regular contact.
TABLE 20 Evidence from stakeholder interviews supporting CMO 6: usability of AT
CMO name Context Mechanism and outcome
Interview
endorsements
6: usability of AT As the dementia trajectory
progresses, AT needs to be
tailored and adapted to the
needs and requirements of the
person living with dementia
and diabetes and their family
(includes social, environmental
and cultural needs), with the
focus on maintaining autonomy
for the person living with
dementia and diabetes . . .
. . . leading to the person living
with dementia and diabetes
and their family gaining an
understanding (awareness) of
the usefulness of AT in their
management of dementia and
diabetes (M), leading to a more
effective and sustained use of AT
to maintain autonomy and
diabetes SM strategies (O)
Dem (n = 6)
Diab (n = 15)
Res (n = 13)
Total (N= 34)
. . . I was familiar with the sort of dosette box . . . which is a great idea and does really help people, you know, to
manage their medications . . .
Dem 1
. . . there’s electronic dosette boxes that can be linked to telecare, so if the person doesn’t take the medication, telecare
will come through the intercom . . . and then if they don’t take them it clicks on and locks anyway so they
can’t overdose
Dem 2
. . . you can get clocks that actually tell you. . .exactly which 7 o’clock of the day it is, so it will tell you it’s 7 o’clock in
the evening rather than the morning. . .
Dem 2
. . . some of the insulin pens are really fiddly as well, like they’ve got really tiny numbers and you have to dial it up and
all that kind of thing, I don’t know how well they’re adapted for people with visual problems or cognitive problems
Dem 6
Timesulin device . . . they can use that lid instead of the normal lid and then when the person takes the lid off, it times
when their next inject, when they last took the lid off . . .
Diab 9
Luckily meters do keep a record of what the blood sugar levels were so you don’t have to write them down
Diab 8
continued
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TABLE 20 Evidence from stakeholder interviews supporting CMO 6: usability of AT (continued )
CMO name Context Mechanism and outcome
Interview
endorsements
. . . as health-care professionals, we need to be taught . . . what are the best resources out there that we can use as,
if you like, a menu of options that we’ve got with these patients, that we can say well you could try using this alert
system, you know, or you can try using this app . . .
Diab 9a,b
With socialising there’s technologies that can make things simpler like telephones that can have direct dials with
pictures that they could access medical attention if they needed it or their carer
Res 2
Well, there’s lots of technologies that prompt reminders for anything and you can actually set them up
Res 2
. . . the pendant alarms . . . now are kind of more standard and that people know that when they press the button that
someone’s speaking at the end . . . there’s something about whether they keep the pendant on . . .
Res 2
I think technologies are great but you need to think is it the right thing for the patient, what they want, is there enough
support around it to implement it and respond to it and just to make sure that it’s all OK?
Res 2
. . . what we found is quite a lot of the carers liked these things because . . . it meant they [carers] would have a sleep,
the alarm wouldn’t go off unless they [person with dementia] got out of bed
Res 2
App, application; dem, interviewee with expertise in dementia care; diab, interviewee with expertise in diabetes;
res, researchers.
a Person-centred approaches to care planning.
b Developing skills for tailored and flexible care.
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Appendix 7 Table of included studies on
self-management for people living with dementia
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Study ID Aim/focus Details of intervention and context Mechanisms Outcomes
Camp et al., 201559 Determine whether or
not a distance-based
education intervention
would result in positive
health outcomes for
persons with both
diabetes and CI (n= 40)
l Delivered by iPad (involved two
iPad orientation sessions)
l Ten diabetes education sessions
with a certified diabetes educator
l Goal-setting
l MCI or early-stage dementia
l T2DM (taking oral medication)
l Face-to-face nature of contact via
Skype beneficial in establishing
good rapport
Develop a connection
with CDE: trust
(long-term connections
important)
Participants feel that
contacts are positive
HbA1c: initially declined
after treatment but
returned to baseline levels
after 6 months
Self-efficacy: significant
increase, which was
maintained across
follow-ups (increased in
both groups)
Davis et al., 201262 Test the effect of
targeted intervention on
self-care, heart failure
knowledge and 30-day
readmissions in people
with MCI
l Intervention tailored to personal
routine and environment
l Focused on environmental
manipulations (e.g. simplifying
tasks, providing external cues
or prompts)
l Training in compensatory
strategies to compensate for
memory loss
l Suggest that education needs to
be provided over a period of time
(not done in this study)
Teaching in hospital
environment could not
be translated into self-
care management when
the person returned
home. Self-care
behaviours may improve,
not as a function of
increased knowledge,
but more as a function
of confidence
Improved knowledge but
had no impact on
readmission rates or
self-care
Laakkonen et al.,
2016106
Investigate the effects of
SM group rehabilitation
for people living with
dementia and their
spouses on their
health-related quality of
life (136 couples
recruited: intervention
group, n = 67; usual
care group, n = 69)
l Group-based intervention (4 hours
once per week for 8 weeks)
l Involved people living with
dementia–carer dyad – but in
separate groups
l Psychological rehabilitation model
l SM capabilities such as problem-
solving skills, self-efficacy and
mastery built gradually during
the intervention
l Delivered by trained professionals
(specialists in gerontology)
l Inclusion criteria: people who had
recently received a diagnosis, but
26 in intervention group had
moderate to severe dementia
l Shared expertise, equality, and
collaboration between participants
and facilitators was supported in
the groups
Suggest that elements
of the programme that
encouraged participants’
sense of control,
empowerment and
self-efficacy may have
improved health-related
quality of life
Development of trust
between participants
Better health-related
quality of life in carers at
3 months but not at
9 months
Cognition of people living
with dementia in SM
group improved
No increase in health and
social service costs
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Study ID Aim/focus Details of intervention and context Mechanisms Outcomes
Martin et al., 2013109 To explore barriers to
SM among people living
with dementia
l SM interventions for people living
with dementia may need to focus
more on promoting meaningful
positive experiences and outlook,
with an emotion focus rather than
a problem focus
l Memory problems make planning
and SM more difficult for people
living with dementia
l HCPs lack skills to support SM in
people living with dementia
l Health services have deficit model,
which creates dependence
Barriers lead to
people living with
dementia feeling
disempowered
If people living with
dementia are
disempowered, then they
are more likely to be
disengaged from SM
Martin et al., 2015110 Qualitative evaluation of
a SM intervention for
people in the early
stage of dementia
(n= 6 participants)
l Intervention delivered by lay SM
tutor and clinical psychologist
l Involves people in early stages
of dementia
l Programme addresses
(1) relationship with family,
(2) maintenance of an active
lifestyle, (3) psychological
well-being, (4) techniques to cope
with memory changes and
(5) information about dementia
l Group environment provides
peer support
l Social interaction is important
Positivity and
empowerment (‘still
me’)
Group environment and
ability to share
experience of living with
dementia led to
participants ‘feeling
safe’
Feeling of belonging
Potentially enables people
to reject a passive role
Mountain, 200637 Considers concept of
SM for people living
with dementia
l Negative beliefs about ability of
people living with dementia a
barrier – seen as passive objects
l Course of illness and impact on
people living with dementia and
others have to be taken into
account
l Factors likely to be important
include early diagnosis, focus on
needs of people living with
dementia, providing appropriate
education and support, and a
whole-systems approach
Maintaining a sense of
self
Stimulate strengths and
personal abilities
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Study ID Aim/focus Details of intervention and context Mechanisms Outcomes
Mountain and
Craig, 2012115
Identify priority topics
for a potential SM
programme and to
explore the relevance of
the identified topics with
a consultation group of
people living with
dementia and
their carers
l Experiences described through the
consultation highlighted the need
for skilled facilitation for
SM group
l Important component: full and
timely information about the
condition and what to expect
l Dementia as part of a process
of change
l Need to consider health,
well-being and activity
l Enabling environments
l Need meaningful activity
l Keeping connected important
l Need to involve family carers –
but balance needs with those of
people living with dementia
Information aimed at
carers may increase
feelings of
powerlessness or
helplessness in people
living with dementia
Maintaining a sense
of self
Not explored in this paper
Quinn et al., 2016121 A pilot RCT of a SM
group intervention for
people with early-stage
dementia (the SMART
study) (n= 24)
l Group environment provided
peer support
l Carer had to participate
l Mean MMSE score of 23.5
Findings from qualitative
interviews suggest that
increased self-efficacy
may be related to
increased confidence
and the widening of
social support
opportunities
Small effect on
self-efficacy in
intervention group
Quinn et al., 2016136 To identify group-based
psychosocial interventions
for people living with
dementia or MCI that
incorporate significant
elements of SM. Included
15 studies (12 with
people living with
dementia and three with
people with MCI)
l Group-based interventions with
duration of < 6 months
l Having accurate information is
important as it enables people to
develop effective coping strategies
l Cognitive stimulation could be
incorporated as a way to maintain
functioning and promote feelings
of self-efficacy
l Interventions need to explore
feelings of stigma about
memory problems
l Sharing skills and knowledge
within a group
Reduce feeling of
helplessness
Assist people to feel
confidence in their
abilities to perform
certain behaviours
successfully
Development of
reciprocal relationships
(people living with
dementia as provider as
well as receiver of
information and support)
Many of the included
studies did not report any
measurable outcomes or
reported patient feedback
only
The findings from these
studies suggest that
interventions for people
with MCI could improve
memory functioning,
memory strategy use,
knowledge and
acceptance. Interventions
for people with dementia
could improve quality of
life and depression
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Study ID Aim/focus Details of intervention and context Mechanisms Outcomes
Toms et al., 2015132 Explored the views of
people living with
dementia and family
caregivers on the use of
SM in dementia
l Early-stage dementia (MMSE score
of ≥ 20)
l Disparity between people living
with dementia and care partners
in terms of views on
independence/supervision
l Care partners and HCPs make
assumptions about what a person
living with dementia can and
cannot do
l People living with dementia
expressed insight into the
importance of good working
relationships for good SM
l SM occurs in the context of
people’s family and social
relationships and emerging
relationships with
professional services
l Emotional response to diagnosis
of dementia (coping with impact
on roles and relationships)
Mental activity (C),
keeps the neural
pathways active (M),
which maintains
cognitive abilities for as
long as possible
CDE, certified diabetes educator; CI, cognitive impairment; MCI, mild cognitive impairment; MMSE, Mini Mental State Examination; T2DM, type 2 diabetes mellitus.
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